<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34675729</article-id>
      <article-id pub-id-type="pmc">8520448</article-id>
      <article-id pub-id-type="publisher-id">332474</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S332474</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acupuncture: A Promising Approach for Comorbid Depression and Insomnia in Perimenopause</article-title>
        <alt-title alt-title-type="running-authors">Zhao et al</alt-title>
        <alt-title alt-title-type="running-title">Zhao et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9009-8870</contrib-id>
          <name>
            <surname>Zhao</surname>
            <given-names>Fei-Yi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2369-1508</contrib-id>
          <name>
            <surname>Fu</surname>
            <given-names>Qiang-Qiang</given-names>
          </name>
          <xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8832-4824</contrib-id>
          <name>
            <surname>Spencer</surname>
            <given-names>Sarah J</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4419-050X</contrib-id>
          <name>
            <surname>Kennedy</surname>
            <given-names>Gerard A</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref>
          <xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9356-6844</contrib-id>
          <name>
            <surname>Conduit</surname>
            <given-names>Russell</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3716-6800</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Wen-Jing</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6777-1166</contrib-id>
          <name>
            <surname>Zheng</surname>
            <given-names>Zhen</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="an0002" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>School of Health and Biomedical Sciences, RMIT University</institution>, <addr-line>Bundoora</addr-line>, <addr-line>Victoria</addr-line>, <addr-line>3083</addr-line>, <country>Australia</country></aff>
        <aff id="aff0002"><label>2</label><institution>Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine</institution>, <addr-line>Shanghai</addr-line>, <addr-line>200071</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Department of Nursing, School of International Medical Technology, Shanghai Sanda University</institution>, <addr-line>Shanghai</addr-line>, <addr-line>201209</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0004"><label>4</label><institution>Yangpu Hospital, School of Medicine, Tongji University</institution>, <addr-line>Shanghai</addr-line>, <addr-line>200090</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0005"><label>5</label><institution>ARC Centre of Excellence for Nanoscale Biophotonics, RMIT University</institution>, <addr-line>Bundoora</addr-line>, <addr-line>Victoria</addr-line>, <addr-line>3083</addr-line>, <country>Australia</country></aff>
        <aff id="aff0006"><label>6</label><institution>School of Science, Psychology and Sport, Federation University</institution>, <addr-line>Mount Helen</addr-line>, <addr-line>Victoria</addr-line>, <country>Australia</country></aff>
        <aff id="aff0007"><label>7</label><institution>Institute for Breathing and Sleep, Austin Health</institution>, <addr-line>Heidelberg</addr-line>, <addr-line>Victoria</addr-line>, <addr-line>3084</addr-line>, <country>Australia</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Wen-Jing Zhang <institution>Department of Psychiatry, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine</institution>, <addr-line>Shanghai</addr-line>, <addr-line>200071</addr-line>, <country>People’s Republic of China</country>
<phone>Tel +86 021-6605 0366</phone> Email 1072@szy.sh.cn.com</corresp>
        <corresp id="an0002">Zhen Zheng <institution>School of Health and Biomedical Sciences, College of Science, Engineering and Health, RMIT University</institution>, <addr-line>P.O. Box 71</addr-line>, <addr-line>Bundoora</addr-line>, <addr-line>Victoria</addr-line>, <addr-line>3083</addr-line>, <country>Australia</country>
<phone>Tel +61 9925 7167</phone>
<fax>Fax +61 3 9925 7178</fax> Email zhen.zheng@rmit.edu.au</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>10</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>1823</fpage>
      <lpage>1863</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>8</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>9</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Zhao et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Zhao et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p><citation_analysis attribute="positive">Comorbid depression and insomnia are ubiquitous mental complaints among women going through the perimenopausal stage of life and can result in major decline in quality of life. Antidepressive agents combined with/without hypnotics, and/or hormone therapy are currently the most common treatment for perimenopausal depression (PMD) and insomnia (PMI). Balancing the benefits of these pharmacotherapies against the risk of adverse events (AEs) is a difficult task for both clinicians and women. There has been a growing body of research regarding the utilization of acupuncture for treatment of PMD or PMI, whereas no studies of acupuncture for comorbid PMD and PMI have appeared. In this review, we summarize the clinical and preclinical evidence of acupuncture as a treatment for PMD or PMI, and then discuss the potential mechanisms involved and the role of acupuncture in helping women during this transition. Most clinical trials indicate that acupuncture ameliorates not only PMD/PMI but also climacteric symptoms with minimal AEs. It also regulates serum hormone levels. The reliability of trials is however limited due to methodological flaws in most studies. Rodent studies suggest that acupuncture prolongs total sleep time and reduces depression-like behavior in PMI and PMD models, respectively. These effects are possibly mediated through multiple mechanisms of action, including modulating sex hormones, neurotransmitters, hypothalamic-pituitary-adrenal axis/hypothalamic-pituitary-ovary axis, oxidative stress, signaling pathways, and other cellular events. In conclusion, acupuncture is a promising therapeutic strategy for comorbid depression and insomnia during perimenopause. Neuroendocrine modulation is likely to play a major role in mediating those effects. High-quality trials are required to further validate acupuncture’s effectiveness.</citation_analysis></p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>acupuncture</kwd>
        <kwd>perimenopause</kwd>
        <kwd>insomnia</kwd>
        <kwd>depression</kwd>
        <kwd>comorbid</kwd>
        <kwd>mechanisms</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>RMIT Research Stipend Scholarship, RMIT University, Australia, and University’s scientific research project, Shanghai Sanda University</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>Three-year Action Plan for Public Health 2020–2022 (Key discipline construction-TCM psychology/TCM psychiatry), Shanghai Municipal Health Commission</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>Project Management and Technical Specifications of Insomnia Treatment Service Key Promotion, Shanghai Municipal Health Commission</institution></institution-wrap>
</funding-source>
        </award-group>
        <funding-statement>This work was sponsored by RMIT Research Stipend Scholarship, RMIT University, Australia, and University’s scientific research project, Shanghai Sanda University [2021zz02-yj] to FYZ; and Three-year Action Plan for Public Health 2020–2022 (Key discipline construction-TCM psychology/TCM psychiatry), Shanghai Municipal Health Commission [GWV-10.1-XK20], Project Management and Technical Specifications of Insomnia Treatment Service Key Promotion, Shanghai Municipal Health Commission [ZY(2018–2020)-ZWB-1001-FWB-07)] to WJZ.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="8"/>
        <ref-count count="193"/>
        <page-count count="41"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s0001">
      <title>Background</title>
      <p><citation_analysis attribute="neither">Perimenopause is a universal phenomenon that marks a mid-life transition from fertility to infertility in women’s lives.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> It is a stage during which women are particularly vulnerable to the onset of depression,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2–4</xref></citation_analysis><citation_analysis attribute="neither"> even without any previous history of depressive disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> A large quantity of studies also link both insomnia and vasomotor symptoms (hot flushes and night sweating) to perimenopausal depression (PMD),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> while insomnia is correlated more strongly and consistently with depression than vasomotor symptoms are.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7–9</xref></citation_analysis><citation_analysis attribute="neither"> The prevalence of comorbid depression and insomnia in perimenopause is approximately 31.5%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis></p>
      <sec id="s0001-s2001">
        <title>The Comorbidity of Perimenopausal Insomnia and Depression is More Than a “Domino” Effect</title>
        <p><citation_analysis attribute="neither">The interaction between depression and insomnia, and its contribution to psychosomatic impairments, is clear.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="positive"> In comparison to women without sleep disturbances, women with sleep disturbance are 10 times more likely to experience depression; and women with depression are more vulnerable to insomnia, particularly waking during the night and having difficulty falling asleep again.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> In various insomnia patterns, depression is highly associated with difficulty falling asleep and waking up earlier than desired.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="negative"> Women in the menopausal transition are at increased risk for sleep-disordered breathing, which can also contribute to both depressed mood and poor sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="positive"> In light of the actigraphy data, perimenopausal insomniacs with comorbid depression show longer sleep onset latency, shorter sleep duration, and lower sleep efficiency (but not number of awakenings or wakefulness after sleep onset), in comparison to women with insomnia only.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> Depression and insomnia are not only a mental burden for perimenopausal women but they also increase the difficulty of treating menopause-related somatic issues such as cardiovascular disease and osteoporosis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither"> Anticipation of symptom self-healing might be futile as untreated PMD can increase medical morbidity after menopause, including risks of endocrine and cardiovascular disease.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">It is challenging to find an established theoretical basis for interpreting intertwined phenomenon of insomnia and depression as women transit menopause, although the two are commonly co-encountered.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="negative"> Two kinds of “domino” theory are sometimes asserted to partially explain this bidirectionality, or even link this bidirectionality to vasomotor symptoms: 1) PMD due to climacteric vasomotor symptoms or other psychosocial risk factors decreases sleep quality and quantity and 2) frequent night hot flushes may be tied to disrupted sleep patterns, and in turn, trigger the development of depressive symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> The complicated interrelationships between these three symptoms (depression, insomnia, and vasomotor complaints), however, may far exceed the “domino” explanation, because not all women with hot flushes develop depression, insomnia, or both; and many perimenopausal women suffer from depression and/or insomnia in the absence of hot flushes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis></p>
      </sec>
      <sec id="s0001-s2002">
        <title>Current Management Strategies for Comorbid Depression and Insomnia During Perimenopause</title>
        <p><citation_analysis attribute="neither">It is imperative for women in mid-life to find effective strategies to manage comorbid depression and insomnia, and maximize their well-being. Because of the co-occurrence or overlap, interdependent and interactional relationship,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> management of insomnia is also recommended as part of treatment for PMD, in “Guidelines for the Evaluation and Treatment of Perimenopausal Depression” issued by the Board of Trustees for The North American Menopause Society (NAMS) and Mood Disorders Task Force of the National Network of Depression Centers (NNDC).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> According to NAMS and NNDC, antidepressants and cognitive behavioral therapy (CBT) are the front-line antidepressant treatments for PMD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> However, antidepressant medications have some relatively minor adverse events (AEs) that include but are not limited to dryness of mouth, digestive upsets, drowsiness, and fatigue, and some more major AEs such as rapid weight gain and sexual dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16–18</xref></citation_analysis><citation_analysis attribute="positive"> Similarly, sedatives and hypnotics have side effects that patients may find uncomfortable</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="negative"> and are not recommended for longer term treatment of insomnia. CBT is highly recommended for the treatment of both depression and insomnia, but an impediment to its wider utilization is a lack of suitably trained psychologists.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> Hormone replacement therapy (HRT) can be an effective treatment for perimenopausal syndrome, while it is not FDA-approved to treat perimenopausal mood disturbance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Complementary and alternative medicine (CAM) has many proponents and supporters</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> and has been sought to treat depression</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> and insomnia</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> associated with perimenopause. As previously reported, during peri- to post-menopause up to 50% of the women worldwide seek assistance from CAM approaches, including herbal medicine, yoga, massage therapy, dietotherapy, as well as acupuncture for symptomatic relief.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> Acupuncture has a long tradition of usage for the treatment of various menopause-related symptoms, including PMI and PMD, dating back thousands of years.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> Its clinical efficacy has been investigated for natural menopause and chemical-/surgery-induced menopause.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> It has also been reported that menopausal women sustaining insomnia as a major complaint tend to select CAM approaches, particularly body therapies, as their first choice of remedy.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> A menopausal epidemiological study carried out in the US indicated that in women who primarily used alternative therapies including acupuncture to manage menopause-related depression, 1.0% were completely symptom free, 84.6% made symptoms get a little to a lot better, 12.5% showed no change in symptoms, and 1.9% reported the worsening of symptoms, which was slightly less effective than the conditions in women who primarily used anti-depressive or anti-anxiety agents for menopause-related depression (5.6% were completely symptom free, 88.6% made symptoms get a little to a lot better, 3.9% showed no change in symptoms, and 1.9% reported the worsening of symptoms).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> However, due to the limited evidence and uncertainty about its effectiveness and mechanism of action in physiological terms, acupuncture is still striving for general scientific recognition and support.</citation_analysis></p>
        <p><citation_analysis attribute="positive">This review aims to summarize and assess existing clinical and preclinical evidence of acupuncture as a treatment for perimenopausal insomnia and depression, as well as discuss the potential mechanisms involved. We aim to provide an evidence-base for decision-making for clinical practitioners to recommend (or for perimenopausal to women select) acupuncture as a potential therapy.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0002">
      <title>Effects and Safety of Acupuncture on Depression and Insomnia</title>
      <p><citation_analysis attribute="neither">Acupuncture is one of the simplest, popular, and safest CAM procedures.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> It is derived from Traditional Chinese Medicine (TCM) and has a history of use in medicine of at least 4000 years under the influence of oriental philosophical theories.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> It is a clinical treatment modality in which targeted proposed specific locations of the body, the acupuncture points (also called acupoints) have thin, solid, metallic needles inserted deeply for therapeutic purposes. The therapeutic efficacy is more effectively manifested when the pierced needles are manipulated manually with slight rotation (back-and-forth motion) and/or pistoned (up-and-down motion) or other complex combinations (manual acupuncture, MA), or are stimulated by the electric current via an impulse generator (electro-acupuncture, EA).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27–30</xref></citation_analysis><citation_analysis attribute="neither"> As illustrated in neuroimaging reports, acupuncture can cause a wide array of central nervous system (CNS) responses involving the hippocampus, amygdala, cerebellum, hypothalamus, and other limbic structures.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> Dysfunction or disorder in these cerebral regions has been previously implicated in the development of depression</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> and/or insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither"> Both clinical and basic studies indicate these two forms of acupuncture (MA and EA) are different with regard to outcomes and underlying physiological mechanisms, it is however difficult to conclude which one is more efficacious.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> Furthermore, patterns of usage of MA or EA usually vary by condition treated, stimulus demand, and/or acupuncturist preference.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Patients are attracted to acupuncture in part by its reputation for being low-risk. Several prospective surveys with large sample sizes have suggested that acupuncture-related AEs mainly involve minor local reactions at the site of needling, such as bruising, pain, or minor bleeding, and the incidence of these events is generally very low (no more than 3%).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> No serious AEs requiring hospital visits or resulting in permanent disability or death have been reported from acupuncture.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> Twelve prospective studies involving several Asian and European countries validated that the incidence of the acupuncture-related serious AEs (ie, life threatening, hospital admission required or prolongation of existing hospital stay, persistent or significant disability or incapacity, death, etc) was estimated to be 0.55 per 10,000 patients, and 0.05 per 10,000 treatment sessions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="positive"> Given its non-pharmacological basis, acupuncture also obviates the concerns with respect to toxicity and AEs that commonly occur when using hypnotics/sedatives, such as hangover, tolerance, increased alertness, and even endocrinological, hematological or cardiovascular events,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="positive"> and concerns regarding common side effects of contemporary antidepressive agents, such as dry mouth, cardiovascular/gastrointestinal side effects, seizure, bleeding, sexual dysfunction, weight gain, and even suicidality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> Acupuncture also does not increase the metabolic burden of the liver and kidney. It is thus a potentially safe, promising and attractive remedy in the management of comorbid depression and insomnia associated with perimenopause. But, the question remains as to whether it is really effective?</citation_analysis></p>
      <p><citation_analysis attribute="neither">As of March 2019, there were at least 31 systematic reviews and/or meta-analyses (SRs/MAs) regarding acupuncture treatment for depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> As of September 2018, there were at least 34 SRs/MAs regarding acupuncture treatment for insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> Although the included primary randomized controlled trials (RCTs) are less than well-powered and have some methodological flaws, the available evidence is in favor of acupuncture’s effectiveness and safety, and supports it as a monotherapy or adjuvant therapy for patients with depression or insomnia, particularly those who are intolerant to Western medications.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> In China, acupuncture has even been added as a routine remedy in the latest Guidelines for the Diagnosis and Treatment of Insomnia formulated by the Chinese Sleep Research Society (CSRS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> The clinical guidelines issued by the Canadian Network for Mood and Anxiety Treatments (CANMAT) Depression Work Group recommended acupuncture as a third-line treatment with “Level 2 Evidence” for the adjunctive treatment of mild-to-moderate depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis></p>
    </sec>
    <sec id="s0003">
      <title>How is Acupuncture for Perimenopausal Depression and Insomnia Conceptualised in TCM</title>
      <p><citation_analysis attribute="positive">TCM looks upon human life as a holistic, dynamic, spiritual, and functional unity, and the development of disease mainly as the result of a disordered state of the human functional balance (imbalance in the forces between Yin and Yang).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, the basic protocol of preventing and/or treating disease in TCM is to restore the imbalance state and achieve Yin-Yang harmony via various remedies (eg, herbal medicine, acupuncture, moxibustion, Tui-na, etc) depending upon the individual and the malady.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In clinical setting, acupuncture is ubiquitously applied based on the basic theory of TCM, which emphasizes the concept of “syndrome pattern”.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> “Treatment based on Syndrome Differentiation” is the essential principle of TCM. That is, patients are classified into different TCM syndrome patterns according to their clinical symptoms and signs, and then corresponding treatments, including acupuncture, are prescribed.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither"> According to the concept and theory of TCM gynecology, all perimenopausal diseases and disorders including PMI/PMD can be classified into the main category of “Juejing-Qianhou-Zhuzheng” (绝经前后诸症, meaning “symptoms and signs associated with perimenopause”, which is similar to “perimenopausal syndrome” in Western medicine) for treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> In light of different symptoms, patients with PMI/PMD are generally further divided into different syndrome patterns within the scope of perimenopausal syndrome, and then receive corresponding TCM therapies. This strategy is the embodiment and process of “Treatment based on Syndrome Differentiation”. PMI/PMD is usually classified into different syndrome patterns in different published studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> Based on bibliometric analysis,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> we listed the top six syndromes of each of these two disorders and the proportion of patients in each pattern, respectively (see </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">; organs in the syndrome pattern correspond to the TCM understanding). It is interesting to identify that in three out of nine patterns, PMI and PMD overlap. The pattern with the highest proportion of patients in both conditions is consistent, that is, the pattern of “depression of Liver and deficiency of kidney”. Given that TCM prescriptions (eg, acupuncture, herbal medicine, etc) are highly dependent on patterns, establishing standardized pattern classifications of PMI/PMD is essential for research and improved clinical practice.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001" orientation="landscape"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Common TCM Syndrome Patterns of PMI and PMD</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Syndrome Patterns</th><th rowspan="2" align="center" colspan="1">Major Symptoms</th><th rowspan="2" align="center" colspan="1">Tongue</th><th rowspan="2" align="center" colspan="1">Pulse</th><th colspan="2" align="center" rowspan="1">Ratio</th></tr><tr><th rowspan="1" colspan="1">PMI</th><th rowspan="1" colspan="1">PMD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Depression of liver and deficiency of kidney</td><td rowspan="1" colspan="1">Insomnia or dreamful sleep, depressed mood, fatigue, chest distress and preference for sighing, hot flushes and sweating, frequent urination or dribbling urination</td><td rowspan="1" colspan="1">Red tongue with little coating</td><td rowspan="1" colspan="1">Stringy and thready, or stringy and rapid</td><td rowspan="1" colspan="1">60.78%</td><td rowspan="1" colspan="1">30.42%</td></tr><tr><td rowspan="1" colspan="1">Liver depression and spleen deficiency</td><td rowspan="1" colspan="1">Depression or irritability, poor sleep, poor appetite, abdominal distension, loose stool</td><td rowspan="1" colspan="1">White coated tongue</td><td rowspan="1" colspan="1">Stringy and slow</td><td rowspan="1" colspan="1">24.02%</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">Stagnation of Qi due to depression of liver</td><td rowspan="1" colspan="1">Depression or irritability, preference for sighing, hypochondrium distress and/or pain, distending pain of breasts</td><td rowspan="1" colspan="1">Thin whitish coating of the tongue</td><td rowspan="1" colspan="1">Stringy</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">18.80%</td></tr><tr><td rowspan="1" colspan="1">Imbalance between heart-Yang and kidney-Yin</td><td rowspan="1" colspan="1">Irritability and insomnia, palpitation, dizziness and tinnitus, loss of memory, dry mouth, soreness and weakness of waist and knees</td><td rowspan="1" colspan="1">Red tongue with little coating</td><td rowspan="1" colspan="1">Thready and rapid</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">13.46%</td></tr><tr><td rowspan="1" colspan="1">Spleen–kidney Yang deficiency</td><td rowspan="1" colspan="1">Insomnia due to nocturia, soreness and weakness of waist and knees, chilly sensation and the cold limbs, diarrhea before dawn or loose stools, edema in the extremities</td><td rowspan="1" colspan="1">Pale and slight corpulent tongue with whitish and slippery fur</td><td rowspan="1" colspan="1">Deep and retarded without strength</td><td rowspan="1" colspan="1">4.31%</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">Deficiency of both kidney Yin and kidney Yang</td><td rowspan="1" colspan="1">Poor sleep, sometimes hot flushes and sweating and sometimes chilly sensation and the cold limbs, soreness and weakness of waist and knees, dizziness and tinnitus</td><td rowspan="1" colspan="1">Pale tongue with thin coating</td><td rowspan="1" colspan="1">Stringy and thready</td><td rowspan="1" colspan="1">4.31%</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">Heart-Gallbladder Qi deficiency</td><td rowspan="1" colspan="1">Palpitation, timidity, feeling fearful, difficulty in falling asleep, tendency to sleep lightly, nightmares, depressed mood, short of breath, spontaneous perspiration</td><td rowspan="1" colspan="1">Pale tongue with whitish coating</td><td rowspan="1" colspan="1">Stringy and thready</td><td rowspan="1" colspan="1">3.70%</td><td rowspan="1" colspan="1">6.72%</td></tr><tr><td rowspan="1" colspan="1">Heart–spleen deficiency</td><td rowspan="1" colspan="1">Insomnia, dreamful sleep, worry beyond measure, palpitation, poor appetite, loose stool, fatigue, sallow complexion, loss of memory</td><td rowspan="1" colspan="1">Pale tongue with whitish coating</td><td rowspan="1" colspan="1">Thin and weak</td><td rowspan="1" colspan="1">2.87%</td><td rowspan="1" colspan="1">6.11%</td></tr><tr><td rowspan="1" colspan="1">Hyperactivity of fire due to Yin deficiency</td><td rowspan="1" colspan="1">Vexation, irritable and depressed mood, dry mouth, tidal reddening of the cheeks, dysphoria in chest palms-soles</td><td rowspan="1" colspan="1">Red tongue with little coating</td><td rowspan="1" colspan="1">Stringy and rapid</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">4.65%</td></tr></tbody></table><table-wrap-foot><fn><p><citation_analysis attribute="neither">Table 1 is not a direct quote from any paper, but is compiled by us from data in two published papers (Ref 47 &amp; 48 of this manuscript); Similarly, Table 3 is compiled by us from data in two published papers (Ref 19 &amp; 50 of this manuscript); The rest of the tables and figures are original and do not require reference. 47 and 48.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      <p><citation_analysis attribute="negative">Despite a lack of standardized pattern classification, perimenopausal symptoms including PMI/PMD are closely related to liver and kidney in TCM clinical practice.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> Hence, herbal medicines (or acupoints) associated with regulating liver (or Liver Meridian of Foot-Jueyin) and kidney (or Kidney Meridian of Foot-Shaoyin) are often selected for treating depression and insomnia associated with perimenopause.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> Smoothing liver (smooths liver and regulates Qi) and nourishing kidney (nourishes kidney and enriches essence) are regarded as the general principles for perimenopausal disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis></p>
    </sec>
    <sec id="s0004">
      <title>Evidence from Clinical Trials</title>
      <p><citation_analysis attribute="positive">Does the existing clinical evidence support acupuncture as a safe and effective therapy for comorbid PMI and PMD, and is the evidence reliable? To answer this question, a comprehensive literature search with no restrictions for research types was carried out. Unfortunately, no RCTs, cohort studies or case studies within this theme were retrieved, reflecting a significant research and practice gap. Our team thereby is currently carrying out an RCT focusing on this theme. This trial has been registered in the Chinese Clinical Trial Registry (No. ChiCTR2100043054), and the results are expected to be published in 2022. However, we retrieved many RCTs and some SRs/MAs focusing on acupuncture treatment for PMD alone or PMI alone. Those SRs/MAs involved several modified modalities of acupuncture for which mechanisms of action differ from those for MA/EA and were not discussed in this review; therefore, only eligible original RCTs in those SRs/MAs were extracted.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Our team has published two SRs/MAs</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="positive"> within related fields (15 RCTs in SR/MA of PMI; 25 RCTs in SR/MA of PMD) where we covered our retrieval strategy in detail (retrieval in 2020), as well as our quality evaluation and interpretation of the evidence. Based on updated retrieval (July 2021), we have included more RCTs recently published (22 RCTs of PMI; 25 RCTs of PMD). The critical information and major findings of each RCT were extracted and summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">. The results of meta-analyses cited from our SRs/MAs are displayed in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">, and detailed analysis process can be referred to in our published articles.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="positive"> Given that this review is not an SR, a narrative summary on the findings followed by comments on the methodology and implications for future research of these studies is provided. We expect that these summaries will help clinicians and policymakers judge the role of acupuncture, and its potential and feasibility for the management of depression and insomnia associated with perimenopause.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002" orientation="landscape"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Summary of Clinical Trials Investigating the Effects and Safety of Acupuncture on PMI and PMD</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Author/Year</th><th rowspan="1" colspan="1">Study Groups/No. of Participants</th><th rowspan="1" colspan="1">Disease (Diagnostic System)</th><th rowspan="1" colspan="1">TCM Syndrome Pattern</th><th rowspan="1" colspan="1">Acupuncture Interventions</th><th rowspan="1" colspan="1">Acupoints</th><th rowspan="1" colspan="1">Controls</th><th rowspan="1" colspan="1">Outcome Measures</th><th rowspan="1" colspan="1">Results (Compared with the Control Group) at Post-Treatment</th><th rowspan="1" colspan="1">Follow-Up</th><th rowspan="1" colspan="1">Adverse Events</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Fu et al 2017<xref rid="cit0051" ref-type="bibr">51</xref></td><td rowspan="1" colspan="1">- MA/n=37<break/>- placebo-MA/n=37</td><td rowspan="1" colspan="1">PMI (ICSD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">20 min/day for 10 sessions</td><td rowspan="1" colspan="1">BL18, BL23, GB25, LR14</td><td rowspan="1" colspan="1">Streitberger placebo-needle control</td><td rowspan="1" colspan="1">PSQI, ISI, PSG (SOL, TST, WASO, SE, Arl, N1%, N2%, N3%, REM%)</td><td rowspan="1" colspan="1">(i) Lower PSQI and ISI in MA group<break/>(ii) Shorter SOL and WASO, longer TST, higher SE, lower Arl, lower N1%, and higher REM% in MA group; no differences in N2% and N3% between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- placebo-MA/n=4 (worsening of insomnia)</td></tr><tr><td rowspan="1" colspan="1">Wang 2015<xref rid="cit0052" ref-type="bibr">52</xref></td><td rowspan="1" colspan="1">- EA/n=30<break/>- placebo-EA/n=30</td><td rowspan="1" colspan="1">PMI (ICSD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 3 days/week for 8 weeks</td><td rowspan="1" colspan="1">BL15, BL18, BL23, CV3, CV4, CV6, CV12, EX-HN3, GV3, GV4, GV14, GV20, HT7, KI3, LR3, PC6, SP6, ST36</td><td rowspan="1" colspan="1">Streitberger placebo-needle control</td><td rowspan="1" colspan="1">PSQI, MRS, Men-QoL</td><td rowspan="1" colspan="1">No differences in PSQI, MRS and MEN-QoL between two groups</td><td rowspan="1" colspan="1">(1) No difference in PSQI and Men-QoL between two groups at 4-week follow-up<break/>(2) Lower MRS in EA group at 4-week follow-up</td><td rowspan="1" colspan="1">No adverse events</td></tr><tr><td rowspan="1" colspan="1">Lin et al 2017<xref rid="cit0053" ref-type="bibr">53</xref></td><td rowspan="1" colspan="1">- MA/n=33<break/>- waitlist-control/n=32</td><td rowspan="1" colspan="1">PMI (CCMD-3, CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 3 days/week for 4 weeks</td><td rowspan="1" colspan="1">CV4, CV6, CV12, EX-HN3, GV20, GV24, HT7, PC6, SP6, ST36</td><td rowspan="1" colspan="1">Waitlist</td><td rowspan="1" colspan="1">PSQI, KI</td><td rowspan="1" colspan="1">Lower PSQI and KI in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Li et al 2020a<xref rid="cit0054" ref-type="bibr">54</xref></td><td rowspan="1" colspan="1">- EA/n=42<break/>- placebo-EA/n=42</td><td rowspan="1" colspan="1">PMI (ICSD-3)</td><td rowspan="1" colspan="1">Kidney Yin/Yang deficiency</td><td rowspan="1" colspan="1">− 30 min/day for 18 days (3 days/week for 4 weeks + 2 day/week for 2 weeks + 1 day/week for 2 weeks)<break/>- continuous wave, 2.5 Hz, 4–5 mA</td><td rowspan="1" colspan="1">BL23, CV4, CV6, EX, EX-HN3, GV4, GV20, GV24, HT7, KI3, KI7, SP6</td><td rowspan="1" colspan="1">Streitberger placebo-needle control</td><td rowspan="1" colspan="1">PSQI, MEN-QoL, Actigraphy (TST, WASO, SE, ATs, AA), ISI, SAS, SDS</td><td rowspan="1" colspan="1">(i) Lower PSQI, ISI, MEN-QoL, SAS in EA group; no differences in SDS between two groups<break/>(ii) Longer TST, higher SE, and less AA in EA group; no differences in ATs and WASO between two groups</td><td rowspan="1" colspan="1">Lower PSQI and Men-QoL in EA group at 4- and 12- week follow-ups</td><td rowspan="1" colspan="1">- EA/n=2 [mild bleeding (1); mild pain (1)]<break/>- placebo-EA/n=1 (mild pain)</td></tr><tr><td rowspan="1" colspan="1">Wang et al 2015<xref rid="cit0055" ref-type="bibr">55</xref></td><td rowspan="1" colspan="1">- MA/n=33<break/>- sham-MA/n=33</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 3 days/week for 8 weeks</td><td rowspan="1" colspan="1">KI6, LU7, PC6, SP4</td><td rowspan="1" colspan="1">Sham-MA [shallow puncture (2.5–5 mm), no De-qi, no retention of the needle]</td><td rowspan="1" colspan="1">SDS, Men-QoL</td><td rowspan="1" colspan="1">Lower SDS and Men-QoL in MA group</td><td rowspan="1" colspan="1">(i) Lower SDS in MA group at 4-week follow-up<break/>(ii) no difference in Men-QoL between two groups</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Li 2015a<xref rid="cit0056" ref-type="bibr">56</xref></td><td rowspan="1" colspan="1">- EA/n=30<break/>- sham-EA/n=30<break/>- Escitalopram/n=30</td><td rowspan="1" colspan="1">PMD (ICD-10)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 12 weeks<break/>- dense-sparse wave, 10/50 Hz, 0.5–1 mA</td><td rowspan="1" colspan="1">CV4, EX-CA1, EX-HN3, GV20, LI4, LR3, SP6, ST25</td><td rowspan="1" colspan="1">(i) Sham-MA [shallow puncture (3 mm), no De-qi, no current output]<break/>(ii) Escitalopram 10 mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, Men-QoL, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) Lower HAMD and Men-QoL in EA group, compared with sham-EA; no differences in HAMD and Men-QoL between EA and escitalopram groups<break/>(ii) No differences in FSH, LH and E2 levels between two groups (vs sham-EA or vs escitalopram)</td><td rowspan="1" colspan="1">(i) Lower HAMD in EA group in 4-week and 12-week follow-ups (vs sham-EA); no difference in HAMD between EA and escitalopram groups in 4-week and 12-week follow-ups<break/>(ii) Lower Men-QoL in EA in 4-week follow-up (vs sham-EA or vs escitalopram); Men-QoL from low to high (EA &lt; escitalopram &lt; sham-EA) at 8-week and 12-week follow-ups</td><td rowspan="1" colspan="1">- EA/n=2 (hematoma)<break/>- sham-EA/n=0<break/>- Escitalopram/n=25 [fatigue (17); headache (2); sleep disturbance (7); dizziness (7); palpitation (4); sweating (10); dry mouth (14); constipation (8)]</td></tr><tr><td rowspan="1" colspan="1">Ma 2017<xref rid="cit0097" ref-type="bibr">97</xref></td><td rowspan="1" colspan="1">- EA/n=37<break/>- Progynova + Medroxyprogesterone acetate/n=36</td><td rowspan="1" colspan="1">PMI (CCMD-2-R)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 12 weeks<break/>- sparse-dense wave, 2/15 Hz</td><td rowspan="1" colspan="1">CV4, EX-CA1, EX-HN3, HT7, SP6, ST25</td><td rowspan="1" colspan="1">A total of 3 treatment cycles. Each treatment cycle includes Progynova 1mg daily for 21 consecutive days (with Medroxyprogesterone acetate 10mg daily added from day 14 to day 21) and then stop medication for 7 days</td><td rowspan="1" colspan="1">PSQI, KI, Men-QoL, FSH, E2</td><td rowspan="1" colspan="1">(i) Lower PSQI in EA group; no differences in KI and Men-QoL between two groups<break/>(ii) No differences in FSH level between two groups; higher E2 level in EA group</td><td rowspan="1" colspan="1">(i) Lower PSQI in EA group at 12-week follow-up<break/>(ii) No differences in KI MENQOL, and FSH and E2 levels between two groups</td><td rowspan="1" colspan="1">- EA/n=3 [hematoma (2); mild dizziness (1)]<break/>- Progynova + Medroxyprogesterone acetate/n=4 [breast tenderness (2); mild headache (1); colporrhagia (1)]</td></tr><tr><td rowspan="1" colspan="1">Chen et al 2013<xref rid="cit0057" ref-type="bibr">57</xref></td><td rowspan="1" colspan="1">- EA/n=38<break/>- Alprazolam/n=32</td><td rowspan="1" colspan="1">PMI (DSM-IV)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day for 20 days (7 days off every 10 days)<break/>- continuous wave, 0.7 Hz</td><td rowspan="1" colspan="1">EX, GV20, HT7, KI3, KI7, KI10, LR3, PC6, SP6, SP9, SP10</td><td rowspan="1" colspan="1">Alprazolam 0.4 mg/day for 20 days</td><td rowspan="1" colspan="1">AIS</td><td rowspan="1" colspan="1">Lower AIS in EA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- EA/n=0<break/>- Estazolam/n=8 (development of drug dependence after treatment)</td></tr><tr><td rowspan="1" colspan="1">Luo 2020<xref rid="cit0058" ref-type="bibr">58</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Estazolam/n=30</td><td rowspan="1" colspan="1">PMI (CCMD-3, CDTE-TCM)</td><td rowspan="1" colspan="1">Incoordination between heart and kidney</td><td rowspan="1" colspan="1">30 min/day, 5 days/week for 12 weeks</td><td rowspan="1" colspan="1">BL15, BL23, BL62, EX, EX-HN1, GV20, KI3, KI6, PC6, SP6</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 3 days/week for 12 weeks</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">No differences in PSQI between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- Estazolam/n=5 [dizziness (2); nausea and vomiting (2); skin rashes (1)]</td></tr><tr><td rowspan="1" colspan="1">Du et al 2017<xref rid="cit0059" ref-type="bibr">59</xref></td><td rowspan="1" colspan="1">- EA/n=41<break/>- Estazolam/n=41</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 6 days/week for 4 weeks<break/>- continuous wave, &gt;50 Hz</td><td rowspan="1" colspan="1">PC6, SP6, Sishenzhen (1.5 Cun apart from GV20), Dingshenzhen (0.5 Cun up to EX-HN3, and 0.5 Cun up to GB14)</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, KI, WHOQOL-BREF, FSH, E2</td><td rowspan="1" colspan="1">(i) Lower PSQI and KI, and higher WHOQOL-BREF in EA group<break/>(ii) Higher E2 levels, and lower FSH levels in EA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- EA/n=6 (mild tension before EA)<break/>- Estazolam/n=26 [dizziness (26); daytime sleepiness (26)]</td></tr><tr><td rowspan="1" colspan="1">Kang 2015<xref rid="cit0060" ref-type="bibr">60</xref></td><td rowspan="1" colspan="1">- MA/n=31<break/>- Estazolam/n=33</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">Heart and Gallbladder Qi deficiency</td><td rowspan="1" colspan="1">40 min/day, 6 days/week for 4 weeks</td><td rowspan="1" colspan="1">EX, EX-HN1, GB13, GB15, GV16, GV20, GV24, scalp acupoint (1 Cun up to GB15)</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, KI</td><td rowspan="1" colspan="1">Lower PSQI and KI in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- Estazolam/n=1 (mild nausea)</td></tr><tr><td rowspan="1" colspan="1">Lai 2016<xref rid="cit0061" ref-type="bibr">61</xref></td><td rowspan="1" colspan="1">- MA/n=34<break/>- Eszopiclone/n=33</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">Incoordination between heart and kidney</td><td rowspan="1" colspan="1">30 min/day, 6 days/week for 3 weeks (acupuncture on specific time)</td><td rowspan="1" colspan="1">BL62, KI6, LU7, SI3</td><td rowspan="1" colspan="1">Eszopiclone 3 mg/day, 7 days/week for 3 weeks</td><td rowspan="1" colspan="1">PSQI, KI</td><td rowspan="1" colspan="1">(i) Lower KI in MA group; no differences in PSQI between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=2 (hematoma)<break/>- Eszopiclone/n=3 [dizziness (1); dry mouth (2)]</td></tr><tr><td rowspan="1" colspan="1">Li 2014<xref rid="cit0062" ref-type="bibr">62</xref></td><td rowspan="1" colspan="1">- MA/n=120<break/>- Estazolam/n=120</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day for 30 days</td><td rowspan="1" colspan="1">SP6, SP8, Shenguan (Tianhuangfuxue)</td><td rowspan="1" colspan="1">Estazolam 2 mg/day for 30 days</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">Lower PSQI in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Li et al 2018a<xref rid="cit0063" ref-type="bibr">63</xref></td><td rowspan="1" colspan="1">- MA/n=60<break/>- Alprazolam/n=62</td><td rowspan="1" colspan="1">PMI (CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30–40 min/day, 5 days/week for 9 weeks</td><td rowspan="1" colspan="1">BL13, BL15, BL17, BL18, BL20, BL23, HT7</td><td rowspan="1" colspan="1">Alprazolam 0.4–0.8 mg/day, 7 days/week for 9 weeks</td><td rowspan="1" colspan="1">PSQI, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) Lower PSQI in MA group<break/>(ii) Higher E2 levels, and lower FSH and LH levels in MA group</td><td rowspan="1" colspan="1">Follow-up 30 days; NR for valid data</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Lu et al 2014<xref rid="cit0049" ref-type="bibr">49</xref></td><td rowspan="1" colspan="1">- MA/n=52<break/>- Estazolam/n=52</td><td rowspan="1" colspan="1">PMI (CCMD-3, ICD-10)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day for 30 days</td><td rowspan="1" colspan="1">CV12, EX-HN1, GB20, GV20, HT7, LR3, LR14, SP6, SP15</td><td rowspan="1" colspan="1">Estazolam 1 mg/day for 30 days</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">Lower PSQI in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Ma 2014<xref rid="cit0064" ref-type="bibr">64</xref></td><td rowspan="1" colspan="1">- EA/n=45<break/>- Estazolam/n=45</td><td rowspan="1" colspan="1">PMI (CCMD-2)</td><td rowspan="1" colspan="1">Any TCM syndrome pattern according to CDTE-TCM</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 4 weeks<break/>- continuous wave, &gt;50 Hz</td><td rowspan="1" colspan="1">PC6, SP6, Sishenzhen (1.5 Cun apart from GV20), Dingshenzhen (0.5 Cun up to EX-HN3, and 0.5 Cun up to GB14)</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, HAMD</td><td rowspan="1" colspan="1">Lower PSQI and HAMD in EA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">No adverse events</td></tr><tr><td rowspan="1" colspan="1">Qin 2018<xref rid="cit0065" ref-type="bibr">65</xref></td><td rowspan="1" colspan="1">- MA/n=34<break/>- Estazolam/n=33</td><td rowspan="1" colspan="1">PMI (CCMD-3, ICD-10)</td><td rowspan="1" colspan="1">Deficiency of kidney and hyperactivity of liver</td><td rowspan="1" colspan="1">30 min/day, 5 days/week for 4 weeks</td><td rowspan="1" colspan="1">BL17, BL18, BL23, EX, EX-HN1, GV20, KI3, LR3</td><td rowspan="1" colspan="1">Estazolam 1–2 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, HAMA MSMSMS (REM%)</td><td rowspan="1" colspan="1">(i) Lower PSQI in MA group<break/>(ii) Higher REM% in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=3 (hematoma)<break/>- Estazolam/n=7 [dizziness (2); daytime sleepiness (2); fatigue (3)]</td></tr><tr><td rowspan="1" colspan="1">Yang et al 2017<xref rid="cit0066" ref-type="bibr">66</xref></td><td rowspan="1" colspan="1">- MA/n=81<break/>- Estazolam/n=81</td><td rowspan="1" colspan="1">PMI (CCMD-2)</td><td rowspan="1" colspan="1">Liver and kidney Yin deficiency</td><td rowspan="1" colspan="1">30 min/day, 15 days/month (one treatment every other day) for 3 months</td><td rowspan="1" colspan="1">CV12, HT7, KI3, PC6, ST36, ST40, four scalp acupoints (middle 1/3 of frontal apical band, posterior 1/3 of frontal apical band, anterior 1/3 of skull base band, middle 1/3 of skull base band)</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 10 days/month for 3 months</td><td rowspan="1" colspan="1">PSQI, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) Lower PSQI in MA group<break/>(ii) Higher FSH levels, and lower E2 and LH levels in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Zhang et al 2017<xref rid="cit0067" ref-type="bibr">67</xref></td><td rowspan="1" colspan="1">- MA/n=31<break/>- Estazolam/n=30</td><td rowspan="1" colspan="1">PMI (DTICA, CDTE-TCM)</td><td rowspan="1" colspan="1">Six syndrome patterns with liver as the core</td><td rowspan="1" colspan="1">30 min/day, 5 days/week for 4 weeks</td><td rowspan="1" colspan="1">BL17, BL18, EX, EX-HN1, GV20, LR3</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, KI, HAMA, HAMD</td><td rowspan="1" colspan="1">Lower PSQI, KI, HAMA and HAMD in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=1 (hematoma)<break/>- Estazolam/n=4 [dizziness (2); fatigue and daytime sleepiness (2); memory loss (2)]</td></tr><tr><td rowspan="1" colspan="1">Yan et al 2021<xref rid="cit0068" ref-type="bibr">68</xref></td><td rowspan="1" colspan="1">- MA/n=42<break/>- Estazolam/n=43</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 7 days/week for 12 weeks</td><td rowspan="1" colspan="1">CV4, CV6, GV20, GV24, HT7, SP6</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 7 days/week for 12 weeks</td><td rowspan="1" colspan="1">PSQI, Men-QoL</td><td rowspan="1" colspan="1">Lower PSQI and Men-QoL in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=4 [dizziness (3); hematoma (1)]<break/>- Estazolam/n=3 [dizziness (1); fatigue and daytime sleepiness (2)]</td></tr><tr><td rowspan="1" colspan="1">Li et al 2018b<xref rid="cit0069" ref-type="bibr">69</xref></td><td rowspan="1" colspan="1">- EA/n=116<break/>- Escitalopram/n=105</td><td rowspan="1" colspan="1">PMD (DSM-V, ICD-10)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 12 weeks<break/>- dilatational wave, 50 Hz, 0.5–1 mA</td><td rowspan="1" colspan="1">CV4, EX-CA1, EX-HN3, GV20, LI4, LR3, SP6, ST25</td><td rowspan="1" colspan="1">Escitalopram 10mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, Men-QoL, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) No differences in HAMD and Men-QoL between two groups<break/>(ii) No differences in FSH, E2 and LH levels between two groups</td><td rowspan="1" colspan="1">(i) Lower HAMD in EA group at 4-and 12-week follow-ups<break/>(ii) Lower Men-QoL in EA group in 4-, 8-and 12-week follow-ups</td><td rowspan="1" colspan="1">- EA/n=14 (hematoma)<break/>- Escitalopram/n=18 (dizziness, palpitation, stomachache)</td></tr><tr><td rowspan="1" colspan="1">Chi et al 2011<xref rid="cit0070" ref-type="bibr">70</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day for 4 weeks</td><td rowspan="1" colspan="1">EX-HN1, EX-HN3, GV20, KI3, LR3, LR14, SP6, ST36</td><td rowspan="1" colspan="1">Fluoxetine 20 mg/day for 4 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">Lower HAMD in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- Fluoxetine/n=3 [dizziness (1); nausea (2)]</td></tr><tr><td rowspan="1" colspan="1">Deng 2008<xref rid="cit0071" ref-type="bibr">71</xref></td><td rowspan="1" colspan="1">- MA/n=29<break/>- Deanxit/n=29</td><td rowspan="1" colspan="1">PMD (ICD-10)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">20–30 min/day, after 3 consecutive days of treatment, once treatment every 3 days for total 4 weeks</td><td rowspan="1" colspan="1">CV3, CV4, CV6, CV10, CV12, KI17, Qipang (0.5 Cun beside CV6), Xiafengshidian (1 Cun below and beside ST26)</td><td rowspan="1" colspan="1">Deanxit 20mg/day for 4 weeks</td><td rowspan="1" colspan="1">HAMD, KI, 5-HT</td><td rowspan="1" colspan="1">(i) No differences in HAMD and KI between two groups<break/>(ii) No differences in 5-HT levels between two groups</td><td rowspan="1" colspan="1">(i) Lower HAMD in MA at 2-week follow-up<break/>(ii) No difference in HAMD between two groups at 4-week follow-up<break/>(iii) No difference in KI between two groups at 2-and 4-week follow-ups</td><td rowspan="1" colspan="1">- MA/n=3 [changes of character of stool (2); palpitation (1)]<break/>- Deanxit/n=32 [changes of character of stool (6); dry mouth and halitosis (9); dysphoria (6); dreaminess (6); breast distending pain (5)]</td></tr><tr><td rowspan="1" colspan="1">Dong 2015<xref rid="cit0085" ref-type="bibr">85</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Nilestriol + Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CCMD-3, CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day for 30 days</td><td rowspan="1" colspan="1">BL13, BL15, BL17, BL18, BL20, BL21, BL23</td><td rowspan="1" colspan="1">Nilestriol 2mg/15days for 30 days + Fluoxetine 20mg/day for 30 days</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">Lower HAMD in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Li 2015b<xref rid="cit0072" ref-type="bibr">72</xref></td><td rowspan="1" colspan="1">- MA/n=32<break/>- Fluoxetine/n=32</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">Liver stagnation and kidney deficiency</td><td rowspan="1" colspan="1">30 min/day, 6 days/week for 12 weeks</td><td rowspan="1" colspan="1">BL15, BL18, BL23, EX-HN1, EX-HN3, GV20, GV24, PC6</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, KI</td><td rowspan="1" colspan="1">Lower HAMD and KI in MA group</td><td rowspan="1" colspan="1">Follow-up for 12 weeks; no data of HAMD and KI global scores for follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- Fluoxetine/n=8 [nausea and vomiting (2); dry mouth (1); indigestion (1); diarrhea (1); dizziness (1); headache (1)]</td></tr><tr><td rowspan="1" colspan="1">Ma et al 2009<xref rid="cit0073" ref-type="bibr">73</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CCMD-3, CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 5 days/week for 8 weeks</td><td rowspan="1" colspan="1">EX-HN1, EX-HN3, GV20, HT7, PC6, PC7, SP6, ST36</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 8 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=0<break/>- Fluoxetine/n=6 [nausea (2); dizziness (2)]</td></tr><tr><td rowspan="1" colspan="1">Niu et al 2017<xref rid="cit0074" ref-type="bibr">74</xref></td><td rowspan="1" colspan="1">- MA/n=41<break/>- Fluoxetine/n=41</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">Stagnation of liver Qi</td><td rowspan="1" colspan="1">30 min/day, 5 days/week for 6 weeks</td><td rowspan="1" colspan="1">BL13, BL15, BL17, BL18, BL20, BL23</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">Lower PSQI in MA</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=7 [dizziness (2); palpitation (1); dry mouth (1); nausea (3)]<break/>- Fluoxetine/n=6 [dizziness (1); palpitation (2); dry mouth (2); nausea (1)]</td></tr><tr><td rowspan="1" colspan="1">Qian et al 2007<xref rid="cit0075" ref-type="bibr">75</xref></td><td rowspan="1" colspan="1">- MA/n=33<break/>- Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">25 min/day, 5 days/week for 6 weeks</td><td rowspan="1" colspan="1">BL13, BL15, BL17, BL18, BL20, BL23</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=2 [dizziness (1); palpitation (1)]<break/>- Fluoxetine/n=9 [insomnia (1); akathisia (1); dry mouth (1); nausea (1); palpitation (1); skin symptom (1); excitation and agitation (2)]</td></tr><tr><td rowspan="1" colspan="1">Qiang 2008<xref rid="cit0076" ref-type="bibr">76</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">25 min/day, 5 days/week for 6 weeks</td><td rowspan="1" colspan="1">BL15, BL18, BL23, EX-HN1, GB20</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Shi et al 2018<xref rid="cit0077" ref-type="bibr">77</xref></td><td rowspan="1" colspan="1">- EA/n=30<break/>- Escitalopram/n=30</td><td rowspan="1" colspan="1">PMD (DSM-V)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 12 weeks<break/>- dense-sparse wave, 10/50Hz, 0.5–1.0mA</td><td rowspan="1" colspan="1">CV4, EX-CA1, EX-HN3, GV20, LI4, LR3, SP6, ST25</td><td rowspan="1" colspan="1">Escitalopram 10mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">Lower HAMD in EA group</td><td rowspan="1" colspan="1">Lower HAMD in EA at 4- and 12- week follow-ups</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Sun et al 2015<xref rid="cit0078" ref-type="bibr">78</xref></td><td rowspan="1" colspan="1">- EA/n=21<break/>- Escitalopram/n=21</td><td rowspan="1" colspan="1">PMD (DSM-V)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 3 days/week for 12 weeks<break/>- dense-sparse wave, 10/50Hz, 0.5–1.0mA</td><td rowspan="1" colspan="1">CV4, EX-CA1, EX-HN3, GV20, LI4, LR3, SP6, ST25</td><td rowspan="1" colspan="1">Escitalopram 10mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">Lower HAMD in EA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Wang et al 2010<xref rid="cit0079" ref-type="bibr">79</xref></td><td rowspan="1" colspan="1">- MA/n=21<break/>- Deanxit/n=21</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, after 3 consecutive days of treatment, once treatment every 3 days for total 4 weeks</td><td rowspan="1" colspan="1">CV3, CV4, CV6, CV10, CV12, KI17</td><td rowspan="1" colspan="1">Deanxit 10 mg/day for 4 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">Lower HAMD in MA at 2- and 4- week follow-ups</td><td rowspan="1" colspan="1">- MA/n=3 [changes of character of stool (2); palpitation (1)]<break/>- Deanxit/n=15 [dry mouth and halitosis (9); dysphoria, dreaminess, or breast distending pain (6)]</td></tr><tr><td rowspan="1" colspan="1">Zhang 2010<xref rid="cit0086" ref-type="bibr">86</xref></td><td rowspan="1" colspan="1">- EA/n=44<break/>- Nilestriol+ Fluoxetine/n=46</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 30 min/day, 5 days/week for 12 weeks<break/>- dilatational wave, 8–9 mA, 6V</td><td rowspan="1" colspan="1">BL13, BL15, BL17, BL20, BL23, GV20, KI3, LR3, PC6, SP6</td><td rowspan="1" colspan="1">Nilestriol 2mg/14 days for 30 days + Fluoxetine 20mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, KI, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) No differences in HAMD and KI between two groups<break/>(ii) No differences in FSH, LH and E2 levels between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- EA/n=5 (sweating, dizziness, vomiting)<break/>- Nilestriol+ Fluoxetine/n=23 [dry mouth and halitosis (5); nausea (6); dysphoria (2); constipation (6); dreaminess (2); breast distending pain (2)]</td></tr><tr><td rowspan="1" colspan="1">Zhang 2013<xref rid="cit0087" ref-type="bibr">87</xref></td><td rowspan="1" colspan="1">- MA/n=94<break/>- Premarin + Provera + Fluoxetine/n=94</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 7 days/week for 12 weeks</td><td rowspan="1" colspan="1">EX-HN1, GB13, GV20, GV24, HT7</td><td rowspan="1" colspan="1">Premarin 0.625mg/day and Provera 6mg/day + Fluoxetine 20mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) Lower HAMD in MA group<break/>(ii) No differences in FSH, LH and E2 levels between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- MA/n=2 (feeling pain when inserting needle)<break/>- Premarin + Provera + Fluoxetine/n=12 [dizziness (5); nausea and vomiting (4); hypersomnia (3)]</td></tr><tr><td rowspan="1" colspan="1">Zheng et al 2010<xref rid="cit0088" ref-type="bibr">88</xref></td><td rowspan="1" colspan="1">- MA/n=60<break/>- Premarin + Provera + Fluoxetine/n=60</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 7 days/week for 12 weeks<break/>[needle retaining time for 8 hour in three acupoints (BL8, GV19, GV21) per session]</td><td rowspan="1" colspan="1">BL8, BL18, BL23, GV19, GV21, KI3, LR3, SP6</td><td rowspan="1" colspan="1">Premarin 0.625mg/day for 20 days + and Provera 6mg/day + Fluoxetine 20mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, KI, FSH, E2, LH</td><td rowspan="1" colspan="1">(i) No differences in HAMD and KI between two groups<break/>(ii) No differences in FSH and LH levels between two groups; Lower E2 level in MA group</td><td rowspan="1" colspan="1">Lower HAMD and KI in MA at 24-week follow-up</td><td rowspan="1" colspan="1">- MA/n=2 (feeling pain when inserting needle)<break/>- Premarin + Provera + Fluoxetine/n=18 [loss of appetite (5); dizziness (4); diarrhea (3); breast distending pain (3); leukorrhagia (2); spasmus (1)]</td></tr><tr><td rowspan="1" colspan="1">Ding et al 2007<xref rid="cit0080" ref-type="bibr">80</xref></td><td rowspan="1" colspan="1">- MA/n=39<break/>- Fluoxetine/n=39</td><td rowspan="1" colspan="1">PMD (CCMD-2-R)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 6 days/week for 4 weeks</td><td rowspan="1" colspan="1">BL15, BL18, BL20, BL23, GV20, HT7, LR3, SP6</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 4 weeks</td><td rowspan="1" colspan="1">HAMD, KI</td><td rowspan="1" colspan="1">No differences in HAMD between two groups; Lower KI in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Li et al 2020b<xref rid="cit0081" ref-type="bibr">81</xref></td><td rowspan="1" colspan="1">- EA/n=30<break/>- Fluoxetine/n=30</td><td rowspan="1" colspan="1">PMD (CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 25 min/day, 3 days/week for 6 weeks<break/>- dilatational wave, 15 Hz, 1 mA</td><td rowspan="1" colspan="1">EX-HN1, EX-HN3, GV20, HT7, LI4, PC6, SP6, ST36</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD, HAMA</td><td rowspan="1" colspan="1">No differences in HAMD between two groups; Lower HAMA in EA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Zhang 2015<xref rid="cit0082" ref-type="bibr">82</xref></td><td rowspan="1" colspan="1">- MA/n=29<break/>- Deanxit/n=29</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, after 3 consecutive days of treatment, once treatment every 3 days for total 4 weeks</td><td rowspan="1" colspan="1">CV3, CV4, CV6, CV10, CV12, KI17</td><td rowspan="1" colspan="1">Deanxit 20 mg/day for 4 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">Lower HAMD in MA at 2- and 4- week follow-ups</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Xing 2011<xref rid="cit0083" ref-type="bibr">83</xref></td><td rowspan="1" colspan="1">- MA/n=120<break/>- Fluoxetine/n=120</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">Stagnation of liver Qi, heart and spleen deficiency; liver depression and phlegm-heat</td><td rowspan="1" colspan="1">20 min/day, 7 days/week for 6 weeks</td><td rowspan="1" colspan="1">GV26, PC5</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Zhou et al 2007<xref rid="cit0084" ref-type="bibr">84</xref></td><td rowspan="1" colspan="1">- MA/n=30<break/>- Fluoxetine/n=28</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">Liver and kidney Yin deficiency, spleen and kidney Yang deficiency, stagnated Qi transforming into fire, stagnation of phlegm and Qi</td><td rowspan="1" colspan="1">30 min/day, 6 days/week for 6 weeks</td><td rowspan="1" colspan="1">BL15, BL18, BL23, EX-HN1, GB13, GV24, SP6, ST36</td><td rowspan="1" colspan="1">Fluoxetine 20mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD, 5-HIAA, NE, DA</td><td rowspan="1" colspan="1">(i) Lower HAMD in MA group<break/>(ii) No differences in 5-HIAA and NE levels between two groups; Lower DA level in MA group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Gao et al 2014<xref rid="cit0089" ref-type="bibr">89</xref></td><td rowspan="1" colspan="1">- MA + Estazolam/n=32<break/>- Estazolam/n=32</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">20 min/day, 6 days/week for 4 weeks</td><td rowspan="1" colspan="1">EX-B2</td><td rowspan="1" colspan="1">Estazolam 2 mg/day for 4 weeks</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">Lower PSQI in MA + Estazolam group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Xu 2020<xref rid="cit0090" ref-type="bibr">90</xref></td><td rowspan="1" colspan="1">- MA + Alprazolam/n=50<break/>- Alprazolam/n=50</td><td rowspan="1" colspan="1">PMI (CDTE-TCM)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 7 days/week for 9 weeks</td><td rowspan="1" colspan="1">EX-HN1, GV24, HT7, KI3, LR3, PC6, SP6, ST36</td><td rowspan="1" colspan="1">Alprazolam 0.4–0.8 mg/day, 7 days/week for 9 weeks</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">Lower PSQI in MA + Alprazolam group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Ma 2016<xref rid="cit0091" ref-type="bibr">91</xref></td><td rowspan="1" colspan="1">- MA + Estazolam/n=35<break/>- Estazolam/n=35</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">7 days/week for 4 weeks</td><td rowspan="1" colspan="1">EX, HT7, KI3, KI7, KI10, LR3, SP6, SP10, ST36</td><td rowspan="1" colspan="1">Estazolam 2 mg/day, 7 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI, FSH, E2</td><td rowspan="1" colspan="1">(i) Lower PSQI in MA + Estazolam group<break/>(ii) Higher E2 levels, and lower FSH levels in MA + Estazolam group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Zhu et al 2016<xref rid="cit0092" ref-type="bibr">92</xref></td><td rowspan="1" colspan="1">- MA + Estazolam/n=37<break/>- Estazolam/n=37</td><td rowspan="1" colspan="1">PMI (CCMD-3)</td><td rowspan="1" colspan="1">Heart and Spleen deficiency</td><td rowspan="1" colspan="1">20 min/day, 5 days/week for 4 weeks</td><td rowspan="1" colspan="1">CV12, EX, EX-HN1, GV20, GV24, HT7, KI3, LR3, SP9, ST25</td><td rowspan="1" colspan="1">Estazolam 1 mg/day, 5 days/week for 4 weeks</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">No differences in PSQI between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Ma et al 2011<xref rid="cit0095" ref-type="bibr">95</xref></td><td rowspan="1" colspan="1">- EA + Paroxetine/n=55<break/>- Paroxetine/n=50</td><td rowspan="1" colspan="1">PMD (CCMD-3)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">− 45 min/day, 7 days/week for 6 weeks<break/>- dilatational wave, 8–9 mA</td><td rowspan="1" colspan="1">EX-HN3, GV20, LI4, PC6, ST36</td><td rowspan="1" colspan="1">Paroxetine 10mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">No differences in HAMD between two groups</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">- EA + Paroxetine/n=2 [dizziness (1); nausea (1)]<break/>- Paroxetine/n=3 [dizziness (1); elevated blood pressure (2)]</td></tr><tr><td rowspan="1" colspan="1">Liu et al 2019<xref rid="cit0093" ref-type="bibr">93</xref></td><td rowspan="1" colspan="1">- MA + Sertraline/n=40<break/>- Sertraline/n=40</td><td rowspan="1" colspan="1">PMD (CCMD-3, ICD-10)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 3 days/week for 12 weeks</td><td rowspan="1" colspan="1">BL23, CV4, HT7, KI3, LI4, LR3, SP6</td><td rowspan="1" colspan="1">Sertraline 50mg/day for 6 weeks</td><td rowspan="1" colspan="1">HAMD, FSH, E2, 5-HT, GABA</td><td rowspan="1" colspan="1">(i) Lower HAMD in MA + Sertraline group<break/>(ii) Lower FSH level in MA + Sertraline group; higher E2, 5-HT and GABA levels in MA + Sertraline group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="1" colspan="1">Ning 2015<xref rid="cit0094" ref-type="bibr">94</xref></td><td rowspan="1" colspan="1">- MA + Nilestriol + Fluoxetine/n=45<break/>- Nilestriol + Fluoxetine/n=45</td><td rowspan="1" colspan="1">PMD (Psychiatry textbook)</td><td rowspan="1" colspan="1">NR</td><td rowspan="1" colspan="1">30 min/day, 7 days/week for 12 weeks</td><td rowspan="1" colspan="1">BL13, BL15, BL18, BL20, BL23, GV20, HT7, KI3, LI4, LR3</td><td rowspan="1" colspan="1">Nilestriol 2mg/15days + Fluoxetine 20mg/day for 12 weeks</td><td rowspan="1" colspan="1">HAMD, TESS</td><td rowspan="1" colspan="1">Lower HAMD and TESS in MA + Nilestriol + Fluoxetine group</td><td rowspan="1" colspan="1">No follow-up</td><td rowspan="1" colspan="1">NR</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: NR, no report; MA, manual acupuncture; EA, electroacupuncture; PMI, perimenopausal insomnia; PMD, perimenopausal depression; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition); ICSD-3, International classification of sleep disorders (Third Edition); CCMD-2-R, revised Chinese Classification of Mental Disorders (Second Edition); CCMD-3, Chinese Classification of Mental Disorders (Third Edition); ICD-10, International Classification of Diseases (10th edition); DTICA, Guidelines for Diagnosis and Treatment of Insomnia in Chinese Adults (2012 Edition); CDTE-TCM, Criteria of Diagnosis and Therapeutic Effect of Diseases and Syndromes in TCM; PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; AIS, Athens Insomnia Scale; KI, Kupperman Index; MRS, Menopause Rating Scale; Men-QoL, Menopause-Specific Quality of Life; HAMA, Hamilton Anxiety Scale; HAMD, Hamilton Depression Scale; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; WHOQOL-BREF, World Health Organization’s quality of life scale-brief form questionnaire; TESS, Treatment Emergent Symptom Scale; PSG, polysomnography; MSMSMS, micromovement sensitive mattress sleep monitoring system; SOL, sleep onset latency; WASO, wake after sleep onset; TST, total sleep time; SE, sleep efficiency; ATs, awakening times; AA, average awakening; ArI, arousal index; REM, rapid eye movement; N1(2, 3, 4), 1st(2nd, 3rd, 4th) period of non-rapid eye movement sleep (NREM); FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; 5-HT, 5-hydroxy tryptamine; NE, norepinephrine; DA, dopamine; GABA, gamma-aminobutyric acid; six syndrome patterns with liver as the core [liver stagnation (stasis); excessive liver fire due to emotional suppression; Disturbance of liver Yang; deficiency of kidney and hyperactivity of liver; liver depression invading the stomach; liver depression invading the heart]; five TCM syndrome patterns according to CDTE-TCM [excessive liver fire due to emotional suppression; disturbance of Heart due to phlegm heat; Yin deficiency leading to excessive fire; Heart and Spleen deficiency; Heart and Gallbladder Qi deficiency]; BL8, Luoque; BL13, Feishu; BL15, Xinshu; BL17, Geshu; BL18, Ganshu; BL20, Pishu; BL21, Weishu; BL23, Shenshu; BL62, Shenmai; CV3, Zhongji; CV3, Zhongji; CV4, Guanyuan; CV6, Qihai; CV10, Xiawan; CV12, Zhongwan; EX, Anmian; EX-B2, Jiaji; EX-CA1, Zigong; EX-HN1, Sishencong; EX-HN3, Yintang; GB13, Benshen; GB14, Yangbai; GB15, Toulinqi; GB20, Fengchi; GB25, Jingmen; GV3, Yaoyangguan; GV4, Mingmen; GV14, Dazhui; GV16, Fengfu; GV19, Houding; GV20, Baihui; GV21, Qianding; GV24, Shenting; GV26, Shuigou; HT7, Shenmen; KI3, Taixi; KI6, Zhaohai; KI7, Fuliu; KI10, Yingu; KI13, Qixue; KI17, Shangqu; LI4, Hegu; LR3, Taichong; LR14, Qimen; LU7, Lieque; PC5, Jianshi; PC6, Neiguan; PC7, Daling; SI3, Houxi; SP4, Gongsun; SP6, Sanyinjiao; SP8, Diji; SP9, Yinlingquan; SP10, Xuehai; SP15, Daheng; ST25, Tianshu; ST26, Wailing; ST36, Zusanli; ST40, Fenglong.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003" orientation="landscape"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Results of Meta-Analyses for Existing RCTs</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Comparison</th><th rowspan="1" colspan="1">Study (n); Participants (n)</th><th rowspan="1" colspan="1">Outcomes</th><th rowspan="1" colspan="1">Mean/Std. Mean Difference IV, Random, 95% CI</th><th rowspan="1" colspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Acupuncture vs waitlist-control or placebo-/sham- acupuncture</td><td rowspan="1" colspan="1">RCTs (n = 4); PMI women (n = 283)</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">MD = −4.03, 95% CI (−6.85, −1.21)</td><td rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td rowspan="1" colspan="1">RCTs (n &lt; 3, no meta-analysis); PMD women (n = 126) </td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="2" colspan="1">Acupuncture vs hypnotic</td><td rowspan="1" colspan="1">RCTs (n = 12); PMI women (n = 1204)</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">MD = −2.24, 95% CI (−3.13, −1.36)</td><td rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td rowspan="1" colspan="1">RCTs (n = 4); PMI women (n = 274)</td><td rowspan="1" colspan="1">KI</td><td rowspan="1" colspan="1">MD = −5.95, 95% CI (−10.68, −1.21)</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="5" colspan="1">Acupuncture vs antidepressant/antidepressant + HRT</td><td rowspan="1" colspan="1">RCTs (n = 21); PMD women (n = 1842)</td><td rowspan="1" colspan="1">HAMD at post-treatment</td><td rowspan="1" colspan="1">SMD = −0.54, 95% CI (−0.91, −0.16)</td><td rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td rowspan="1" colspan="1">RCTs (n = 3); PMD women (n = 169)</td><td rowspan="1" colspan="1">HAMD at 2-week follow-up</td><td rowspan="1" colspan="1">SMD= −0.64, 95% CI (−0.95, −0.33)</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1">RCTs (n = 6); PMD women (n = 504)</td><td rowspan="1" colspan="1">HAMD at 4-week follow-up</td><td rowspan="1" colspan="1">SMD = −1.36, 95% CI (−2.72, 0.00)</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">RCTs (n = 3); PMD women (n = 341)</td><td rowspan="1" colspan="1">HAMD at 12-week follow-up</td><td rowspan="1" colspan="1">SMD = −2.73, 95% CI (−6.14, 0.67)</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">RCTs (n = 5); PMD women (n = 410)</td><td rowspan="1" colspan="1">KI</td><td rowspan="1" colspan="1">MD= −2.80, 95% CI (−5.60, −0.01)</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">Acupuncture + hypnotics vs hypnotics</td><td rowspan="1" colspan="1">RCTs (n = 4); PMI women (n = 308)</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">MD = −2.80, 95% CI (−4.23, −1.37)</td><td rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td rowspan="1" colspan="1">Acupuncture + antidepressant/antidepressant + HRT vs antidepressant or antidepressant + HRT</td><td rowspan="1" colspan="1">RCTs (n = 3); PMD women (n = 275)</td><td rowspan="1" colspan="1">HAMD at post-treatment</td><td rowspan="1" colspan="1">SMD = −0.82, 95% CI (−1.07, −0.58)</td><td rowspan="1" colspan="1">&lt;0.01</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Note</bold></citation_analysis><citation_analysis attribute="neither">: Data from references 19 and 50.</citation_analysis></p><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: PSQI, Pittsburgh Sleep Quality Index; KI, Kupperman Index; HAMD, Hamilton Depression Scale; HRT, hormone replacement therapy.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      <sec id="s0004-s2001">
        <title>Effectiveness and Efficacy of Acupuncture for PMI and PMD</title>
        <p><citation_analysis attribute="neither">We classified the retrieved RCTs into two categories: acupuncture as an independent or as an adjuvant to standard care in the management of PMI/PMD.</citation_analysis></p>
        <p><citation_analysis attribute="positive">In the first category, six RCTs confirmed significant improvements acupuncture produced on sleep duration and quality</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51–54</xref></citation_analysis><citation_analysis attribute="neither"> as well as depressed mood,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0055" ref-type="bibr">55</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0056" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="positive"> when compared with waitlist or placebo controls. Thirteen RCTs compared the effects between acupuncture and various hypnotics including Estazolam, Alprazolam, and Eszopiclone.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57–68</xref></citation_analysis><citation_analysis attribute="positive"> All these studies reported that acupuncture reduced global scores of Pittsburgh Sleep Quality Index (PSQI)/Athens Insomnia Scale (AIS) more effectively than hypnotics, except for two trials</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0058" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0061" ref-type="bibr">61</xref></citation_analysis><citation_analysis attribute="positive"> that reported the sleep-promoting effects between the two therapies were equivalent. Twelve out of these 13 trials employed the PSQI as an outcome measure, and the results of meta-analysis favored acupuncture [MD = −2.24, 95% CI (−3.13, −1.36), </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="positive">&lt; 0.01]. Twenty-one RCTs compared the effects between acupuncture and antidepressants including escitalopram, fluoxetine, and deanxit,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0056" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0069" ref-type="bibr">69–84</xref></citation_analysis><citation_analysis attribute="positive"> or the effects between acupuncture and antidepressants combined with HRT.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0085" ref-type="bibr">85–88</xref></citation_analysis><citation_analysis attribute="positive"> All trials adopted the Hamilton Depression Scale (HAMD) as an outcome measure. The results of meta-analysis favored acupuncture in reducing the HAMD global scores [SMD= −0.54, 95% CI (−0.91, −0.16), </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="positive">&lt; 0.01]. Some of these RCTs also reported that the effects of acupuncture remained no weaker than those of Western medications at 2-, 4-, and 12-week follow-ups, suggesting an intermediate- to long-term antidepressive efficacy of acupuncture (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="positive">In the second category, the meta-analysis pooled the effects of four RCTs</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0089" ref-type="bibr">89–92</xref></citation_analysis><citation_analysis attribute="neither"> and supported a better effect of acupuncture combined with hypnotics in reducing PSQI global score, in comparison with hypnotics alone [MD = −2.80, 95% CI (−4.23, −1.37), </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01]. Two RCTs</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0093" ref-type="bibr">93</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0094" ref-type="bibr">94</xref></citation_analysis><citation_analysis attribute="neither"> indicated that acupuncture combined with antidepressants produced lower HAMD scores than antidepressants alone. Although another RCT</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0095" ref-type="bibr">95</xref></citation_analysis><citation_analysis attribute="positive"> found no statistically significant differences in HAMD scores between the two therapies at post-treatment, the clinical effectiveness rate (calculated based on the HAMD reduction rate) favored the combination therapy (acupuncture + Paroxetine 90.91% vs Paroxetine alone 78.00%). The meta-analysis based on these three RCTs favored the combination therapy in reducing HAMD global scores as well [SMD = −0.82, 95% CI (−1.07, −0.58), </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01] (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec id="s0004-s2002">
        <title>Safety of Acupuncture for PMI and PMD</title>
        <p><citation_analysis attribute="positive">The incidence of AEs associated with each intervention in the included RCTs is summarized in </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=332474.docx" ext-link-type="uri">Appendix 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither"> (in order of highest % for acupuncture). Consistent with the previous studies that acupuncture is safe to manipulate,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> there appears to be few risks associated with utilizing acupuncture in the management of PMI/PMD as the AEs caused by acupuncture were minimal and very mild. Hematoma (7.72%), the most frequent complaint, usually faded within a few days.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="positive"> The incidence of other acupuncture-related AEs was less than 4%, with the exception of sweating (6.76%). The latter however is likely to be related to menopause rather than acupuncture as this is a common symptom for perimenopausal women.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0096" ref-type="bibr">96</xref></citation_analysis><citation_analysis attribute="positive"> The incidence and severity of AEs associated with psychotropic agents (hypnotics or antidepressants) far exceeded those of acupuncture. The most common of these were daytime sleepiness and/or fatigue (29.38%), breast tenderness (22%) and night-time sleep disturbance (18.18%). These findings are noteworthy given the problem of PMI/PMD and suggest that some of these treatments may exacerbate rather than alleviate the symptoms. Only one RCT</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0097" ref-type="bibr">97</xref></citation_analysis><citation_analysis attribute="neither"> used HRT alone as a control but still identified at least three types of AEs.</citation_analysis></p>
        <p><citation_analysis attribute="positive">These findings are highly supportive of the use of acupuncture as a therapeutic strategy in PMI and/or PMD. The data suggest that it does not matter whether the therapeutic effect of acupuncture is better or only equivalent to that of HRT and/or hypnotics/antidepressants, acupuncture can be supported as a front-line, first-choice therapeutic because of its exemplary safety profile.</citation_analysis></p>
      </sec>
      <sec id="s0004-s2003">
        <title>Implications for Clinical Practice</title>
        <p><citation_analysis attribute="positive">This section discusses the meaningfulness and feasibility of acupuncture for PMI and PMD. In addition to improving sleep or depression outcomes, acupuncture also showed positive effects on indices of climacteric symptoms (ie, Kupperman Index, Menopause Rating Scale, etc), quality of life in menopause (ie, Menopause-Specific Quality of Life, World Health Organization’s quality of life scale-brief form questionnaire, etc), and/or anxiety symptoms (ie, Hamilton Anxiety Scale, etc). (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Tables 2</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">3</xref></citation_analysis><citation_analysis attribute="positive">) These findings suggest that women with PMI/PMD as their chief complaint benefited from acupuncture in a broad range of signs and symptoms associated with life change. This finding is consistent with the “holistic medicine” concept highlighted in the TCM, which views the body as a complete entirety.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0098" ref-type="bibr">98</xref></citation_analysis><citation_analysis attribute="neither"> “Healthy” in TCM does not simply mean “disease free”; it means that all Zang and Fu (organs), meridians and collaterals are working in harmony, and the flow of Qi, blood and body fluids is at ease, and emotions and spiritual state are in balance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> In terms of TCM theory, a diseased condition is not only a problem in a local part of the body but a local reflection of disharmony of the entire body.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> Hence, TCM therapies generally address a diseased condition (condition with an imbalance between Yin and Yang) by regulating and mobilizing the entire body rather than just regulating a single factor (one symptom or one part/organ of the body).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0098" ref-type="bibr">98</xref></citation_analysis><citation_analysis attribute="neither"> As suggested, any potential climacteric condition (eg, nocturnal hot flushes, chronic pain, neuropsychiatric problems, etc) that may adversely affect sleep and/or mood should be considered when menopausal women seek medical advice.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> This circumstance is in line with the “holistic medicine” theory of TCM, which makes acupuncture more worthy of being recommended.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Limited evidence suggests acupuncture is likely to have an add-on effect to hypnotic and/or antidepressive drugs. However, in seven trials focusing on acupuncture combined with standard care, only one study</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0095" ref-type="bibr">95</xref></citation_analysis><citation_analysis attribute="positive"> reported the AEs; no trials included follow-up (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Tables 2</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">3</xref></citation_analysis><citation_analysis attribute="positive">). Consequently, the safety and long-term effects of this integrative remedy is still less well understood. Consumers who are not familiar with acupuncture may not be willing to give up drug-based medicines immediately.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> Whether reduced use of conventional drugs can be made up by the addition of acupuncture is a topic with important clinical significance because reduction of dosage in conventional drugs means fewer risks of side effects. Likewise, this add-on effect of acupuncture is also of importance in personalized medicine. Given the efficacy for all therapies may be hampered by the fact that women respond differently to each, acupuncture is ideal to be recommended as the first therapy in a layered approach, so that if acupuncture is ineffective then lower dose Western medication (eg, HRT, psychotropic agents, etc) could be tried in combination with the acupuncture prior to direct usage of pharmacotherapy or higher dose of pharmacotherapy. This treatment strategy may be particularly suitable for those women with PMI/PMD who are intolerant of drugs.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Acupoint selection is one of the decisive factors affecting the clinical effectiveness of acupuncture.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0099" ref-type="bibr">99</xref></citation_analysis><citation_analysis attribute="neither"> As illustrated in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">, the three most commonly used acupoints for PMI were Sanyinjiao (SP6), Baihui (GV20), and Shenmen (HT7), while the three most commonly used acupoints for PMD were GV20, SP6, and Yintang (EX-HN3). According to “Indications of Acupuncture Points [GB/T 30233–2013]” (National Standard of People’s Republic of China, 2013 Version),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0100" ref-type="bibr">100</xref></citation_analysis><citation_analysis attribute="neither"> GV20, HT7, and EX-HN3 are classic acupoints for the treatment of psychiatric and psychological disorders. SP6 is the preferred acupoint for gynaecological disorders, and together with HT7, it promotes sleep. Based on TCM syndrome patterns, for any deficient patterns, the Back-shu are used as these acupoints where the Qi of the internal organs is accumulated, and are used to strengthen the corresponding organs.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0100" ref-type="bibr">100</xref></citation_analysis><citation_analysis attribute="neither"> Ganshu (BL18), the Back-shu of liver, as well as Shenshu (BL23), the Back-shu of kidney, were selected in many trials (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">), which is consistent with the aforementioned findings that smoothing liver and nourishing kidney is the general principle for all perimenopausal disorders. In treating comorbid PMI and PMD, practitioners are hence recommended to select Back-shu of liver and kidney, and/or acupoints of Liver Meridian of Foot-Jueyin and Kidney Meridian of Foot-Shaoyin, in addition to the classical acupoints utilized for mental disease/disorders. Both MA and EA showed significant clinical benefits for PMI/PMD (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">). However, no study has compared MA with EA. The differences in clinical effects and underlying mechanisms of MA and EA should be explored in future clinical trials and animal studies.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Our comprehensive retrieval of literature failed to identify any RCT carried outside of China, reflecting the extremely inadequate awareness and attention paid to acupuncture in PMI/PMD management among Western researchers, despite well-documented evidence supporting the growing widespread use of CAM therapy for psychiatric complaints among Western populations.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0101" ref-type="bibr">101</xref></citation_analysis><citation_analysis attribute="neither"> Meanwhile, some surveys alluded that most Western women may also underestimate the value and role of acupuncture as a management strategy for PMI and/or PMD. As reported, only 4.8% women in Australia have visited an acupuncturist due to menopausal symptoms;</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0102" ref-type="bibr">102</xref></citation_analysis><citation_analysis attribute="neither"> In the UK, 6.4% climacteric women utilize aromatherapy, reflexology, or acupuncture to reduce symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0103" ref-type="bibr">103</xref></citation_analysis><citation_analysis attribute="positive"> This review thereby is expected to evoke awareness of the potential of acupuncture among both perimenopausal women and clinicians working in this field (ie, gynaecologists, psychiatrists, and naturopaths) in Western countries. Given all the participants in the included RCTs were Chinese women, generalizing the currently optimistic results to women of other races requires some further evidence.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0104" ref-type="bibr">104</xref></citation_analysis><citation_analysis attribute="neither"> According to the differences in awareness, perception, and tolerance of acupuncture between Westerners and Chinese, limited modification to the nature acupuncture prescription/protocol summarized in published Chinese studies may also enhance the acceptance and applicability of acupuncture among Western perimenopausal women.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Another issue that has not yet been addressed is whether interventions can be provided during pre-menopause to prevent or reduce the occurrence of PMI and/or PMD. Women with a history of depression</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0105" ref-type="bibr">105</xref></citation_analysis><citation_analysis attribute="neither"> or experiencing stressful events</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="negative"> at pre-menopause are at high risk for PMD. Women with a history of severe premenstrual syndrome and/or psychological disturbances may benefit from preventive treatments for reducing the likelihood of PMI or ameliorating the symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> These women may be a target group for preventive acupuncture (also called “acupuncture pre-treatment”), which is in line with the idea of “preventive treatment of disease” (治未病, prevent individuals from being trapped by diseases) in TCM theory.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> Despite the lack of direct evidence, acupuncture pre-treatment may have positive preventive effects for perimenopausal symptoms. Most research in this area has been based on animal models. Acupuncture pre-treatment was observed to reduce oxidative stress levels,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0106" ref-type="bibr">106</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0107" ref-type="bibr">107</xref></citation_analysis><citation_analysis attribute="neither"> inhibit the hyperactivity of hypothalamic-pituitary-ovary (HPO) axis,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0106" ref-type="bibr">106</xref></citation_analysis><citation_analysis attribute="neither"> as well as regulate the inflammatory response and disorders of the immune system</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0108" ref-type="bibr">108</xref></citation_analysis><citation_analysis attribute="positive"> in either ageing female rats or rats that were ovariectomized to mimic menopause. Li et al reported that EA pre-treatment (EA was provided 10 days before chronic stress) effectively prevented the depression-like behavior of rats after undergoing chronic unpredicted mild stress (CUMS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0109" ref-type="bibr">109</xref></citation_analysis></p>
      </sec>
      <sec id="s0004-s2004">
        <title>Implications for Research</title>
        <p><citation_analysis attribute="negative">The data from the few clinical trials discussed here appears to be promising, it is however too early to draw any definitive conclusions. Many RCTs have missing components in their methodology, which dilutes and weakens the quality of evidence, and may hinder the development of acupuncture as a form of evidence-based healthcare for comorbid depression and insomnia during perimenopause.</citation_analysis></p>
        <p><citation_analysis attribute="neither">We have summarized the common deficiencies among these RCTs and listed the potential negative consequences in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="positive">. Detailed assessment and analysis on quality of evidence is described in our published SRs/MAs.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="positive"> As reported, poor-quality acupuncture studies usually show a higher proportion of positive results than high-quality studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0104" ref-type="bibr">104</xref></citation_analysis><citation_analysis attribute="neither"> Well-designed trials with robust methodology and high-quality reporting quality are warranted in future research.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0004"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Common Defects of Study Design and Reporting Quality Among Current RCTs</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Items</th><th align="center" rowspan="1" colspan="1">Limitations</th><th align="center" rowspan="1" colspan="1">Potential Negative Consequences</th></tr></thead><tbody><tr><td rowspan="6" colspan="1">Study design</td><td rowspan="1" colspan="1">Lack of appropriate sample size estimation</td><td rowspan="1" colspan="1">Diminishment of credibility of the results; reduction in likelihood of finding an effect of the treatment</td></tr><tr><td rowspan="1" colspan="1">Lack of sham-/placebo- acupuncture as parallel control in trials comparing acupuncture with Western medications</td><td rowspan="1" colspan="1">Potential bias and uncertainty on the placebo effects of acupuncture</td></tr><tr><td rowspan="1" colspan="1">Without appropriate statistics (ie intention-to-treat analysis, etc) for data of those withdrawal/dropout patients</td><td rowspan="1" colspan="1">Increased risk of an overestimation/underestimation of the efficacy of acupuncture or Western medications</td></tr><tr><td rowspan="1" colspan="1">Lack of follow-ups</td><td rowspan="1" colspan="1">Unable to evaluate medium- and long- term effects/safety of acupuncture</td></tr><tr><td rowspan="1" colspan="1">Objective indices (ie, polysomnography, actigraphy, etc) is seldom used in PMI studies</td><td rowspan="1" colspan="1">(i) Unable to understand the effects of acupuncture on sleep architecture<break/>(ii) A biased judgement or even a question on acupuncture’s real efficacy due to a mismatch between the subjective and objective sleep-wake duration</td></tr><tr><td rowspan="1" colspan="1">No discussion of the effects of acupuncture responding to specific/each TCM syndrome pattern (all TCM syndrome patterns are mixed for efficacy assessment)</td><td rowspan="1" colspan="1">Difficult to judge the real therapeutic effect of acupuncture</td></tr><tr><td rowspan="4" colspan="1">Reporting quality</td><td rowspan="1" colspan="1">Lack of reports on if or how allocation concealment and blinding of patients/outcome assessments are performed</td><td rowspan="1" colspan="1">Inadequate blinding is associated with an exaggeration of the estimated efficacy</td></tr><tr><td rowspan="1" colspan="1">Lack of description and in-depth analysis of the specific causes of withdrawal/dropout</td><td rowspan="1" colspan="1">Unable to understand patient’s compliance and acceptance of acupuncture, placebo or Western medications</td></tr><tr><td rowspan="1" colspan="1">Protocols and/or registration Information are not always available</td><td rowspan="1" colspan="1">Greatly weakens the reliability of the evidence</td></tr><tr><td rowspan="1" colspan="1">Incomplete descriptions of needling details and/or treatment regimen, as well as acupuncturists’ background</td><td rowspan="1" colspan="1">(i) Poor reproducibility of the trial results<break/>(ii) Hinder the clinical promotion of effective acupuncture prescription</td></tr></tbody></table></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0005">
      <title>Underlying Mechanisms of Acupuncture’s Effects Against Depression and Insomnia During Perimenopause</title>
      <p><citation_analysis attribute="positive">It is challenging to explore the mechanisms underlying the effects of acupuncture on depression and insomnia during the transition to menopause in only RCTs. To enhance our understanding, investigation via animal studies is a valuable option. Together with clinical findings, animal studies can shed light on the mechanisms of action of acupuncture (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">) as well as give an insight into the direction of further research. Findings of animal studies are summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0005" orientation="landscape"><label>Table 5</label><caption><p><citation_analysis attribute="neither">Summary of Animal Studies Determining the Mechanisms Underlying Acupuncture on PMI and PMD</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Author/Year</th><th rowspan="1" colspan="1">Animals</th><th rowspan="1" colspan="1">Disease Models</th><th rowspan="1" colspan="1">Methods of Modeling</th><th rowspan="1" colspan="1">Study Groups/No. of Participants</th><th rowspan="1" colspan="1">Interventions</th><th rowspan="1" colspan="1">Acupuncture Protocol</th><th rowspan="1" colspan="1">Acupoints</th><th rowspan="1" colspan="1">Outcome Measures</th><th rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cao et al 2019<xref rid="cit0152" ref-type="bibr">152</xref></td><td rowspan="1" colspan="1">SD rats, 280–320g, 12 months</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) Electrical stimulation</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Model/n= 12<break/>- Sham-surgery/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + electrical stimulation + EA<break/>- Model/OVX + electrical stimulation<break/>- Sham-surgery/sham-OVX + electrical stimulation</td><td rowspan="1" colspan="1">− 20 min/day for 14 days<break/>- Dense wave, 50Hz</td><td rowspan="1" colspan="1">SP6</td><td rowspan="1" colspan="1">(i) MER (REM, SWS)<break/>(ii) 5-HT, 5-HIAA, 5-HT1A in hippocampus</td><td rowspan="1" colspan="1">(i) EA increased REM and SWS<break/>(ii) EA increased 5-HT and 5-HT1A levels; no significant change in 5-HIAA level</td></tr><tr><td rowspan="1" colspan="1">Cao et al 2020<xref rid="cit0136" ref-type="bibr">136</xref></td><td rowspan="1" colspan="1">Wistar rats, 230–270g, 5–7 months</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) Electrical stimulation</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Model/n= 10<break/>- Sham-surgery/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + electrical stimulation + EA<break/>- Model/OVX + electrical stimulation<break/>- Sham-surgery/sham-OVX + electrical stimulation</td><td rowspan="1" colspan="1">− 15 min/day for 21 days<break/>- Dense wave, 50Hz</td><td rowspan="1" colspan="1">EX-HN1, HT7</td><td rowspan="1" colspan="1">(i) MER (TST, REM, SWS, LS)<break/>(ii) L-PGDS, PGD2, PGE2 in CSF<break/>(iii) GABA in VLPO</td><td rowspan="1" colspan="1">(i) EA increased REM, SWS; no significant change in TST and LS<break/>(ii) EA increased L-PGDS and PGD2 levels; no significant change in PGE2 level<break/>(iii) EA increased GABA level</td></tr><tr><td rowspan="1" colspan="1">Jin et al 2010<xref rid="cit0189" ref-type="bibr">189</xref></td><td rowspan="1" colspan="1">SD rats, 230–270g, 3 months</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) Electrical stimulation</td><td rowspan="1" colspan="1">- EA/n= 30<break/>- Model/n= 30<break/>- Sham-surgery/n= 30</td><td rowspan="1" colspan="1">- EA/OVX + electrical stimulation + EA<break/>- Model/OVX + electrical stimulation<break/>- Sham-surgery/sham-OVX + electrical stimulation</td><td rowspan="1" colspan="1">− 30 min/day for 7 days<break/>- Continuous wave, 15Hz, 2mA</td><td rowspan="1" colspan="1">BL23, SP6</td><td rowspan="1" colspan="1">(i) SOL and TST<break/>(ii) Heat-resistant time<break/>(iii) Energy<break/>(iv) Times of locomotor activity</td><td rowspan="1" colspan="1">(i) EA increased TST and reduced SOL<break/>(ii) EA increased heat-resistant time<break/>(iii) EA increased energy<break/>(iv) No significant change in times of locomotor activity<break/>(v) The earlier the intervention of EA in the perimenopausal period, the better the effect</td></tr><tr><td rowspan="1" colspan="1">Jin et al 2011<xref rid="cit0190" ref-type="bibr">190</xref></td><td rowspan="1" colspan="1">SD rats, 150–180g</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) Electrical stimulation</td><td rowspan="1" colspan="1">- EA/n= 30<break/>- Model/n= 30<break/>- Sham-surgery/n= 30</td><td rowspan="1" colspan="1">- EA/OVX + electrical stimulation + EA<break/>- Model/OVX + electrical stimulation<break/>- Sham-surgery/sham-OVX + electrical stimulation</td><td rowspan="1" colspan="1">− 30 min/day for 7 days<break/>- Continuous wave, 15Hz, 2mA</td><td rowspan="1" colspan="1">BL23, SP6</td><td rowspan="1" colspan="1">(i) SOL and TST<break/>(ii) Heat-resistant time<break/>(iii) Energy</td><td rowspan="1" colspan="1">(i) EA increased TST and reduced SOL<break/>(ii) EA increased heat-resistant time<break/>(iii) EA increased energy<break/>(iv) The earlier the intervention of EA in the perimenopausal period, the better the effect</td></tr><tr><td rowspan="1" colspan="1">Xie 2013<xref rid="cit0116" ref-type="bibr">116</xref></td><td rowspan="1" colspan="1">SD rats, 216–245.8g, 6–8 weeks</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">OVX</td><td rowspan="1" colspan="1">- EA/n= 25<break/>- Model/n= 25<break/>- Sham-surgery/n= 25<break/>- Sham-EA/n= 25</td><td rowspan="1" colspan="1">- EA/OVX + EA<break/>- Model/OVX<break/>- Sham-surgery/sham-OVX<break/>-Sham-EA/OVX + sham-EA</td><td rowspan="1" colspan="1">− 15 min/day for 7 days<break/>- Continuous wave, 2Hz</td><td rowspan="1" colspan="1">BL23, EX</td><td rowspan="1" colspan="1">(i) EEG/EMG recording systems for rats and mice (WASO, REM, NREM)<break/>(ii) Serum FSH, E2<break/>(iii) Estrogen receptor in VLPO and TMN<break/>(iv) Weight</td><td rowspan="1" colspan="1">(i) EA increased NREM, and reduced WASO and REM<break/>(ii) EA increased E2 and decreased FSH levels<break/>(iii) No significant change in estrogen receptor<break/>(iv) EA reduced weight</td></tr><tr><td rowspan="1" colspan="1">Yu 2012<xref rid="cit0117" ref-type="bibr">117</xref></td><td rowspan="1" colspan="1">SD rats, 230–270g, 6–8 weeks</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">OVX</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Model/n= 12<break/>- Sham-surgery/n= 12<break/>- Sham-EA/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + EA<break/>- Model/OVX<break/>- Sham-surgery/sham-OVX<break/>- Sham-EA/OVX + sham-EA</td><td rowspan="1" colspan="1">− 15 min every other day for 7 days<break/>- Continuous wave, 2Hz</td><td rowspan="1" colspan="1">EX</td><td rowspan="1" colspan="1">(i) EEG/EMG recording systems for rats and mice (WASO, REM, NREM)<break/>(ii) Serum FSH, E2, LH</td><td rowspan="1" colspan="1">(i) EA increased NREM and reduced WASO; no significant change in REM; EA alleviated sleep fragmentation during the daytime<break/>(ii) EA increased E2 and reduced FSH levels; no significant change in LH level</td></tr><tr><td rowspan="1" colspan="1">Yang 2017<xref rid="cit0121" ref-type="bibr">121</xref></td><td rowspan="1" colspan="1">SD rats, 230–270g, 6–8 weeks</td><td rowspan="1" colspan="1">PMI</td><td rowspan="1" colspan="1">OVX</td><td rowspan="1" colspan="1">- EA/n= 40<break/>- Model/n= 40<break/>- Sham-surgery/n= 40<break/>- Sham-EA/n= 40</td><td rowspan="1" colspan="1">- EA/OVX + EA<break/>- Model/OVX<break/>- Sham-surgery/sham-OVX<break/>- Sham-EA/OVX + sham-EA</td><td rowspan="1" colspan="1">− 15 min/day for 7 days<break/>- Continuous wave, 15Hz</td><td rowspan="1" colspan="1">BL23, EX</td><td rowspan="1" colspan="1">(i) EEG/EMG recording systems for rats and mice (WASO, REM, NREM)<break/>(ii) serum E2 and 5-HT<break/>(iii) Adrenocortical E2<break/>(iv) Hypothalamic 5-HT, NE, ER-α mRNA, ER-β mRNA</td><td rowspan="1" colspan="1">(i) EA increased NREM, and reduced WASO and REM; EA alleviated sleep fragmentation during the daytime<break/>(ii) EA increased E2 and 5-HT levels<break/>(iii) EA increased E2 level<break/>(iv) EA increased 5-HT, and decreased NE and ERβmRNA; no significant change in ERαmRNA</td></tr><tr><td rowspan="1" colspan="1">Jing et al 2020<xref rid="cit0174" ref-type="bibr">174</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 56–62days</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10<break/>- Sham-surgery/n= 10<break/>- Clomipramine/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Sham-surgery/sham-OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-isperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (OFT, SPT)<break/>(ii) Serum E2, LH, GnRH<break/>(iii) GSK-3β mRNA, β-catenin mRNA in hippocampus<break/>(iv) β-Catenin protein, p-β-catenin protein in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) EA increased E2, and decreased LH and GnRH levels<break/>(iii) EA decreased GSK-3β mRNA and increased β-catenin mRNA expression<break/>(iii) EA increased β-catenin protein and decreased p-β-catenin protein expression</td></tr><tr><td rowspan="1" colspan="1">Guo et al 2019<xref rid="cit0145" ref-type="bibr">145</xref></td><td rowspan="1" colspan="1">KM mice, 18–22g</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10<break/>- Clomipramine/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 2/10Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, IAT, ADE, TSE)<break/>(ii) Serum E2, FSH, LH<break/>(iii) 5-HT, NE, DA in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved mice’ depression-like behavior in behavioral tests<break/>(ii) EA increased E2 and decreased LH and FSH levels<break/>(ii) EA increased 5-HT, NE and DA levels</td></tr><tr><td rowspan="1" colspan="1">Seo et al 2018<xref rid="cit0170" ref-type="bibr">170</xref></td><td rowspan="1" colspan="1">SD rats, 250–300g</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">OVX</td><td rowspan="1" colspan="1">- EA/n= NR<break/>- Model/n= NR<break/>- Sham-surgery/n= NR<break/>-Sham-EA/n= NR</td><td rowspan="1" colspan="1">- EA/OVX + EA<break/>- Model/OVX<break/>- Sham-surgery/sham-OVX<break/>- Sham-EA/OVX + sham-EA</td><td rowspan="1" colspan="1">60 seconds/day for 4 days</td><td rowspan="1" colspan="1">SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, OFT, EPM)<break/>(ii) E2 and estrogen receptor expression in plasma and hippocampus<break/>(iii) BDNF and p-TrkB receptor in hippocampus<break/>(iv) NPY in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) no significant change in E2 level or estrogen receptor expression<break/>(iii) EA increased BDNF and p-TrkB receptor levels<break/>(iv) EA increased NPY levels</td></tr><tr><td rowspan="1" colspan="1">Deng et al 2017<xref rid="cit0185" ref-type="bibr">185</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 56–62days</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Control/n= 12<break/>- Model/n= 12<break/>- Clomipramine/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, OFT)<break/>(ii) MAP-2, Notch1, Jagged1, Hes1 in hippocampus<break/>(iii) MAP-2 mRNA, Notch1 mRNA, Jagged1 mRNA, Hes1 mRNA in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) EA increased MAP-2 protein and Notch1 protein levels, and decreased Jagged1 protein and Hes1 protein levels<break/>(ii) EA increased MAP-2 mRNA and Notch1 mRNA expression, and decreased Jagged1 mRNA and Hes1 mRNA expression</td></tr><tr><td rowspan="1" colspan="1">Deng 2017<xref rid="cit0177" ref-type="bibr">177</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 56–62days</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10<break/>- Sham-surgery/n= 10<break/>- Clomipramine/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Sham-surgery/sham-OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, OFT, SPT)<break/>(ii) GSK-3β, β-catenin in hippocampus<break/>(iii) β-catenin protein, p-β-catenin protein in hippocampus<break/>(iv) GSK-3β mRNA, β-catenin mRNA in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) EA decreased GSK-3β and increased β-catenin contents<break/>(iii) EA increased β-catenin protein expression; no significant change in p-β-catenin protein expression<break/>(iv) EA decreased GSK-3β mRNA and increased β-catenin mRNA expression</td></tr><tr><td rowspan="1" colspan="1">Huangfu 2018<xref rid="cit0129" ref-type="bibr">129</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 56–62days</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10<break/>- Clomipramine/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, OFT, SPT, TSE)<break/>(ii) Glucocorticoid receptor, mineralocorticoid receptor in hippocampus</td><td rowspan="1" colspan="1">(ii) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) EA increased glucocorticoid receptor and mineralocorticoid receptor levels</td></tr><tr><td rowspan="1" colspan="1">Jiang 2017<xref rid="cit0124" ref-type="bibr">124</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 56–62days</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Control/n= 12<break/>- Model/n= 12<break/>- Sham-surgery/n= 12<break/>- Clomipramine/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Sham-surgery/sham-OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (FST, SPT, TSE)<break/>(ii) Serum E2, FSH, LH, GnRH, CRH, ACTH, CORT, β-EP</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral tests<break/>(ii) EA increased E2 andβ-EP, and decreased FSH, LH, GnRH, CORT, ACTH and CRH levels</td></tr><tr><td rowspan="1" colspan="1">Jiang et al 2017<xref rid="cit0127" ref-type="bibr">127</xref></td><td rowspan="1" colspan="1">SD rats, 190–210g, 8–9 weeks</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Control/n= 12<break/>- Model/n= 12<break/>- Sham-surgery/n= 12<break/>- Clomipramine/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Sham-surgery/sham-OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 4/20Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral test (SPT)<break/>(ii) Serum E2, LH, GnRH, β-EP</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased E2 andβ-EP, and decreased LH and GnRH levels</td></tr><tr><td rowspan="1" colspan="1">Jing et al 2018<xref rid="cit0178" ref-type="bibr">178</xref></td><td rowspan="1" colspan="1">SD rats, 180–220g, 17 weeks</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 12<break/>- Control/n= 12<break/>- Model/n= 12<break/>- Clomipramine/n= 12</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 2/10Hz, 18V</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral test (TSE)<break/>(ii) E2, NE in hippocampus<break/>(iii) DKK1, LRP-5, LRP-6 in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased E2 and NE levels<break/>(iii) EA decreased DKK1, and decreased LRP-5 and LRP-6 expression</td></tr><tr><td rowspan="1" colspan="1">Zhou et al 2015<xref rid="cit0146" ref-type="bibr">146</xref></td><td rowspan="1" colspan="1">SD rats, 220–260g</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- MA/n= 9<break/>- Model-1/n= 9<break/>- Model-2/n= 8<break/>- Sham-surgery/n= 6<break/>- Nilestriol + Fluoxetine/n= 9</td><td rowspan="1" colspan="1">- MA/OVX + CUMS + MA<break/>- Model-1/OVX + CUMS<break/>- Model-2/OVX<break/>- Sham-surgery/sham-OVX<break/>- Nilestriol + Fluoxetine/OVX + CUMS + Nilestriol + Fluoxetine</td><td rowspan="1" colspan="1">20 min/day for 21 days</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral test (OFT)<break/>(ii) 5-HT, NE, DA in hypothalamus</td><td rowspan="1" colspan="1">(i) MA improved rats’ depression-like behavior in behavioral test<break/>(ii) MA increased 5-HT level; no significant changes in NE and DA levels</td></tr><tr><td rowspan="1" colspan="1">Shi et al 2012<xref rid="cit0147" ref-type="bibr">147</xref></td><td rowspan="1" colspan="1">SD rats, 300–350g, 4 months</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- MA/n= 10<break/>- Model/n= 5<break/>- Sham-surgery/n= 5<break/>- Estradiol benzoate/n= 10</td><td rowspan="1" colspan="1">- MA/OVX + CUMS + MA<break/>- Model/OVX + CUMS<break/>- Sham-surgery/sham-OVX + CUMS<break/>- Estradiol benzoate/OVX + CUMS + Estradiol benzoate</td><td rowspan="1" colspan="1">30 min/session, once session every 2 days for total 30 sessions</td><td rowspan="1" colspan="1">CV4, CV6, LI4, LR3, PC6, SP6, ST36</td><td rowspan="1" colspan="1">(i) Serum E2<break/>(ii) 5-HT in hypothalamus</td><td rowspan="1" colspan="1">(i) EA increased E2 level<break/>(ii) EA increased 5-HT level</td></tr><tr><td rowspan="1" colspan="1">Sun 2009<xref rid="cit0118" ref-type="bibr">118</xref></td><td rowspan="1" colspan="1">(i) SD rats, 250–300g, 11–15 months (n= 45)<break/>(ii) Young SD rats, 150–200g, 4 months (n= 10)</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">CUMS</td><td rowspan="1" colspan="1">- EA/n= 15<break/>- Model/n= 15<break/>- Clomipramine/n= 15<break/>- Young/n= 10</td><td rowspan="1" colspan="1">- EA/CUMS + EA<break/>- Model/CUMS<break/>- Clomipramine/CUMS + Clomipramine<break/>- Young/CUMS</td><td rowspan="1" colspan="1">− 20 min/day for 7 days-<break/>disperse-dense wave, 4/20Hz, 2V</td><td rowspan="1" colspan="1">BL18, BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral tests (OFT)<break/>(ii) Serum E2, NE</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased E2 and NE levels</td></tr><tr><td rowspan="1" colspan="1">Wang et al 2016<xref rid="cit0171" ref-type="bibr">171</xref></td><td rowspan="1" colspan="1">SD rats, 220–260g, 17weeks</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) CUMS</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10<break/>- Clomipramine/n= 10</td><td rowspan="1" colspan="1">- EA/OVX + CUMS + EA<break/>- Control/no treatment<break/>- Model/OVX + CUMS<break/>- Clomipramine/OVX + CUMS + Clomipramine</td><td rowspan="1" colspan="1">− 20 min/day for 28 days-<break/>disperse-dense wave, 2/10Hz</td><td rowspan="1" colspan="1">BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral test (OFT)<break/>(ii) CREB, BDNF in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased BDNF and CREB levels</td></tr><tr><td rowspan="1" colspan="1">Wu 2012<xref rid="cit0148" ref-type="bibr">148</xref></td><td rowspan="1" colspan="1">(i) SD rats, 260–471g, 11–13 months (n= 73)<break/>(ii) Young SD rats, 140–191g, 4 months (n= 20)</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">CUMS</td><td rowspan="1" colspan="1">- EA/n= 18<break/>- Model/n= 19<break/>- Clomipramine/n= 18<break/>- Herbal medicine/n= 18<break/>- Young/n= 20</td><td rowspan="1" colspan="1">- EA/CUMS + EA<break/>- Model/CUMS<break/>- Clomipramine/CUMS + Clomipramine<break/>- Herbal medicine/ CUMS + XiaoYao-Pill<break/>- Young/CUMS</td><td rowspan="1" colspan="1">− 20 min/day for 10 days-<break/>disperse-dense wave, 2/15Hz, 2V</td><td rowspan="1" colspan="1">BL18, BL23, GV20, SP6, ST36</td><td rowspan="1" colspan="1">(i) Behavioral test (OFT)<break/>(ii) Serum E2<break/>(iii) 5-HT2A mRNA, p-ERK 1/2 in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased E2 level<break/>(ii) EA decreased 5-HT2A mRNA expression; EA increased p-ERK 1/2 expression</td></tr><tr><td rowspan="1" colspan="1">Zhang 2009<xref rid="cit0128" ref-type="bibr">128</xref></td><td rowspan="1" colspan="1">(i) SD rats, 250–300g, 11–15 months (n= 45)<break/>(ii) Young SD rats, 150–200g, 4 months (n= 10)</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">CUMS</td><td rowspan="1" colspan="1">- EA/n= 15<break/>- Model/n= 15<break/>- Clomipramine/n= 15<break/>- Young/n= 10</td><td rowspan="1" colspan="1">- EA/CUMS + EA<break/>- Model/CUMS<break/>- Clomipramine/CUMS + Clomipramine<break/>- Young/CUMS</td><td rowspan="1" colspan="1">− 20 min/day for 7 days-<break/>continuous wave, 20Hz, 2V</td><td rowspan="1" colspan="1">BL18, BL23, GV20, SP6</td><td rowspan="1" colspan="1">(i) Behavioral test (OFT)<break/>(ii) Serum E2<break/>(iii) β-EP in hippocampus</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased E2 level<break/>(ii) EA increased β-EP level</td></tr><tr><td rowspan="1" colspan="1">Zhao et al 2011<xref rid="cit0149" ref-type="bibr">149</xref></td><td rowspan="1" colspan="1">(i) SD rats, 260–471g, 11–13 months (n= 66)<break/>(ii) Young SD rats, 140–191g, 4 months (n= 20)</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">CUMS</td><td rowspan="1" colspan="1">- EA/n= 15<break/>- Model/n= 18<break/>- Clomipramine/n= 17<break/>- Herbal medicine/n= 16<break/>- Young/n= 20</td><td rowspan="1" colspan="1">- EA/CUMS + EA<break/>- Model/CUMS<break/>- Clomipramine/CUMS + Clomipramine<break/>- Herbal medicine/ CUMS + XiaoYao-Pill<break/>- Young/CUMS</td><td rowspan="1" colspan="1">− 20 min/day for 28 days</td><td rowspan="1" colspan="1">BL18, BL23, GV20, SP6, ST36</td><td rowspan="1" colspan="1">(i) Behavioral test (OFT)<break/>(ii) Serum 5-HT, HDL</td><td rowspan="1" colspan="1">(i) EA improved rats’ depression-like behavior in behavioral test<break/>(ii) EA increased 5-HT and HDL levels</td></tr><tr><td rowspan="1" colspan="1">Song et al 2021<xref rid="cit0119" ref-type="bibr">119</xref></td><td rowspan="1" colspan="1">KM mice, 18–22g, 5–6 weeks</td><td rowspan="1" colspan="1">PMD</td><td rowspan="1" colspan="1">(i) OVX<break/>(ii) Ice-water swimming stimulation (I-WSS)</td><td rowspan="1" colspan="1">- EA/n= 10<break/>- Control/n= 10<break/>- Model/n= 10</td><td rowspan="1" colspan="1">- MA/OVX + I-WSS + MA<break/>- Control/I-WSS<break/>- Model/OVX + I-WSS</td><td rowspan="1" colspan="1">− 30 min/day, 6 days/week for 4 weeks</td><td rowspan="1" colspan="1">CV4, KI3, KI15, SP6, SP10, ST36</td><td rowspan="1" colspan="1">Serum E2</td><td rowspan="1" colspan="1">EA increased E2 level</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: NR, no report; PMI, perimenopausal insomnia; PMD, perimenopausal depression; MA, manual acupuncture; EA, electroacupuncture; OVX, ovariectomy; CUMS, chronic unpredictable mild stress; MER, multichannel electrophysiological recordings; SOL, sleep onset latency; TST, total sleep time; WASO, wake after sleep onset; REM, rapid eye movement; NREM, non-rapid eye movement; LS, light sleep; SWS, slow wave sleep; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; CSF, cerebrospinal fluid; VLPO, ventrolateral preoptic; TMN, tuberomammillary nucleus; PGD2, prostaglandin D2; PGE2, prostaglandin E2; L-PGDS, lipocalin-type prostaglandin D synthase; GABA, gamma-amino butyric acid; 5-HT, 5-hydroxytryptamine; 5-HIAA, 5-hydroxyindole acetic acid; NE, norepinephrine; DA, dopamine; ER-α, Estrogen receptor-α; ER-β, Estrogen receptor-β; GnRH, gonadotropin-releasing hormone; GSK-3β, glycogen synthase kinase-3β; p-β-catenin, phosphorylated β-catenin; BDNF, brain-derived neurotrophic factor; NPY, neuropeptide Y; MAP-2, microtubule- associated protein-2; CRH, corticotropin releasing hormone; ACTH, adrenocorticotropic hormone; CORT, cortisol; β-EP, beta-endorphin; DKK1, Dickkopf1; LRP-5, low density lipoprotein receptor related protein 5; LRP-6, low density lipoprotein receptor related protein 6; CREB, cyclic-AMP response binding protein; p-ERK 1/2, phosphorylated-extracellular regulated kinase 1/2; HDL, high-density lipoprotein; CUMS, chronic unpredictable mild stress; SPT, sucrose preference test; OFT, open field test; FST, forced swimming test; IAT, independent activity test; ADE, avoiding dark experiment; TSE, tail suspension experiment; EPM, elevated plus maze; BL18, Ganshu; BL23, Shenshu; CV4, Guanyuan; CV6, Qihai; EX, Anmian; EX-HN1, Sishencong; GV20, Baihui; HT7, Shenmen; KI3, Taixi; KI15, Zhongzhu; LI4, Hegu; LR3, Taichong; PC6, Neiguan; SP6, Sanyinjiao; SP10, Xuehai; ST36, Zusanli.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Potential mechanisms by which acupuncture may improve perimenopausal depression and insomnia. Manual- and/or electro-acupuncture may alter hypothalamic-pituitary-adrenal and -ovarian hyperactivity; modulate reproductive hormones and their receptors, or regulate neurotransmitters, signaling pathways, and oxidative stress. Green indicates an upregulation/increase by acupuncture (↑); red indicates a downregulation/decrease (↓). Acupuncture may also improve perimenopausal depression and insomnia by improving vasomotor symptoms, while this indirect effect is not shown. Images are adapted from Servier Medical Art under Creative Commons CC-BY license.</citation_analysis></p></caption><graphic xlink:href="NSS-13-1823-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: HPA, hypothalamic-pituitary-adrenal; HPO, hypothalamic-pituitary-ovary; GR, glucocorticoid receptor; MR, mineralocorticoid receptor; GnRH, gonadotropin-releasing hormone; E2, estradiol; FSH, follicle-stimulating hormone; LH, luteinizing hormone; CRH, corticotropin-releasing hormone; ACTH, adrenocorticotropic hormone; CORT, cortisol; ERβ, estrogen receptor beta; 5-HT, 5-hydroxytryptamine; GABA, gamma-amino butyric acid; CREB, cAMP-response element-binding protein; BDNF, brain-derived neurotrophic factor; p-TrkB, phosphorylated-TrkB; PGD-2, prostaglandin D2; L-PGDS, lipocalin-type prostaglandin D synthase; LPO, lipid peroxidation; GSK-3β, glycogen synthase kinase-3 beta.</attrib></fig></citation_analysis></p>
      <sec id="s0005-s2001">
        <title>Modulation of Reproductive Hormones and Their Receptors</title>
        <p><citation_analysis attribute="neither">The established association between fluctuating hormonal milieu and sleep as well as mood is one explanation for the development of insomnia and/or depression during perimenopause.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2–4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0110" ref-type="bibr">110</xref></citation_analysis><citation_analysis attribute="neither"> The endocrine system is regarded as one of the principal intrinsic factors affecting women’s sleep and mood during their reproductive life span.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0096" ref-type="bibr">96</xref></citation_analysis><citation_analysis attribute="neither"> As estrogen is involved in the regulation and stabilization of the circadian rhythm system, its physiological fluctuation as well as a decreased sensitivity to estrogens in the hypothalamus during perimenopause contributes to circadian rhythm disturbances, and possibly the subsequent development of PMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="positive"> Woods et al investigated 286 women approaching menopause by establishing a mixed effects model, and found that in addition to age, crucial factors influencing sleep included the usage of exogenous hormones and women’s endogenous reproductive hormone levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0111" ref-type="bibr">111</xref></citation_analysis><citation_analysis attribute="positive"> The former can be used to explain the improvement that HRT produces in terms of PMI; and the latter may be a pathway to understand the possible mechanism underlying the benefits of acupuncture. That is, acupuncture moderates estrogen level in perimenopausal women as shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">. Likewise, the changing hormonal milieu also contributes to the depressive symptoms in women who are in menopausal transition.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="positive"> Some longitudinal analyses have suggested the correlation between reproductive hormones [eg, estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), etc] levels and sleep disturbances</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> or depressive symptoms</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="neither"> in perimenopause. Increased FSH levels are correlated with trouble staying asleep, while decreased E2 levels are correlated with both difficulty in falling and staying asleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="positive"> A strong linkage between frequent nocturnal awakenings and altered sex hormone levels (increments in FSH, and decrements in E2 and estrone) were reported in both the Study of Women’s Health Across the Nation (SWAN) and the Seattle Midlife Women’s Health Study (SMWHS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> The alteration of reproductive hormone levels due to ovarian aging also contributes to vasomotor symptoms via at least three pathways: 1) slight increases in core body temperature; 2) altered thermal threshold/resetting and narrowing of the thermoregulatory system; and 3) a decreased thermoneutral zone in the brain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0110" ref-type="bibr">110</xref></citation_analysis><citation_analysis attribute="neither"> The latter two alterations can reduce women’s ability to tolerate nocturnal hot flushes and subsequently cause sleep disruption.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0110" ref-type="bibr">110</xref></citation_analysis><citation_analysis attribute="positive"> An interesting finding is the inconsistent results in the links between different sleep indexes and FSH. Data from SWAN showed a relationship between the increased FSH over time and more slow wave sleep (SWS) recorded by polysomnography (PSG), which contrasts with findings correlating hormone fluctuation with subjective sleep indexes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> Among women with PMI, Fu et al also observed that acupuncture induced reductions in both wake after sleep onset (WASO) and arousal index (ArI),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither"> which were negatively correlated with E2 levels but positively correlated with FSH.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0113" ref-type="bibr">113</xref></citation_analysis><citation_analysis attribute="neither"> Estrogen is a mood-elevator as well, and its effect on emotional functions is partly mediated by the amygdala and hypothalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="neither"> New onset of PMD was strikingly associated with increased FSH and LH levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0112" ref-type="bibr">112</xref></citation_analysis><citation_analysis attribute="neither"> Decreasing E2 levels that occur approaching menopause are weakly linked to more depressive symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0115" ref-type="bibr">115</xref></citation_analysis><citation_analysis attribute="positive"> Exogenous estrogen (in the form of E2) has also been shown to be related to the reduction of PMD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="negative"> Among women without a history of depression, high variability in levels of FSH, LH, and E2 is linked to increased prevalence of PMD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Many clinical and animal studies cited in this review have confirmed the regulation of serum sex hormone levels by acupuncture (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Tables 2</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">5</xref></citation_analysis><citation_analysis attribute="positive">). Despite the lack of correlational analysis, almost all studies showed a consistent trend— the amelioration of PMI and/or PMD produced by acupuncture, along with increments in circulating E2 and/or decrements in FSH and LH levels. Researchers thereby inferred that the improvement of PMI/PMD by acupuncture might be achieved via the modulation of expression of one or more of these three hormones.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0116" ref-type="bibr">116–119</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">The estrogen receptors (ERα and ERβ) are closely related to the pathophysiology of climacteric-related neurological and psychiatric illness,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0120" ref-type="bibr">120</xref></citation_analysis><citation_analysis attribute="neither"> and their aberrant expression has been linked to a variety of cancers, particularly breast and ovarian cancers.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0120" ref-type="bibr">120</xref></citation_analysis><citation_analysis attribute="positive"> Yang reported that successful PMI modeling resulted in an increased expression of ERβ in the hypothalamus, which was prevented by acupuncture.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither"> This kind of aberrant expression of estrogen receptors are observed when rodents exposed to ovariectomy (OVX), modelling menopause, followed by CUMS, to induce depressive-like behaviours, as well.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0120" ref-type="bibr">120</xref></citation_analysis><citation_analysis attribute="positive"> These findings suggest that acupuncture may have brain-predominant effects in modulating estrogen receptors, with potential protective benefits underlying its sleep-promoting and antidepressive effects.</citation_analysis></p>
      </sec>
      <sec id="s0005-s2002">
        <title>Inhibition of Hyperactivity of HPA and HPO Axes</title>
        <p><citation_analysis attribute="positive">Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is a significant biological marker of depressive disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="positive"> A previous SR suggested that EA could reduce cortisol (CORT) release from the adrenal glands and thereby modify the HPA axis by downregulating the expression of corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) in the hypothalamus and pituitary gland, respectively, as well as decreasing the expression of CRH mRNA in the hypothalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither"> This hypothesis was tested in a PMD model by Jiang et al.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0124" ref-type="bibr">124</xref></citation_analysis><citation_analysis attribute="positive"> In this study, EA showed antidepressant-like effects that were no weaker than clomipramine in PMD rats, along with significant reductions in CRH, ACTH and CORT. Jiang also reported an increase in E2 and a decrease in FSH and LH levels in the rats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0124" ref-type="bibr">124</xref></citation_analysis><citation_analysis attribute="neither"> The response of HPA axis can be modulated by estrogen.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="positive"> Hence, Jiang’s findings further support the idea that acupuncture’s regulation of estrogen also contributes to its inhibition of hyperfunction of the HPA axis. This theory also partially explains the benefits of acupuncture on PMI. Since increased expression of ACTH and CORT causes an awakening effect, insomnia closely links to the hyperactivity of HPA axis as well.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0125" ref-type="bibr">125</xref></citation_analysis><citation_analysis attribute="positive"> Xi et al reported significant symptom-relief in chronic insomniacs who underwent acupuncture, accompanied by downregulation in serum CRH, ACTH and CORT expression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0126" ref-type="bibr">126</xref></citation_analysis><citation_analysis attribute="neither"> A reciprocal relationship has been established between the HPO and HPA axes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="neither"> Acupuncture appears to suppress these two axes synchronously. In three animal studies,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0124" ref-type="bibr">124</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0127" ref-type="bibr">127</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128</xref></citation_analysis><citation_analysis attribute="positive"> EA’s effects on HPO axis-related hormones was observed, including normalizing the reduced E2 and beta-endorphin as well as the increased LH and gonadotropin-releasing hormone (GnRH) in a PMD model. The sleep-promoting benefit of acupuncture may be further explained as well because there is also an interaction between the sleep-wake cycle system and the HPO axis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0113" ref-type="bibr">113</xref></citation_analysis><citation_analysis attribute="neither"> There is also an association between HPO axis and the orexin system, which is involved in the regulation of arousal and plays a cardinal role in sleep and wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0113" ref-type="bibr">113</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Huangfu et al have provided further prominent evidence that the inhibition of the HPA axis by EA might also be achieved via its modulation of the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0129" ref-type="bibr">129</xref></citation_analysis><citation_analysis attribute="neither"> Disruption of GR signaling is proposed to underlie HPA axis dysregulation observed in stress-related psychiatric illness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0130" ref-type="bibr">130</xref></citation_analysis><citation_analysis attribute="positive"> Huangfu reported a significant decline of both GR and MR in the hippocampus of PMD rats, which was reversed with 28-day EA (20 min per day). Along with the improvement of depression-like behavior, EA also increased the number and functional activity of neurons in the hippocampal CA3 region in this group of rats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0129" ref-type="bibr">129</xref></citation_analysis></p>
      </sec>
      <sec id="s0005-s2003">
        <title>Regulation of Neurotransmitters</title>
        <p><citation_analysis attribute="neither">At the neurochemical level, several mechanisms of sleep-wakefulness control and emotion regulation have been identified. Coordination of various neurotransmitters appears to play a vital role in this regulated alternation state.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0131" ref-type="bibr">131</xref></citation_analysis><citation_analysis attribute="positive"> For instance, the positive regulation of estrogen in sleep and mood disorders associated with menopause</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0132" ref-type="bibr">132</xref></citation_analysis><citation_analysis attribute="positive"> can be partially explained by its wide involvement in the metabolism of gamma-amino butyric acid (GABA), serotonin [5-hydroxytryptamine (5-HT)], norepinephrine, and acetylcholine.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0132" ref-type="bibr">132</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">It is well known that GABA is the dominant inhibitory transmitter.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0133" ref-type="bibr">133</xref></citation_analysis><citation_analysis attribute="neither"> Decreased GABAergic activity links to a weakening of the sleep-promotion system or a strengthening of the arousal system.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0134" ref-type="bibr">134</xref></citation_analysis><citation_analysis attribute="neither"> As the first-line hypnotics, benzodiazepines and benzodiazepine receptor agonists (Z-drugs) act by increasing the intrinsic activity of the GABA via binding to the receptor binding region of the GABA</citation_analysis><citation_analysis attribute="positive"><sub>A</sub></citation_analysis><citation_analysis attribute="neither"> receptor, which in turn exerts an inhibitory and suppressing effect on the outputs to all of the major cell groups in the brainstem and hypothalamus that promote hyperarousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0134" ref-type="bibr">134</xref></citation_analysis><citation_analysis attribute="neither"> Acupuncture appears to be able to ameliorate PMI via a similar pathway. The ventrolateral preoptic nucleus (VLPO) is a main cerebral region containing cluster of neurons essential for the initiation and maintenance of sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0135" ref-type="bibr">135</xref></citation_analysis><citation_analysis attribute="neither"> Cao et al observed that acupuncture upregulated the GABA levels in the VLPO in a PMI rat, which was positively correlated with prolonged REM sleep and SWS.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0136" ref-type="bibr">136</xref></citation_analysis><citation_analysis attribute="positive"> The same study also reported the effects of acupuncture on prostaglandin (PG) D2 system in cerebrospinal fluid. There were significant increments in lipocalin-type PGD synthase and PGD2 levels, and exiguity decrements in PGE2 levels, indicative of the multi-targeted effect of the intervention. Although acupuncture’s regulation of GABA is rarely investigated in PMI-related clinical trials, many trials have reported that acupuncture up-regulated serum GABA levels in patients with primary insomnia and chronic insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0137" ref-type="bibr">137</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0138" ref-type="bibr">138</xref></citation_analysis><citation_analysis attribute="positive"> Estrogen receptors are found throughout the brain, so estrogen shows modulatory effects on the neurotransmitter systems.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> One of the interpretations for the increased risk of PMD posits that depression is caused by the impacts of E2 fluctuations on neurotransmitter systems in cerebral regions that regulate mood and emotion.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> Dysregulation of the GABA balance between GABA</citation_analysis><citation_analysis attribute="positive"><sub>A</sub></citation_analysis><citation_analysis attribute="neither"> and GABA</citation_analysis><citation_analysis attribute="positive"><sub>B</sub></citation_analysis><citation_analysis attribute="neither"> due to hormone fluctuations also contributes to the increased vulnerability to depression during perimenopause.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0096" ref-type="bibr">96</xref></citation_analysis><citation_analysis attribute="neither"> Among women with PMD, the decreased GABA concentrations were found mainly in the anterior cingulate cortex, which is usually activated by diverse tasks including emotion processing and regulation and is closely associated with the occurrence and development of depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0139" ref-type="bibr">139</xref></citation_analysis><citation_analysis attribute="positive"> The GABAergic system and GABAergic neurosteroids show potential involvements in the etiology of PMD, as women whose GABARAR receptor fails to adjust to the rapid change in neurosteroid levels may be more prone to PMD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0133" ref-type="bibr">133</xref></citation_analysis><citation_analysis attribute="neither"> The effect of acupuncture in reinstating reduced hippocampal GABA content in rats with depression has been widely investigated and confirmed.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0140" ref-type="bibr">140</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0141" ref-type="bibr">141</xref></citation_analysis><citation_analysis attribute="neither"> It is worthwhile noting that the GABA system also plays a key role in restraining the HPA axis at the level of the paraventricular nucleus of the hypothalamus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0133" ref-type="bibr">133</xref></citation_analysis><citation_analysis attribute="neither"> The close relationship between the hyperactivity of the HPA and HPO axes and PMI and/or PMD has been mentioned in the earlier section. Furthermore, in many animal experiments cited in this review (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">), ovarian hormone deprivation due to OVX evoked significantly increased serum FSH and LH levels as well as reduced serum E2 level, suggesting ovarian failure results in the exhausted hypothalamic GABA contents. The acupuncture-induced reversal of these disrupted hormone and neurotransmitter levels thereby seems to modulate the upstream factors of the HPO axis and inhibit the HPA-axis hyperactivity, potentially by reinstating the hypothalamic GABAergic neuronal function.</citation_analysis></p>
        <p><citation_analysis attribute="neither">As with GABA system, a dysfunctional serotonergic system is another factor contributing to the development of PMD, a mechanism that is receiving increasing attention.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0133" ref-type="bibr">133</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0142" ref-type="bibr">142</xref></citation_analysis><citation_analysis attribute="positive"> The available evidence suggests there are lower serum 5-HT levels in postmenopausal women than in regularly menstruating women;</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0143" ref-type="bibr">143</xref></citation_analysis><citation_analysis attribute="neither"> and in comparison to the natural menopause in humans, the decline of 5-HT levels following ovariectomy is more drastic.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0143" ref-type="bibr">143</xref></citation_analysis><citation_analysis attribute="neither"> Selective serotonin reuptake inhibitors are one of the most frequently utilized non-hormonal substitutes for menopausal symptoms,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0144" ref-type="bibr">144</xref></citation_analysis><citation_analysis attribute="neither"> suggesting that serotonin is widely involved in multiple symptoms during the menopausal stage. Both the odds of PMD and the severity of PMD symptoms are negatively correlated with serotonin levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0142" ref-type="bibr">142</xref></citation_analysis><citation_analysis attribute="neither"> Both human clinical</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0071" ref-type="bibr">71</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0084" ref-type="bibr">84</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0093" ref-type="bibr">93</xref></citation_analysis><citation_analysis attribute="neither"> and animal studies</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0145" ref-type="bibr">145–149</xref></citation_analysis><citation_analysis attribute="positive"> have revealed the increases in serum 5-HT and/or hippocampal 5-HT and its major metabolites caused by acupuncture, along with decreased PMD symptoms or depression-like behaviors. In addition to the enhancement of 5-HT synthesis and the increase of 5-HT and its metabolite content in the brain and synaptic gaps, previous studies also suggested that acupuncture restored synaptic plasticity by regulating serotonin expression in the hippocampus resulting in relieved depression symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0150" ref-type="bibr">150</xref></citation_analysis><citation_analysis attribute="neither"> This process involves acupuncture-induced bidirectional regulation of the expression of serotonin transporters (5-HTTs) and serotonin-1A (5-HT1A), which then increases the expression of hippocampal galanin (Gal) and tryptophan hydroxylase (TPH) as well as restores or reverses the impairments in synaptic plasticity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither"> Given existing animal studies mainly focused on hippocampus, future studies within in field might benefit from some investigations of other cerebral regions important for depressive-like symptoms including amygdala and prefrontal cortex. Serotonin also plays an integral part in the process of sleep preparation, initiation, and maintenance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0151" ref-type="bibr">151</xref></citation_analysis><citation_analysis attribute="neither"> In both serum and hippocampus of PMI rats,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0121" ref-type="bibr">121</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0152" ref-type="bibr">152</xref></citation_analysis><citation_analysis attribute="positive"> researchers observed that acupuncture treatment led to increments in serotonin and its chief end-product of metabolism, accompanied by significant increases in REM and SWS. This finding is also meaningful for PMD, because these two sleep outcomes are usually shown to be less in women with depression compared with the healthy women.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> Estrogen affects the serotonin system in several ways, including promoting the synthesis of serotonin by increasing the rate of degradation of monoamine oxidase (the enzyme that catabolizes serotonin), and inhibiting the reuptake of serotonin by affecting intraneuronal serotonin transport.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0153" ref-type="bibr">153</xref></citation_analysis><citation_analysis attribute="neither"> E2, for instance, is able to stimulate the production of neurotransmitters such as serotonin and to enhance serotonergic function in depression and its treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0114" ref-type="bibr">114</xref></citation_analysis><citation_analysis attribute="positive"> In the previous section, we displayed both clinical and animal evidence that acupuncture increased E2 levels. It is hence reasonable to summarize that acupuncture can directly elevate serotonin levels, but also indirectly strengthen the benign regulation of serotonin in sleep and mood with this increased E2.</citation_analysis></p>
      </sec>
      <sec id="s0005-s2004">
        <title>Reduction of Oxidative Stress Levels</title>
        <p><citation_analysis attribute="neither">Oxidative stress plays a critical part in the pathophysiology of sleep disturbance, as brain-free radicals accumulate during wakefulness and are removed during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0154" ref-type="bibr">154</xref></citation_analysis><citation_analysis attribute="neither"> Compared with good sleepers, insomniacs generally have much higher oxidative stress parameters.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0155" ref-type="bibr">155</xref></citation_analysis><citation_analysis attribute="neither"> Meanwhile, oxidative stress is a pivotal factor in ageing.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0156" ref-type="bibr">156</xref></citation_analysis><citation_analysis attribute="neither"> Menopause is an aging process, in which oxidative stress plays a crucial role in developing a diversity of symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0156" ref-type="bibr">156</xref></citation_analysis><citation_analysis attribute="neither"> The decline of estrogen during menopause results in the massive release of reactive oxygen species (ROS) and creates a pro-oxidant state,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0157" ref-type="bibr">157</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0158" ref-type="bibr">158</xref></citation_analysis><citation_analysis attribute="positive"> which explains the association between increased oxidative stress and climacteric symptoms due to insufficient estrogen. Treatment with antioxidant estrogen has been shown to lead to a reduction in the occurrence of sleep disturbances, implying that the improvement of oxygen metabolism may be a potential management strategy for climacteric-related sleep disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0159" ref-type="bibr">159</xref></citation_analysis><citation_analysis attribute="neither"> Recent study identified an evident imbalance between lipid peroxidation (LPO) and the antioxidant defense system among the menopausal insomniacs,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0160" ref-type="bibr">160</xref></citation_analysis><citation_analysis attribute="neither"> providing a pathogenic rationale for including drugs that inhibit LPO activation in the synthetical therapy of these patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0161" ref-type="bibr">161</xref></citation_analysis><citation_analysis attribute="positive"> A cross-sectional study involving 187 perimenopausal women also suggested that there was a positive correlation between insomnia score, menopause rating score, and LPO.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0157" ref-type="bibr">157</xref></citation_analysis><citation_analysis attribute="neither"> Acupuncture has been found to normalize disordered LPO processes, and prevent formation and accumulation of LPO products in sleep deprivation-associated regions of the brain, particularly hippocampus.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0162" ref-type="bibr">162</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0163" ref-type="bibr">163</xref></citation_analysis><citation_analysis attribute="positive"> The association between menopause-related depression and oxidative stress has been identified as well. Hirose et al reported that depressive symptoms among middle-aged women were independently associated with high urinary 8-OHdG, a biomarker indicator of oxidatively damaged DNA reflecting the severity of oxidative stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0164" ref-type="bibr">164</xref></citation_analysis><citation_analysis attribute="positive"> Although there is no direct evidence investigating the effect of acupuncture on 8-OHdG in PMD populations, MA was found to improve cognitive function and mood in patients with vascular dementia, along with significant decline in urinary 8-OHdG.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0165" ref-type="bibr">165</xref></citation_analysis><citation_analysis attribute="neither"> The mechanisms linking PMD to oxidative stress appear to be bidirectional: high oxidative stress may lower norepinephrine and serotonin and levels, which in turn results in depression; depression may contribute to ROS production as well as weaken the antioxidant defense system.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0164" ref-type="bibr">164</xref></citation_analysis><citation_analysis attribute="neither"> Tian observed striking increases in serum malondialdehyde (MDA) which is the LPO product as well as striking decreases in serum superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) which are the two major intracellular antioxidant enzymes in rats that underwent OVX, which were reversed by acupuncture.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0106" ref-type="bibr">106</xref></citation_analysis><citation_analysis attribute="neither"> A recent RCT revealed that EA significantly decreased level of lipid hydroperoxides, a byproduct of oxidative stress, among insomniacs.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0166" ref-type="bibr">166</xref></citation_analysis><citation_analysis attribute="positive"> Acupuncture was also reported to retard the drastic decline of SOD and nitric oxide synthase (NOS) levels in plasma and uterine tissues of rats naturally entering menopause.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0107" ref-type="bibr">107</xref></citation_analysis><citation_analysis attribute="neither"> Besides the increment of GSH-Px and SOD contents, the upregulation in expression of CuZnSOD mRNA and protein is another pathway by which acupuncture may ameliorate oxidative injuries.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0162" ref-type="bibr">162</xref></citation_analysis><citation_analysis attribute="positive"> These findings suggest that the antioxidant mechanism underlying acupuncture may be associated with its effects on a cluster of oxidative stress-related enzymes inducing a nonspecific response. Oxidative stress levels are also positively correlated with climacteric hot flushes,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0167" ref-type="bibr">167</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0168" ref-type="bibr">168</xref></citation_analysis><citation_analysis attribute="neither"> a potential contributor of PMI</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0169" ref-type="bibr">169</xref></citation_analysis><citation_analysis attribute="neither"> and PMD</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> as mentioned. Among women aged 45–55 years, those with hot flushes were found to show lower levels of plasma total antioxidant activity compared with women free of this symptom.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0168" ref-type="bibr">168</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, acupuncture may also reduce hot flushes via resisting the oxidation effects, which in turn reduces PMI and PMD.</citation_analysis></p>
      </sec>
      <sec id="s0005-s2005">
        <title>Promotion of Signaling Pathways</title>
        <p><citation_analysis attribute="positive">The effects of acupuncture on signaling pathways have also been widely studied, providing a new perspective to understand the clinical efficacy of acupuncture at a molecular level.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="positive"> We identified six animal studies involving three signal transduction pathways that revealed possible mechanisms implicated in the improvement of PMD by acupuncture.</citation_analysis></p>
        <p><citation_analysis attribute="neither">Brain-derived neurotrophic factor (BDNF) in the hippocampus is a crucial target for the treatment of depression,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0170" ref-type="bibr">170</xref></citation_analysis><citation_analysis attribute="neither"> and it may be linked with the development of depression by cAMP-response element-binding protein (CREB) and its upstream pathways.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0140" ref-type="bibr">140</xref></citation_analysis><citation_analysis attribute="positive"> Many conventional antidepressive agents mediate antidepressant-like effects via increasing synthesis and signal transduction of cerebral BDNF expression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0123" ref-type="bibr">123</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0170" ref-type="bibr">170</xref></citation_analysis><citation_analysis attribute="positive"> Acupuncture appears to work on the same signaling pathway. Two studies demonstrated that EA altered depression-like behavior in PMD rats by normalizing the downregulated expression of hippocampal CREB, BDNF, and phosphorylated-TrkB (p-TrkB) which is a high-affinity receptor of BDNF.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0170" ref-type="bibr">170</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0171" ref-type="bibr">171</xref></citation_analysis><citation_analysis attribute="positive"> Activation of BDNF/TrkB/CREB pathway is thereby suggested as a potential mechanism implicated in the beneficial effects of acupuncture on PMD. This pathway may also link to the improvements in PMI by acupuncture. Although there is no direct evidence, Liu reported that EA improved both sleep and cognitive functions (learning and memory) in sleep-deprived rats by activating the PKA-Cβ/CREB/BDNF/TrkB signaling pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0172" ref-type="bibr">172</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Activation of the Wnt/β-catenin signaling pathway has moderation effect on multiple aspects of hippocampal neurogenesis, which has been linked to depressive symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0173" ref-type="bibr">173</xref></citation_analysis><citation_analysis attribute="neither"> Glycogen synthase kinase-3β (GSK-3β) and β-catenin are key proteins of Wnt signaling, which comprise a degradation complex to phosphorylated (p)-β-catenin to be ubiquitined.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0174" ref-type="bibr">174</xref></citation_analysis><citation_analysis attribute="positive"> These critical regulatory molecules particularly GSK-3β and β-catenin are suggested to be targets and/or action modifiers of antidepressants such as lithium</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0175" ref-type="bibr">175</xref></citation_analysis><citation_analysis attribute="neither"> and fluoxetine.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0176" ref-type="bibr">176</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, regulation of these proteins was also observed in two studies in which acupuncture improved depressive-like symptoms in PMD rats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0174" ref-type="bibr">174</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0177" ref-type="bibr">177</xref></citation_analysis><citation_analysis attribute="neither"> As reported, hippocampal mRNA and protein expression of GSK-3β were decreased, while mRNA and protein expression of β-catenin were increased after 28-days EA treatment. Another study showed that acupuncture reduced the expression of Dickkopf 1 (DKK1) and low-density lipoprotein receptor-related protein (LRP) 5/6 in the hippocampus of PMD rats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0178" ref-type="bibr">178</xref></citation_analysis><citation_analysis attribute="neither"> As an endogenous inhibitor, DKK1 binds to LRP 5/6 and results in the inhibition of canonical Wnt signaling pathway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0179" ref-type="bibr">179</xref></citation_analysis><citation_analysis attribute="positive"> These findings suggest that activation of the Wnt/β-catenin signaling pathway may be another mechanism by which acupuncture mediates antidepressant-like effects. We identified no studies investigating PMI in association with the Wnt/β-catenin signaling pathway, highlighting a significant gap in the literature, but Qu et al have reported that activation of this pathway enhanced hippocampal neurogenesis and improved learning and memory in sleep-deprived mice.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0180" ref-type="bibr">180</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">The Notch signaling pathway is involved in the promotion of neurogenesis and brain plasticity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0181" ref-type="bibr">181</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0182" ref-type="bibr">182</xref></citation_analysis><citation_analysis attribute="neither"> Notch1 is the principal Notch receptor,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0183" ref-type="bibr">183</xref></citation_analysis><citation_analysis attribute="neither"> and it can interact with ligands such as Jagged1 and then trigger the release of the Notch intracellular domain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0182" ref-type="bibr">182</xref></citation_analysis><citation_analysis attribute="neither"> As the major downstream target genes of Notch signaling, Hes is found to take part in the inhibition of neuronal differentiation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0184" ref-type="bibr">184</xref></citation_analysis><citation_analysis attribute="positive"> Emerging evidence has shown that Notch signaling is associated with the depression-like performance in mid-aged female rats undergoing chronic restraint stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0182" ref-type="bibr">182</xref></citation_analysis><citation_analysis attribute="positive"> Deng et al established PMD model by chronic stress and reported decreased expression in hippocampal Notch1 protein and mRNA, as well as increased expression in both hippocampal Jagged1 protein and mRNA as well as hippocampal Hes1 protein and mRNA in PMD rats, which were reversed by EA treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0185" ref-type="bibr">185</xref></citation_analysis><citation_analysis attribute="neither"> These results imply that acupuncture can improve PMD performance, possibly by increased neurogenesis and promoted neuronal differentiation via activating the Notch signaling pathway.</citation_analysis></p>
      </sec>
      <sec id="s0005-s2006">
        <title>Attenuation of Vasomotor and Other Perimenopausal Symptoms</title>
        <p><citation_analysis attribute="positive">Krystal et al suggested that PMI is a vasomotor-initiated sleep disruption as it is usually triggered initially by night sweats.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0169" ref-type="bibr">169</xref></citation_analysis><citation_analysis attribute="positive"> Some longitudinal investigations and SRs/MAs of perimenopause have also indicated the positive correlation between vasomotor complaints and poor sleep and/or depressive symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> In comparison with those without vasomotor symptoms, women suffering from more night sweats weekly are with more likelihood to report sleep difficulties.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="negative"> Translated, women with vasomotor symptoms are more at risk for insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0186" ref-type="bibr">186</xref></citation_analysis><citation_analysis attribute="neither"> However, there is a theory that vasomotor symptoms are not a necessary prerequisite for PMD,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="negative"> while perimenopausal women with hot flushes are indeed at higher risk of developing depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, women with PMD have a higher likelihood of being irritable from vasomotor symptoms and report greater severity of their hot flushes. They are also most likely to seek help from primary health care services.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> Some recent evidence reveals a bidirectional relationship between PMD and vasomotor complaints.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="positive"> It is thought that this relationship may not be simply explained by the mediating effect of sleep disruption,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0122" ref-type="bibr">122</xref></citation_analysis><citation_analysis attribute="neither"> whereas PMD and perimenopausal anxiety due to vasomotor symptoms do contribute to the impaired sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0110" ref-type="bibr">110</xref></citation_analysis><citation_analysis attribute="neither"> Attenuation of vasomotor symptoms by acupuncture thereby partially explains why it promotes the PMI relief.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0186" ref-type="bibr">186</xref></citation_analysis><citation_analysis attribute="positive"> Plenty of clinical data cited in our review have shown that acupuncture significantly lowered the Kupperman Index global scores (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">). Hot flushes and sweating are the critical and most weighted items of the Kupperman Index scale.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0187" ref-type="bibr">187</xref></citation_analysis><citation_analysis attribute="positive"> Although the frequency of hot flushes and night sweats were not directly assessed in our included clinical papers, acupuncture is sure to be promising to mitigate menopausal-associated vasomotor symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0188" ref-type="bibr">188</xref></citation_analysis><citation_analysis attribute="positive"> As denoted in the umbrella systematic review performed by Befus et al in 2018, evidence from RCTs supports the utilization of acupuncture as an adjunctive or stand-alone remedy option for reducing vasomotor symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0188" ref-type="bibr">188</xref></citation_analysis><citation_analysis attribute="positive"> Additionally, two included animal studies</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0189" ref-type="bibr">189</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0190" ref-type="bibr">190</xref></citation_analysis><citation_analysis attribute="positive"> reported that acupuncture significantly increased total sleep time and reduced sleep onset latency in PMI rats, along with enhancement of the rats’ heat-resistant ability (prolongation of heat-resistant time). Accumulating evidence suggests that acupuncture-induced temperature control and reduction in hot flushes among climacteric women is achieved by elevating beta-endorphin level and suppressing GnRH secretion.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0191" ref-type="bibr">191</xref></citation_analysis><citation_analysis attribute="positive"> These benefits of acupuncture were validated again in PMD rats and were accompanied by a significant reduction in depression-like behavior.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0124" ref-type="bibr">124</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0127" ref-type="bibr">127</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0128" ref-type="bibr">128</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, serotonin regulates thermoregulation and peripheral vasculature.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0153" ref-type="bibr">153</xref></citation_analysis><citation_analysis attribute="positive"> The effect of acupuncture on serotonin may therefore explain the reduced vasomotor symptoms as well. Although there is debate available regarding acupuncture treatment for hot flushes, the controversy focuses only on its placebo effects. A comprehensive review by Ee et al suggested that acupuncture did not show better effects in comparison with sham-acupuncture;</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0192" ref-type="bibr">192</xref></citation_analysis><citation_analysis attribute="neither"> another network meta-analysis exhibited opposite conclusion.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0193" ref-type="bibr">193</xref></citation_analysis><citation_analysis attribute="neither"> In comparison with no treatment, however, the benefits of acupuncture or placebo-acupuncture are clear, according to both papers.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0192" ref-type="bibr">192</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0193" ref-type="bibr">193</xref></citation_analysis><citation_analysis attribute="neither"> In summary, reducing the sleep disruption and/or depressive symptoms by relieving hot flushes is a possible explanation for acupuncture’s benefits on PMI and PMD, although further research is required.</citation_analysis></p>
        <p><citation_analysis attribute="neither">The interdependent and interactional relationship between anxiety, depression, and insomnia has been established in women with perimenopausal complaints.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="positive"> However, this relationship appears to be underestimated and does not receive adequate attention in the current research, as only 4 of the 22 PMI RCTs included emotion-related indicators</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0064" ref-type="bibr">64</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0065" ref-type="bibr">65</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0067" ref-type="bibr">67</xref></citation_analysis><citation_analysis attribute="positive"> and none of the 25 PMD RCTs included sleep-related indicators. According to the domino theory mentioned in the previous section, the improvement of insomnia caused by acupuncture may also be one of the mechanisms of PMD remission, and vice versa. Future trials hence should be more comprehensive in their outcome tools. For instance, scales/questionnaires should cover sleep, mood, vasomotor symptoms as well as quality of life, and even consider introducing PSG/actigraphy and neuropsychological tests. With these data we will be able to appraise intricate associations between menopausal characteristics, sleep, mood, lifestyle factors, and women’s expectation and experience of acupuncture, which will further our understanding of the true role of acupuncture in perimenopause management. Animal experiments are also required to investigate the mechanisms behind acupuncture on a larger scale.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0006">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">Our review demonstrates that acupuncture has a positive and broad effect on PMI and PMD, being beneficial on mood, sleep, and vasomotor symptoms. Consistent data from clinical trials and animal studies support that those effects possibly are mediated through a number of mechanisms, from regulation of reproductive hormones and neurotransmitters, and inhibitions in oxidative stress and HPA and HPO axis hyperactivity, to activation and deactivation of key proteins in various signaling pathways. Neuroendocrine modulation is likely to play a major role in mediating those effects. Despite some methodological deficiencies, acupuncture could be an adjunct therapy or viable and safe option for women with comorbid depression and insomnia during perimenopause. The multi-faceted effects of acupuncture on, and the TCM syndrome patterns of, PMI and PMD provide an innovative direction for future research.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <sec sec-type="COI-statement" id="s0007">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">None of the authors have any conflicts of interest to declare in this study.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kravitz</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Joffe</surname>
<given-names>H</given-names></string-name>. <article-title>Sleep during the perimenopause: a SWAN story</article-title>. <source><italic toggle="yes">Obstet Gynecol Clin North Am</italic></source>. <year>2011</year>;<volume>38</volume>(<issue>3</issue>):<fpage>567</fpage>–<lpage>586</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ogc.2011.06.002</pub-id><pub-id pub-id-type="pmid">21961720</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Augoulea</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Moros</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lykeridou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kaparos</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lyberi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Panoulis</surname>
<given-names>K</given-names></string-name>. <article-title>Psychosomatic and vasomotor symptom changes during transition to menopause</article-title>. <source><italic toggle="yes">Prz Menopauzalny</italic></source>. <year>2019</year>;<volume>18</volume>(<issue>2</issue>):<fpage>110</fpage>–<lpage>115</lpage>.<pub-id pub-id-type="pmid">31485208</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Raglan</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Schulkin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Micks</surname>
<given-names>E</given-names></string-name>. <article-title>Depression during perimenopause: the role of the obstetrician-gynecologist</article-title>. <source><italic toggle="yes">Arch Womens Ment Health</italic></source>. <year>2020</year>;<volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00737-019-0950-6</pub-id><pub-id pub-id-type="pmid">30758732</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Caruso</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Masci</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Cipollone</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>. <article-title>Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop</article-title>. <source><italic toggle="yes">Maturitas</italic></source>. <year>2019</year>;<volume>123</volume>:<fpage>78</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.maturitas.2019.02.007</pub-id><pub-id pub-id-type="pmid">31027682</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gyllstrom</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Schreiner</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Harlow</surname>
<given-names>BL</given-names></string-name>. <article-title>Perimenopause and depression: strength of association, causal mechanisms and treatment recommendations</article-title>. <source><italic toggle="yes">Best Pract Res Clin Obstet Gynaecol</italic></source>. <year>2007</year>;<volume>21</volume>(<issue>2</issue>):<fpage>275</fpage>–<lpage>292</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpobgyn.2006.11.002</pub-id><pub-id pub-id-type="pmid">17166771</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Maki</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Kornstein</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Joffe</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Board of trustees for the North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2018</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1069</fpage>–<lpage>1085</lpage>.<pub-id pub-id-type="pmid">30179986</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ayaki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tsubota</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kawashima</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kishimoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mimura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Negishi</surname>
<given-names>K</given-names></string-name>. <article-title>Sleep disorders are a prevalent and serious comorbidity in dry eye</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2018</year>;<volume>59</volume>(<issue>14</issue>):<fpage>DES143</fpage>–<lpage>DES150</lpage>. doi:<pub-id pub-id-type="doi">10.1167/iovs.17-23467</pub-id><pub-id pub-id-type="pmid">30481819</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joffe</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Petrillo</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Koukopoulos</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2011</year>;<volume>96</volume>(<issue>7</issue>):<fpage>E1044</fpage>–<lpage>E1054</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2010-2503</pub-id><pub-id pub-id-type="pmid">21525161</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terauchi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Obayashi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Akiyoshi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Matsushima</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kubota</surname>
<given-names>T</given-names></string-name>. <article-title>Insomnia in Japanese peri- and postmenopausal women</article-title>. <source><italic toggle="yes">Climacteric</italic></source>. <year>2010</year>;<volume>13</volume>(<issue>5</issue>):<fpage>479</fpage>–<lpage>486</lpage>. doi:<pub-id pub-id-type="doi">10.3109/13697130903353478</pub-id><pub-id pub-id-type="pmid">19886814</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baker</surname>
<given-names>FC</given-names></string-name>, <string-name><surname>de Zambotti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Colrain</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Bei</surname>
<given-names>B</given-names></string-name>. <article-title>Sleep problems during the menopausal transition: prevalence, impact, and management challenges</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2018</year>;<volume>10</volume>:<fpage>73</fpage>–<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S125807</pub-id><pub-id pub-id-type="pmid">29445307</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morssinkhof</surname>
<given-names>MWL</given-names></string-name>, <string-name><surname>van Wylick</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Priester-Vink</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Associations between sex hormones, sleep problems and depression: a systematic review</article-title>. <source><italic toggle="yes">Neurosci Biobehav Rev</italic></source>. <year>2020</year>;<volume>118</volume>:<fpage>669</fpage>–<lpage>680</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.08.006</pub-id><pub-id pub-id-type="pmid">32882313</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Im</surname>
<given-names>EO</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>YL</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chee</surname>
<given-names>W</given-names></string-name>. <article-title>The association of depressive symptoms to sleep-related symptoms during menopausal transition: racial/ethnic differences</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2020</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1315</fpage>–<lpage>1321</lpage>. doi:<pub-id pub-id-type="doi">10.1097/GME.0000000000001611</pub-id><pub-id pub-id-type="pmid">33110048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Santoro</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Epperson</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Mathews</surname>
<given-names>SB</given-names></string-name>. <article-title>Menopausal symptoms and their management</article-title>. <source><italic toggle="yes">Endocrinol Metab Clin North Am</italic></source>. <year>2015</year>;<volume>44</volume>(<issue>3</issue>):<fpage>497</fpage>–<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ecl.2015.05.001</pub-id><pub-id pub-id-type="pmid">26316239</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Miller</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Girgis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>R</given-names></string-name>. <article-title>Depression and related disorders during the female reproductive cycle</article-title>. <source><italic toggle="yes">Womens Health (Lond)</italic></source>. <year>2009</year>;<volume>5</volume>(<issue>5</issue>):<fpage>577</fpage>–<lpage>587</lpage>. doi:<pub-id pub-id-type="doi">10.2217/WHE.09.44</pub-id><pub-id pub-id-type="pmid">19702456</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krystal</surname>
<given-names>AD</given-names></string-name>. <article-title>Depression and insomnia in women</article-title>. <source><italic toggle="yes">Clin Cornerstone</italic></source>. <year>2004</year>;<volume>6</volume>(<issue>1</issue>):<fpage>S19</fpage>–<lpage>S28</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1098-3597(04)80022-X</pub-id><pub-id pub-id-type="pmid">15457812</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xiao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Q</given-names></string-name>. <article-title>Effectiveness and safety of acupuncture for perimenopausal depression: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source><italic toggle="yes">Evid Based Complement Alternat Med</italic></source>. <year>2020</year>;<volume>2020</volume>:<fpage>5865697</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2020/5865697</pub-id><pub-id pub-id-type="pmid">32051687</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>De Las Cuevas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Peñate</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Sanz</surname>
<given-names>EJ</given-names></string-name>. <article-title>Risk factors for non-adherence to antidepressant treatment in patients with mood disorders</article-title>. <source><italic toggle="yes">Eur J Clin Pharmacol</italic></source>. <year>2014</year>;<volume>70</volume>(<issue>1</issue>):<fpage>89</fpage>–<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00228-013-1582-9</pub-id><pub-id pub-id-type="pmid">24013851</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ashton</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Jamerson</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Weinstein</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wagoner</surname>
<given-names>C</given-names></string-name>. <article-title>Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey</article-title>. <source><italic toggle="yes">Curr Ther Res Clin Exp</italic></source>. <year>2005</year>;<volume>66</volume>(<issue>2</issue>):<fpage>96</fpage>–<lpage>106</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.curtheres.2005.04.006</pub-id><pub-id pub-id-type="pmid">24672116</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>FY</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>QQ</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>GA</given-names></string-name>, et al. <article-title>Comparative utility of acupuncture and Western medication in the management of perimenopausal insomnia: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Evid Based Complement Alternat Med</italic></source>. <year>2021</year>;<volume>2021</volume>:<fpage>5566742</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2021/5566742</pub-id><pub-id pub-id-type="pmid">33986818</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Asnis</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Henderson</surname>
<given-names>MA</given-names></string-name>. <article-title>Pharmacotherapy treatment options for insomnia: a primer for clinicians</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2015</year>;<volume>17</volume>(<issue>1</issue>):<fpage>50</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms17010050</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dodin</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Blanchet</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Marc</surname>
<given-names>I</given-names></string-name>, et al. <article-title>Acupuncture for menopausal hot flushes</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2013</year>;(<issue>7</issue>):<fpage>CD007410</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD007410.pub2</pub-id><pub-id pub-id-type="pmid">23897589</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baumelou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Nie</surname>
<given-names>GN</given-names></string-name>. <article-title>Perspectives in clinical research of acupuncture on menopausal symptoms</article-title>. <source><italic toggle="yes">Chin J Integr Med</italic></source>. <year>2011</year>;<volume>17</volume>(<issue>12</issue>):<fpage>893</fpage>–<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11655-011-0930-9</pub-id><pub-id pub-id-type="pmid">22139540</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hachul</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Oliveira</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Bittencourt</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Tufik</surname>
<given-names>S</given-names></string-name>. <article-title>The beneficial effects of massage therapy for insomnia in postmenopausal women</article-title>. <source><italic toggle="yes">Sleep Sci</italic></source>. <year>2014</year>;<volume>7</volume>(<issue>2</issue>):<fpage>114</fpage>–<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.slsci.2014.09.005</pub-id><pub-id pub-id-type="pmid">26483913</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Newton</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Buist</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Keenan</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>LaCroix</surname>
<given-names>AZ</given-names></string-name>. <article-title>Use of alternative therapies for menopause symptoms: results of a population-based survey</article-title>. <source><italic toggle="yes">Obstet Gynecol</italic></source>. <year>2002</year>;<volume>100</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">12100799</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Williams</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Kalilani</surname>
<given-names>L</given-names></string-name>, <string-name><surname>DiBenedetti</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Fehnel</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>RV</given-names></string-name>. <article-title>Healthcare seeking and treatment for menopausal symptoms in the United States</article-title>. <source><italic toggle="yes">Maturitas</italic></source>. <year>2007</year>;<volume>58</volume>(<issue>4</issue>):<fpage>348</fpage>–<lpage>358</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.maturitas.2007.09.006</pub-id><pub-id pub-id-type="pmid">17964093</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cheuk</surname>
<given-names>DKL</given-names></string-name>, <string-name><surname>Yeung</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>V</given-names></string-name>. <article-title>Acupuncture for insomnia</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2012</year>;<volume>9</volume>(<issue>9</issue>):<fpage>CD005472</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yeung</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>YK</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Law</surname>
<given-names>AC</given-names></string-name>. <article-title>Traditional needle acupuncture treatment for insomnia: a systematic review of randomized controlled trials</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2009</year>;<volume>10</volume>(<issue>7</issue>):<fpage>694</fpage>–<lpage>704</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2008.08.012</pub-id><pub-id pub-id-type="pmid">19303356</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chon</surname>
<given-names>TY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MC</given-names></string-name>. <article-title>Acupuncture</article-title>. <source><italic toggle="yes">Mayo Clin Proc</italic></source>. <year>2013</year>;<volume>88</volume>(<issue>10</issue>):<fpage>1141</fpage>–<lpage>1146</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mayocp.2013.06.009</pub-id><pub-id pub-id-type="pmid">24079683</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Langevin</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Schnyer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>MacPherson</surname>
<given-names>H</given-names></string-name>, et al.; <collab>Executive Board of the Society for Acupuncture Research</collab>. <article-title>Manual and electrical needle stimulation in acupuncture research: pitfalls and challenges of heterogeneity</article-title>. <source><italic toggle="yes">J Altern Complement Med</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>3</issue>):<fpage>113</fpage>–<lpage>128</lpage>. doi:<pub-id pub-id-type="doi">10.1089/acm.2014.0186</pub-id><pub-id pub-id-type="pmid">25710206</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>He</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zuo</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Acupuncture for treatment of insomnia: an overview of systematic reviews</article-title>. <source><italic toggle="yes">Complement Ther Med</italic></source>. <year>2019</year>;<volume>42</volume>:<fpage>407</fpage>–<lpage>416</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ctim.2018.12.020</pub-id><pub-id pub-id-type="pmid">30670275</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Smith</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Armour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LQ</given-names></string-name>, <string-name><surname>Hay</surname>
<given-names>PJ</given-names></string-name>. <article-title>Acupuncture for depression</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2018</year>;<volume>3</volume>(<issue>3</issue>):<fpage>CD004046</fpage>.<pub-id pub-id-type="pmid">29502347</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Femenía</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gómez-Galán</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lindskog</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Magara</surname>
<given-names>S</given-names></string-name>. <article-title>Dysfunctional hippocampal activity affects emotion and cognition in mood disorders</article-title>. <source><italic toggle="yes">Brain Res</italic></source>. <year>2012</year>;<volume>1476</volume>:<fpage>58</fpage>–<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brainres.2012.03.053</pub-id><pub-id pub-id-type="pmid">22541166</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hamidi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Drevets</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Price</surname>
<given-names>JL</given-names></string-name>. <article-title>Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2004</year>;<volume>55</volume>(<issue>6</issue>):<fpage>563</fpage>–<lpage>569</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2003.11.006</pub-id><pub-id pub-id-type="pmid">15013824</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hua</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>G</given-names></string-name>. <article-title>Abnormal whole-brain functional connectivity in patients with primary insomnia</article-title>. <source><italic toggle="yes">Neuropsychiatr Dis Treat</italic></source>. <year>2017</year>;<volume>13</volume>:<fpage>427</fpage>–<lpage>435</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S128811</pub-id><pub-id pub-id-type="pmid">28243094</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>O’Byrne</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Berman Rosa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gouin</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Dang-Vu</surname>
<given-names>TT</given-names></string-name>. <article-title>Neuroimaging findings in primary insomnia</article-title>. <source><italic toggle="yes">Pathol Biol (Paris)</italic></source>. <year>2014</year>;<volume>62</volume>(<issue>5</issue>):<fpage>262</fpage>–<lpage>269</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.patbio.2014.05.013</pub-id><pub-id pub-id-type="pmid">25129873</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>MacPherson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Walters</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fitter</surname>
<given-names>M</given-names></string-name>. <article-title>The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2001</year>;<volume>323</volume>(<issue>7311</issue>):<fpage>486</fpage>–<lpage>487</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.323.7311.486</pub-id><pub-id pub-id-type="pmid">11532841</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>White</surname>
<given-names>A</given-names></string-name>. <article-title>The safety of acupuncture–evidence from the UK</article-title>. <source><italic toggle="yes">Acupunct Med</italic></source>. <year>2006</year>;<volume>24</volume>(<issue>1S</issue>):<fpage>53</fpage>–<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1136/aim.24.Suppl.53</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>White</surname>
<given-names>A</given-names></string-name>. <article-title>A cumulative review of the range and incidence of significant adverse events associated with acupuncture</article-title>. <source><italic toggle="yes">Acupunct Med</italic></source>. <year>2004</year>;<volume>22</volume>(<issue>3</issue>):<fpage>122</fpage>–<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1136/aim.22.3.122</pub-id><pub-id pub-id-type="pmid">15551936</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="book"><collab>European Medicines Agency</collab>. <source><italic toggle="yes">Guideline on Medicinal Products for the Treatment of Insomnia</italic></source>. <publisher-loc>London</publisher-loc>: <publisher-name>European Medicines Agency</publisher-name>; <year>2011</year>:<fpage>14</fpage>–<lpage>16</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bahk</surname>
<given-names>WM</given-names></string-name>, et al. <article-title>Addressing the side effects of contemporary antidepressant drugs: a comprehensive review</article-title>. <source><italic toggle="yes">Chonnam Med J</italic></source>. <year>2018</year>;<volume>54</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.4068/cmj.2018.54.2.101</pub-id><pub-id pub-id-type="pmid">29854675</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>P</given-names></string-name>, et al. <article-title>The effectiveness and safety of acupuncture for depression: an overview of meta-analyses</article-title>. <source><italic toggle="yes">Complement Ther Med</italic></source>. <year>2020</year>;<volume>50</volume>:<fpage>102202</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ctim.2019.102202</pub-id><pub-id pub-id-type="pmid">32444032</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ravindran</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Balneaves</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Faulkner</surname>
<given-names>G</given-names></string-name>, et al.; <collab>CANMAT Depression Work Group</collab>. <article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments</article-title>. <source><italic toggle="yes">Can J Psychiatry</italic></source>. <year>2016</year>;<volume>61</volume>(<issue>9</issue>):<fpage>576</fpage>–<lpage>587</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0706743716660290</pub-id>.<pub-id pub-id-type="pmid">27486153</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>DZ</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mei</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>MH</given-names></string-name>. <article-title>Differences in the origin of philosophy between Chinese medicine and Western medicine: exploration of the holistic advantages of Chinese medicine</article-title>. <source><italic toggle="yes">Chin J Integr Med</italic></source>. <year>2013</year>;<volume>19</volume>:<fpage>706</fpage>–<lpage>711</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11655-013-1435-5</pub-id><pub-id pub-id-type="pmid">23975136</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="book"><string-name><surname>Zheng</surname>
<given-names>HX</given-names></string-name>. <source><italic toggle="yes">The Basic Theory of Traditional Chinese Medicine (Tenth Edition) [Article in Chinese]</italic></source>. <publisher-loc>Beijing, China</publisher-loc>: <publisher-name>China Press of Traditional Chinese Medicine</publisher-name>; <year>2016</year>.</mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jiang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>Investigation into the influence of physician for treatment based on syndrome differentiation</article-title>. <source><italic toggle="yes">Evid Based Complement Alternat Med</italic></source>. <year>2013</year>;<volume>2013</volume>:<fpage>587234</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2013/587234</pub-id><pub-id pub-id-type="pmid">24288563</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Volker</surname>
<given-names>S</given-names></string-name>. <article-title>Globalising Chinese medical understandings of menopause</article-title>. <source><italic toggle="yes">East Asian Sci Technol Soc</italic></source>. <year>2008</year>;<volume>2</volume>:<fpage>485</fpage>–<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1215/s12280-009-9069-6</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhuo</surname>
<given-names>ZW</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>QL</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>WN</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>CD</given-names></string-name>. <article-title>Study on syndrome elements and literature laws in patients with perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Trad Chin Med J</italic></source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>58</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Wu Song</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>The distribution and characteristics of TCM syndromes of perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Trad Chin Med J</italic></source>. <year>2013</year>;<volume>54</volume>(<issue>18</issue>):<fpage>1574</fpage>–<lpage>1576</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>J</given-names></string-name>. <article-title>Efficacy comparison between acupuncture smoothing-Liver and regulating-Spleen method and regulating Governor-Vessel method for perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Acup Moxib</italic></source>. <year>2014</year>;<volume>34</volume>(<issue>8</issue>):<fpage>759</fpage>–<lpage>762</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>FY</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>QQ</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Conduit</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>Z</given-names></string-name>. <article-title>Acupuncture as an independent or adjuvant management to standard care for perimenopausal depression: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2021</year>;<volume>12</volume>:<fpage>666988</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2021.666988</pub-id><pub-id pub-id-type="pmid">34122180</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Acupuncture improves perimenopausal insomnia: a randomized controlled trial</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2017</year>;<volume>40</volume>(<issue>11</issue>):<fpage>zsx153</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsx153</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="book"><string-name><surname>Wang</surname>
<given-names>WD</given-names></string-name>. <source><italic toggle="yes">Effect Comparison Between Electroacupuncture with Yinyang-Tiaoheng-Touci Needling Method and Placebo-Electroacupuncture in Treating Perimenopausal Insomnia [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Shanghai University of Traditional Chinese Medicine</publisher-name>; <year>2015</year>.</mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>WX</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>SF</given-names></string-name>. <article-title>Clinical efficacy evaluation of Tiaoren-Tongdu needling for perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Shanghai J Acup Moxib</italic></source>. <year>2017</year>;<volume>36</volume>(<issue>8</issue>):<fpage>900</fpage>–<lpage>904</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Electroacupuncture versus sham acupuncture for perimenopausal insomnia: a randomized controlled clinical trial</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020a</year>;<volume>12</volume>:<fpage>1201</fpage>–<lpage>1213</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S282315</pub-id><pub-id pub-id-type="pmid">33376432</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>YF</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>WB</given-names></string-name>, <string-name><surname>He</surname>
<given-names>YH</given-names></string-name>. <article-title>Clinical effect of acupuncture at four acupoints of Qijing on perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Chin J Gerontol</italic></source>. <year>2015</year>;<volume>35</volume>(<issue>12</issue>):<fpage>3390</fpage>–<lpage>3392</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="book"><string-name><surname>Li</surname>
<given-names>ZF</given-names></string-name>. <source><italic toggle="yes">Clinical Study on the Effect of Electroacupuncture on Patients with Mild to Moderate Depression in Perimenopausal Period [Article in Chinese]</italic></source> [<source>Doctorate thesis</source>]. <publisher-name>Guangzhou University of Chinese Medicine</publisher-name>; <year>2015a</year>.</mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>XL</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>XH</given-names></string-name>. <article-title>Clinical study on electroacupuncture for perimenopausal insomnia</article-title>. <source><italic toggle="yes">J Acupunct Tuina Sci</italic></source>. <year>2013</year>;<volume>11</volume>(<issue>6</issue>):<fpage>336</fpage>–<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11726-013-0722-1</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="book"><string-name><surname>Luo</surname>
<given-names>L</given-names></string-name>. <source><italic toggle="yes">Clinical Observation on the Therapeutic Effect of Acupuncture with Tonifying Kidney and Regulating Heart Method on the Patients with Perimenopausal Insomnia [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Nanjing Univeity of Chinese Medicine</publisher-name>; <year>2020</year>.</mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Du</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Fan</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>HJ</given-names></string-name>. <article-title>Clinical observation of Jin’s three-needle combined with Jiaweiwumei-pill in the treatment of perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">China Pharm</italic></source>. <year>2017</year>;<volume>28</volume>(<issue>8</issue>):<fpage>1104</fpage>–<lpage>1107</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="book"><string-name><surname>Kang</surname>
<given-names>H</given-names></string-name>. <source><italic toggle="yes">Clinical Observation of Scalp Acupuncture on the Treatment of Insomnia with Heart and Gallbladder Qi Deficiency in Perimenopausal Period [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Heilongjiang University of Chinese Medicine</publisher-name>; <year>2015</year>.</mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="book"><string-name><surname>Lai</surname>
<given-names>XJ</given-names></string-name>. <article-title>The Clinical Study of Using the Xu’s Feitengbafa on Shenmai and Zhaohai Point on Time in Treating Perimenopausal Insomnia (Disharmony Between the Heart and Kidney) [Article in Chinese]</article-title> [<source>Master thesis</source>]. <publisher-name>Chengdu University of Traditional Chinese Medicine</publisher-name>; <year>2016</year>.</mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>YN</given-names></string-name>. <article-title>Effect of acupuncture “Xiasanhuang” acupoints on 120 cases of perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">China Prac Med</italic></source>. <year>2014</year>;<volume>9</volume>(<issue>19</issue>):<fpage>244</fpage>–<lpage>246</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>OJ</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>. <article-title>Acupuncture at back-shu points of five Zang, Geshu (BL 17) and Shenmen (HT 7) for the treatment of perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Acup Moxib</italic></source>. <year>2018a</year>;<volume>38</volume>(<issue>5</issue>):<fpage>469</fpage>–<lpage>472</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="book"><string-name><surname>Ma</surname>
<given-names>GG</given-names></string-name>. <article-title>Clinical Research on Perimenopausal Insomnia Treated with Jin Three-Needle Therapy [Article in Chinese]</article-title> [<source>Doctorate thesis</source>]. <publisher-name>Guangzhou University of Chinese Medicine</publisher-name>; <year>2014</year>.</mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="book"><string-name><surname>Qin</surname>
<given-names>YY</given-names></string-name>. <source><italic toggle="yes">Clinical Study of Acupuncture in Treating Perimenopausal Insomnia with Liver Hyperactivity and Kidney Deficiency Syndrome Pattern Based on the Theory of Treating Insomnia Based on Liver [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Chengdu University of Traditional Chinese Medicine</publisher-name>; <year>2018</year>.</mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>ZG</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>ZY</given-names></string-name>. <article-title>Scalp and body acupuncture in treating 81 cases of perimenopausal insomnia [Article in Chinese]</article-title>. <source><italic toggle="yes">West J Trad Chin Med</italic></source>. <year>2017</year>;<volume>30</volume>(<issue>2</issue>):<fpage>4</fpage>–<lpage>6</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Pi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>WW</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>ZY</given-names></string-name>. <article-title>Clinical observation of treating perimenopausal insomnia by acupuncture based on the theory of Liver [article in Chinese]</article-title>. <source><italic toggle="yes">J Sichuan Trad Chin Med</italic></source>. <year>2017</year>;<volume>35</volume>(<issue>9</issue>):<fpage>152</fpage>–<lpage>155</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>XM</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>WX</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>ZX</given-names></string-name>. <article-title>Effect of acupuncture with Tongren-Tiaodu method on perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Hubei J TCM</italic></source>. <year>2021</year>;<volume>43</volume>(<issue>5</issue>):<fpage>40</fpage>–<lpage>42</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>ZF</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>A multicenter, randomized, controlled trial of electroacupuncture for perimenopause women with mild-moderate depression</article-title>. <source><italic toggle="yes">Biomed Res Int</italic></source>. <year>2018b</year>;<volume>2018</volume>:<fpage>5351210</fpage>.<pub-id pub-id-type="pmid">30003102</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>W</given-names></string-name>. <article-title>Yishen-tiaoan acupuncture therapy in the treatment of perimenopausal depression: an observation of 30 cases [article in Chinese]</article-title>. <source><italic toggle="yes">JCAM</italic></source>. <year>2011</year>;<volume>27</volume>(<issue>7</issue>):<fpage>4</fpage>–<lpage>7</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="book"><string-name><surname>Deng</surname>
<given-names>AJ</given-names></string-name>. <source><italic toggle="yes">A Randomized Controlled Clinical Trial of Bo’s Abdominal Acupuncture in the Treatment of Perimenopausal Depression [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Guangzhou University of Chinese Medicine</publisher-name>; <year>2008</year>.</mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="book"><string-name><surname>Li</surname>
<given-names>HB</given-names></string-name>. <source><italic toggle="yes">Clinical Observation of Acupuncture Treatment on Perimenopausal Depression with Kidney Deficiency and Liver Stagnation [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Heilongjiang University of Traditional Chinese Medicine</publisher-name>; <year>2015b</year>.</mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>. <article-title>A clinical study of acupuncture treatment on perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">J Psychiatr</italic></source>. <year>2009</year>;<volume>22</volume>(<issue>4</issue>):<fpage>276</fpage>–<lpage>278</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Niu</surname>
<given-names>XS</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>P</given-names></string-name>. <article-title>Clinical study of acupuncture on Wangshi-Wuzangshu combined Geshu in the treatment of perimenopausal depression with stagnation of Liver Qi syndrome pattern [article in Chinese]</article-title>. <source><italic toggle="yes">Int J Trad Chin Med</italic></source>. <year>2017</year>;<volume>39</volume>(<issue>11</issue>):<fpage>999</fpage>–<lpage>1002</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qian</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>J</given-names></string-name>. <article-title>Clinical observation of acupuncture on Wangshi Wuzangshu combined Geshu for perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Beijing J TCM</italic></source>. <year>2007</year>;<volume>26</volume>:<fpage>491</fpage>–<lpage>492</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qiang</surname>
<given-names>BQ</given-names></string-name>. <article-title>Acupuncture treatment on 30 cases of perimenopause depression [article in Chinese]</article-title>. <source><italic toggle="yes">J Shaanxi TCM</italic></source>. <year>2008</year>;<volume>29</volume>(<issue>7</issue>):<fpage>871</fpage>–<lpage>872</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>QF</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>NL</given-names></string-name>. <article-title>Clinical observation of electroacupuncture treatment for mild to moderate depression in perimenopausal period [article in Chinese]</article-title>. <source><italic toggle="yes">China J Mod Med</italic></source>. <year>2018</year>;<volume>28</volume>(<issue>20</issue>):<fpage>52</fpage>–<lpage>56</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>SY</given-names></string-name>. <article-title>Clinical observation of electroacupuncture in the treatment of mild and moderate perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">J Guangxi Univ Chin Med</italic></source>. <year>2015</year>;<volume>18</volume>(<issue>4</issue>):<fpage>13</fpage>–<lpage>15</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0079">
        <label>79.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>AJ</given-names></string-name>. <article-title>Comparative study on abdominal acupuncture and Western medicine for treatment of perimenopause depression [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Acup Moxib</italic></source>. <year>2010</year>;<volume>30</volume>(<issue>11</issue>):<fpage>913</fpage>–<lpage>917</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0080">
        <label>80.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ding</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>B</given-names></string-name>. <article-title>Treatment of perimenopausal depression by acupuncture with Nourishing-Kidney-Regulating-Liver-Strengthening-Spleen-Tranquilizing-Heart method [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Archiv Trad Chin Med</italic></source>. <year>2007</year>;<volume>25</volume>(<issue>5</issue>):<fpage>1066</fpage>–<lpage>1067</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0081">
        <label>81.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>W</given-names></string-name>. <article-title>Clinical observation of electroacupuncture in the treatment of perimenopause depression [article in Chinese]</article-title>. <source><italic toggle="yes">Clin J Trad Chin Med</italic></source>. <year>2020b</year>;<volume>32</volume>(<issue>3</issue>):<fpage>555</fpage>–<lpage>558</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0082">
        <label>82.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>. <article-title>Comparative study on the efficacy of abdominal acupuncture and Western medicine in treating perimenopause depression [article in Chinese]</article-title>. <source><italic toggle="yes">World Latest Med Inf</italic></source>. <year>2015</year>;<volume>64</volume>:<fpage>145</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0083">
        <label>83.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xing</surname>
<given-names>K</given-names></string-name>. <article-title>Clinical observation of 120 cases of perimenopausal depression treated by Xingshen-Jieyu acupuncture [article in Chinese]</article-title>. <source><italic toggle="yes">Matern Child Health Care China</italic></source>. <year>2011</year>;<volume>26</volume>(<issue>34</issue>):<fpage>5373</fpage>–<lpage>5375</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0084">
        <label>84.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>FD</given-names></string-name>. <article-title>Therapeutic effect of acupuncture on perimenopausal depression and its effects on DA, NE and 5-HIAA contents [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Acup Moxib</italic></source>. <year>2007</year>;<volume>27</volume>(<issue>5</issue>):<fpage>317</fpage>–<lpage>321</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0085">
        <label>85.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dong</surname>
<given-names>Y</given-names></string-name>. <article-title>Clinical observation of acupuncture on beishu acupoint in the treatment of perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Jilin J Trad Chin Med</italic></source>. <year>2015</year>;<volume>35</volume>(<issue>3</issue>):<fpage>306</fpage>–<lpage>308</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0086">
        <label>86.</label>
        <mixed-citation publication-type="book"><string-name><surname>Zhang</surname>
<given-names>YL</given-names></string-name>. <source><italic toggle="yes">Effect of Electroacupuncture on Hamilton Score and Sex Hormone Levels in Patients with Perimenopausal Depression [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Shaanxi University of Chinese Medicine</publisher-name>; <year>2010</year>.</mixed-citation>
      </ref>
      <ref id="cit0087">
        <label>87.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>YQ</given-names></string-name>. <article-title>Clinical study of acupuncture treatment on 94 cases of perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Inner Mongol J Trad Chin Med</italic></source>. <year>2013</year>;<volume>32</volume>(<issue>11</issue>):<fpage>41</fpage>–<lpage>42</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0088">
        <label>88.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zheng</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>YT</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>MZ</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>ZN</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>LH</given-names></string-name>. <article-title>Clinical study of Sishen-needle treatment on perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Liaoning J Trad Chin Med</italic></source>. <year>2010</year>;<volume>37</volume>(<issue>4</issue>):<fpage>726</fpage>–<lpage>728</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0089">
        <label>89.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Niu</surname>
<given-names>HY</given-names></string-name>. <article-title>A preliminary study on clinical effects of Panlong-needling on perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Jilin J Tradit Chin Med</italic></source>. <year>2014</year>;<volume>34</volume>(<issue>1</issue>):<fpage>88</fpage>–<lpage>90</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0090">
        <label>90.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>HB</given-names></string-name>. <article-title>Effect of acupuncture on perimenopausal insomnia and its impact on PSQI [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Commun Doctors</italic></source>. <year>2020</year>;<volume>36</volume>(<issue>31</issue>):<fpage>109</fpage>–<lpage>110</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0091">
        <label>91.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>WL</given-names></string-name>. <article-title>Effect of acupuncture combined with medication on perimenopausal insomnia and the impacts on FSH and E2 levels [article in Chinese]</article-title>. <source><italic toggle="yes">Acta Chin Med Pharmacol</italic></source>. <year>2016</year>;<volume>44</volume>(<issue>2</issue>):<fpage>89</fpage>–<lpage>91</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0092">
        <label>92.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>PP</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>XL</given-names></string-name>. <article-title>Observation of the effect of Tiaodu-Anshen acupuncture on perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Mod J Integr Trad Chin West Med</italic></source>. <year>2016</year>;<volume>25</volume>(<issue>26</issue>):<fpage>2885</fpage>–<lpage>2888</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0093">
        <label>93.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>GZ</given-names></string-name>. <article-title>Effect of acupuncture combined with Sertraline on hormone levels and neurotransmitters in women with perimenopausal depression–clinical data of 40 cases [article in Chinese]</article-title>. <source><italic toggle="yes">Jiangsu J Trad Chin Med</italic></source>. <year>2019</year>;<volume>51</volume>(<issue>2</issue>):<fpage>70</fpage>–<lpage>72</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0094">
        <label>94.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ning</surname>
<given-names>Y</given-names></string-name>. <article-title>Clinical study on acupuncture treatment of perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">J Sichuan Trad Chin Med</italic></source>. <year>2015</year>;<volume>33</volume>(<issue>1</issue>):<fpage>154</fpage>–<lpage>155</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0095">
        <label>95.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>XJ</given-names></string-name>. <article-title>Therapeutic effect of electroacupuncture combined with paroxetine on 55 cases of perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Med J Chin Peoples Health</italic></source>. <year>2011</year>;<volume>23</volume>(<issue>11</issue>):<fpage>1426</fpage>–<lpage>1428</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0096">
        <label>96.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Santoro</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Roeca</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Peters</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Neal-Perry</surname>
<given-names>G</given-names></string-name>. <article-title>The menopause transition: signs, symptoms, and management options</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2021</year>;<volume>106</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1210/clinem/dgaa764</pub-id><pub-id pub-id-type="pmid">33095879</pub-id></mixed-citation>
      </ref>
      <ref id="cit0097">
        <label>97.</label>
        <mixed-citation publication-type="confproc"><string-name><surname>Ma</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>He</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>HT</given-names></string-name>. <source><italic toggle="yes">Clinical Effect of Electroacupuncture on Perimenopausal Insomnia [Article in Chinese]</italic></source>. <conf-name>Proceedings of 2017 World Acupuncture Conference/ 2017 Annual Meeting of the Chinese Acupuncture Society</conf-name>; <year>2017</year>: <fpage>302</fpage>–<lpage>303</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0098">
        <label>98.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Systems pharmacology dissecting holistic medicine for treatment of complex diseases: an example using cardiocerebrovascular diseases treated by TCM</article-title>. <source><italic toggle="yes">Evid Based Complement Alternat Med</italic></source>. <year>2015</year>;<fpage>980190</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2015/980190</pub-id><pub-id pub-id-type="pmid">26101539</pub-id></mixed-citation>
      </ref>
      <ref id="cit0099">
        <label>99.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>FY</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>QQ</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Lao</surname>
<given-names>LX</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>Z</given-names></string-name>. <article-title>Verum- versus sham-acupuncture on Alzheimer’s Disease (AD) in animal models: a preclinical systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Biomed Res Int</italic></source>. <year>2020</year>;<volume>2020</volume>:<fpage>5901573</fpage>.<pub-id pub-id-type="pmid">32337259</pub-id></mixed-citation>
      </ref>
      <ref id="cit0100">
        <label>100.</label>
        <mixed-citation publication-type="book"><collab>China National Standardization Administration. China International Standardization Administration</collab>. <source><italic toggle="yes">GB/T 30233-2013, Indications of Acupuncture Points</italic></source>. <publisher-loc>Beijing</publisher-loc>: <publisher-name>Chinese Standard Press</publisher-name>; <year>2013</year>.</mixed-citation>
      </ref>
      <ref id="cit0101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><string-name><surname>van der Watt</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Laugharne</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Janca</surname>
<given-names>A</given-names></string-name>. <article-title>Complementary and alternative medicine in the treatment of anxiety and depression</article-title>. <source><italic toggle="yes">Curr Opin Psychiatry</italic></source>. <year>2008</year>;<volume>21</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>42</lpage>. doi:<pub-id pub-id-type="doi">10.1097/YCO.0b013e3282f2d814</pub-id><pub-id pub-id-type="pmid">18281839</pub-id></mixed-citation>
      </ref>
      <ref id="cit0102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><string-name><surname>van der Sluijs</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Bensoussan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Liyanage</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Shah</surname>
<given-names>S</given-names></string-name>. <article-title>Women’s health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2007</year>;<volume>14</volume>(<issue>3 Pt 1</issue>):<fpage>397</fpage>–<lpage>403</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.gme.0000236937.36078.f4</pub-id><pub-id pub-id-type="pmid">17202872</pub-id></mixed-citation>
      </ref>
      <ref id="cit0103">
        <label>103.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gentry-Maharaj</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Karpinskyj</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Glazer</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening</article-title>. <source><italic toggle="yes">Climacteric</italic></source>. <year>2017</year>;<volume>20</volume>(<issue>3</issue>):<fpage>240</fpage>–<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13697137.2017.1301919</pub-id><pub-id pub-id-type="pmid">28326899</pub-id></mixed-citation>
      </ref>
      <ref id="cit0104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>. <article-title>Does acupuncture help patients with spasticity? A narrative review</article-title>. <source><italic toggle="yes">Ann Phys Rehabil Med</italic></source>. <year>2019</year>;<volume>62</volume>(<issue>4</issue>):<fpage>297</fpage>–<lpage>301</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.rehab.2018.09.010</pub-id><pub-id pub-id-type="pmid">30408516</pub-id></mixed-citation>
      </ref>
      <ref id="cit0105">
        <label>105.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Clayton</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Ninan</surname>
<given-names>PT</given-names></string-name>. <article-title>Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women</article-title>. <source><italic toggle="yes">Prim Care Companion J Clin Psychiatry</italic></source>. <year>2010</year>;<volume>12</volume>(<issue>1</issue>):<page-range>PCC.08r00747</page-range>.</mixed-citation>
      </ref>
      <ref id="cit0106">
        <label>106.</label>
        <mixed-citation publication-type="book"><string-name><surname>Tian</surname>
<given-names>SL</given-names></string-name>. <source><italic toggle="yes">Effect of Pre-Acupuncture on Guanyuan and Sanyinjiao on HPO Axis of Ovariectomized Rats and Its Antioxidant Effect [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Beijing University of Chinese Medicine</publisher-name>; <year>2007</year>.</mixed-citation>
      </ref>
      <ref id="cit0107">
        <label>107.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>XH</given-names></string-name>, et al. <article-title>Pre-acupuncture at Guanyuan acupoint in the regulation of superoxide dismutase and nitric oxide synthase activities in the natural aging rat model [article in Chinese]</article-title>. <source><italic toggle="yes">J Clin Rehabil Tis Eng Res</italic></source>. <year>2005</year>;<volume>9</volume>(<issue>31</issue>):<fpage>147</fpage>–<lpage>149</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0108">
        <label>108.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>XH</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>LL</given-names></string-name>, et al. <article-title>Effect of pre-acupuncture at Guanyuan on the expression of HSP 70 and HSP 70 mRNA in spleen and the contents of serum IL-2, TNF-α in perimenopausal model rat [article in Chinese]</article-title>. <source><italic toggle="yes">Acupunct Res</italic></source>. <year>2009</year>;<volume>34</volume>(<issue>2</issue>):<fpage>83</fpage>–<lpage>88</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0109">
        <label>109.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Mo</surname>
<given-names>YP</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>XF</given-names></string-name>, et al. <article-title>Expression of 5-HT, 5-HTT in hippocampus of chronic unpredictable mild stress-induced depressive rats treated by electroacupuncture pretreatment [article in Chinese]</article-title>. <source><italic toggle="yes">J Clin Acupunct Moxib</italic></source>. <year>2014</year>;<volume>30</volume>(<issue>7</issue>):<fpage>57</fpage>–<lpage>60</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0110">
        <label>110.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ciano</surname>
<given-names>C</given-names></string-name>, <string-name><surname>King</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Perlis</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sawyer</surname>
<given-names>AM</given-names></string-name>. <article-title>Longitudinal study of insomnia symptoms among women during perimenopause</article-title>. <source><italic toggle="yes">J Obstet Gynecol Neonatal Nurs</italic></source>. <year>2017</year>;<volume>46</volume>(<issue>6</issue>):<fpage>804</fpage>–<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jogn.2017.07.011</pub-id></mixed-citation>
      </ref>
      <ref id="cit0111">
        <label>111.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Woods</surname>
<given-names>NF</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>ES</given-names></string-name>. <article-title>Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2010</year>;<volume>33</volume>(<issue>4</issue>):<fpage>539</fpage>–<lpage>549</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/33.4.539</pub-id><pub-id pub-id-type="pmid">20394324</pub-id></mixed-citation>
      </ref>
      <ref id="cit0112">
        <label>112.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Freeman</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Sammel</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>DB</given-names></string-name>. <article-title>Associations of hormones and menopausal status with depressed mood in women with no history of depression</article-title>. <source><italic toggle="yes">Arch Gen Psychiatry</italic></source>. <year>2006</year>;<volume>63</volume>(<issue>4</issue>):<fpage>375</fpage>–<lpage>382</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.63.4.375</pub-id><pub-id pub-id-type="pmid">16585466</pub-id></mixed-citation>
      </ref>
      <ref id="cit0113">
        <label>113.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Zambotti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Colrain</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Baker</surname>
<given-names>FC</given-names></string-name>. <article-title>Interaction between reproductive hormones and physiological sleep in women</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2015</year>;<volume>100</volume>(<issue>4</issue>):<fpage>1426</fpage>–<lpage>1433</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2014-3892</pub-id><pub-id pub-id-type="pmid">25642589</pub-id></mixed-citation>
      </ref>
      <ref id="cit0114">
        <label>114.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Douma</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Husband</surname>
<given-names>C</given-names></string-name>, <string-name><surname>O’Donnell</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Barwin</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Woodend</surname>
<given-names>AK</given-names></string-name>. <article-title>Estrogen-related mood disorders: reproductive life cycle factors</article-title>. <source><italic toggle="yes">ANS Adv Nurs Sci</italic></source>. <year>2005</year>;<volume>28</volume>(<issue>4</issue>):<fpage>364</fpage>–<lpage>375</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00012272-200510000-00008</pub-id><pub-id pub-id-type="pmid">16292022</pub-id></mixed-citation>
      </ref>
      <ref id="cit0115">
        <label>115.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Freeman</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Sammel</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gracia</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Hollander</surname>
<given-names>L</given-names></string-name>. <article-title>Hormones and menopausal status as predictors of depression in women in transition to menopause</article-title>. <source><italic toggle="yes">Arch Gen Psychiatry</italic></source>. <year>2004</year>;<volume>61</volume>(<issue>1</issue>):<fpage>62</fpage>–<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.61.1.62</pub-id><pub-id pub-id-type="pmid">14706945</pub-id></mixed-citation>
      </ref>
      <ref id="cit0116">
        <label>116.</label>
        <mixed-citation publication-type="book"><string-name><surname>Xie</surname>
<given-names>C</given-names></string-name>. <source><italic toggle="yes">Experimental Study of Electroacupuncture Interving Rat’s Sleep-Wake During Perimenopause by Adjusting VLPO and TMN [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Shanghai University of Traditional Chinese Medicine</publisher-name>; <year>2013</year>.</mixed-citation>
      </ref>
      <ref id="cit0117">
        <label>117.</label>
        <mixed-citation publication-type="book"><string-name><surname>Yu</surname>
<given-names>XT</given-names></string-name>. <source><italic toggle="yes">Experimental Study of Electroacupuncture for Sleep-Wake Regulation on Rats with Insomnia During Perimenopause [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Shanghai University of Traditional Chinese Medicine</publisher-name>; <year>2012</year>.</mixed-citation>
      </ref>
      <ref id="cit0118">
        <label>118.</label>
        <mixed-citation publication-type="book"><string-name><surname>Sun</surname>
<given-names>Y</given-names></string-name>. <source><italic toggle="yes">Experimental Study on the Mechanism of Electroacupuncture in the Treatment of Perimenopausal Depression [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2009</year>.</mixed-citation>
      </ref>
      <ref id="cit0119">
        <label>119.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Song</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>HF</given-names></string-name>, et al. <article-title>Effects of acupuncture with YangXueRouGan technique on estrogen level in perimenopausal depression mice [article in Chinese]</article-title>. <source><italic toggle="yes">Occup Health</italic></source>. <year>2021</year>;<volume>37</volume>(<issue>7</issue>):<fpage>902</fpage>–<lpage>904</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0120">
        <label>120.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>XD</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Jie-Yu Pill, a proprietary herbal medicine, ameliorates mood disorder-like behavior and cognitive impairment in estrogen-deprived mice exposed to chronic unpredictable mild stress: implication for a potential therapy of menopause syndrome</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2020</year>;<volume>11</volume>:<fpage>579995</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2020.579995</pub-id><pub-id pub-id-type="pmid">33329121</pub-id></mixed-citation>
      </ref>
      <ref id="cit0121">
        <label>121.</label>
        <mixed-citation publication-type="book"><string-name><surname>Yang</surname>
<given-names>WJ</given-names></string-name>. <source><italic toggle="yes">Study on the Neuroendocrine Mechanism of Acupuncture in the Treatment of Perimenopausal Insomnia Based on Estrogen and Its Receptor [Article in Chinese]</italic></source> [<source>Doctorate thesis</source>]. <publisher-name>Shanghai University of Traditional Chinese Medicine</publisher-name>; <year>2017</year>.</mixed-citation>
      </ref>
      <ref id="cit0122">
        <label>122.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Natari</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Clavarino</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>McGuire</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Dingle</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Hollingworth</surname>
<given-names>SA</given-names></string-name>. <article-title>The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>):<fpage>109</fpage>–<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1097/GME.0000000000000949</pub-id><pub-id pub-id-type="pmid">28719420</pub-id></mixed-citation>
      </ref>
      <ref id="cit0123">
        <label>123.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Han</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>X</given-names></string-name>, et al. <article-title>The mechanism of electroacupuncture for depression on basic research: a systematic review</article-title>. <source><italic toggle="yes">Chin Med</italic></source>. <year>2021</year>;<volume>16</volume>(<issue>1</issue>):<fpage>10</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13020-020-00421-y</pub-id><pub-id pub-id-type="pmid">33436036</pub-id></mixed-citation>
      </ref>
      <ref id="cit0124">
        <label>124.</label>
        <mixed-citation publication-type="book"><string-name><surname>Jiang</surname>
<given-names>XR</given-names></string-name>. <source><italic toggle="yes">Study on the Correlation Between HPO Axis-and HPA-Axis in Perimenopausal Depression Model Rats Treated by Electroacupuncture [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2017</year>.</mixed-citation>
      </ref>
      <ref id="cit0125">
        <label>125.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>W</given-names></string-name>, et al. <article-title>Effects of acupuncture on the hypothalamus-pituitary-adrenal axis in chronic insomnia patients: a study protocol for a randomized controlled trial</article-title>. <source><italic toggle="yes">Trials</italic></source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>810</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13063-019-3964-5</pub-id><pub-id pub-id-type="pmid">31888738</pub-id></mixed-citation>
      </ref>
      <ref id="cit0126">
        <label>126.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xi</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>WZ</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>CY</given-names></string-name>, et al. <article-title>Effect of Tongdu-Tiaoshen acupuncture in treatment of chronic insomnia by regulating the hypothalamus-pituitary-adrenal axis [article in Chinese]</article-title>. <source><italic toggle="yes">Acupunct Res</italic></source>. <year>2020</year>;<volume>45</volume>(<issue>7</issue>):<fpage>552</fpage>–<lpage>556</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0127">
        <label>127.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jiang</surname>
<given-names>XR</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>CR</given-names></string-name>. <article-title>Effect of electroacupuncture on HPO axis in rats with perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Acupunct Res</italic></source>. <year>2017</year>;<volume>42</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>49</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0128">
        <label>128.</label>
        <mixed-citation publication-type="book"><string-name><surname>Zhang</surname>
<given-names>JB</given-names></string-name>. <source><italic toggle="yes">Effect of Electroacupuncture on the Behavior and Brain β-Endorphin and Other Indices of Rats with Perimenopausal Depression [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2009</year>.</mixed-citation>
      </ref>
      <ref id="cit0129">
        <label>129.</label>
        <mixed-citation publication-type="book"><string-name><surname>Huangfu</surname>
<given-names>WL</given-names></string-name>. <source><italic toggle="yes">Effect of Electroacupuncture on Hippocampus and Internal Environment of Perimenopausal Depression Model Rats [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2018</year>.</mixed-citation>
      </ref>
      <ref id="cit0130">
        <label>130.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hartmann</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bajaj</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Klengel</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5</article-title>. <source><italic toggle="yes">Cell Rep</italic></source>. <year>2021</year>;<volume>35</volume>(<issue>9</issue>):<fpage>109185</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2021.109185</pub-id><pub-id pub-id-type="pmid">34077736</pub-id></mixed-citation>
      </ref>
      <ref id="cit0131">
        <label>131.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Oh</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Walsh</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Bittencourt</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Neylan</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Grinberg</surname>
<given-names>LT</given-names></string-name>. <article-title>The role of co-neurotransmitters in sleep and wake regulation</article-title>. <source><italic toggle="yes">Mol Psychiatry</italic></source>. <year>2019</year>;<volume>24</volume>(<issue>9</issue>):<fpage>1284</fpage>–<lpage>1295</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41380-018-0291-2</pub-id><pub-id pub-id-type="pmid">30377299</pub-id></mixed-citation>
      </ref>
      <ref id="cit0132">
        <label>132.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eichling</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Sahni</surname>
<given-names>J</given-names></string-name>. <article-title>Menopause related sleep disorders</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2005</year>;<volume>1</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>300</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.26347</pub-id><pub-id pub-id-type="pmid">17566192</pub-id></mixed-citation>
      </ref>
      <ref id="cit0133">
        <label>133.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schweizer-Schubert</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Eisenlohr-Moul</surname>
<given-names>TA</given-names></string-name>, et al. <article-title>Steroid hormone sensitivity in reproductive mood disorders: on the role of the GABA<sub>A</sub> receptor complex and stress during hormonal transitions</article-title>. <source><italic toggle="yes">Front Med (Lausanne)</italic></source>. <year>2021</year>;<volume>7</volume>:<fpage>479646</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmed.2020.479646</pub-id><pub-id pub-id-type="pmid">33585496</pub-id></mixed-citation>
      </ref>
      <ref id="cit0134">
        <label>134.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nissen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Otte</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Perlis</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Spiegelhalder</surname>
<given-names>K</given-names></string-name>. <article-title>The neurobiology, investigation, and treatment of chronic insomnia</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2015</year>;<volume>14</volume>(<issue>5</issue>):<fpage>547</fpage>–<lpage>558</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(15)00021-6</pub-id><pub-id pub-id-type="pmid">25895933</pub-id></mixed-citation>
      </ref>
      <ref id="cit0135">
        <label>135.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Saito</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Maejima</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nishitani</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Monoamines inhibit GABAergic neurons in ventrolateral preoptic area that make direct synaptic connections to hypothalamic arousal neurons</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2018</year>;<volume>38</volume>(<issue>28</issue>):<fpage>6366</fpage>–<lpage>6378</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2835-17.2018</pub-id><pub-id pub-id-type="pmid">29915137</pub-id></mixed-citation>
      </ref>
      <ref id="cit0136">
        <label>136.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>KX</given-names></string-name>. <article-title>Effects of electroacupuncture at HT7 and EX-HN1 on sleep phases and PGD2 system of CSF in ovariectomized rats [article in Chinese]</article-title>. <source><italic toggle="yes">JCAM</italic></source>. <year>2020</year>;<volume>36</volume>(<issue>05</issue>):<fpage>71</fpage>–<lpage>75</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0137">
        <label>137.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>HL</given-names></string-name>. <article-title>Study on the effect of acupuncture at Sishencong and Baihui on the serum amino acids neurotransmitters of insomnia patients</article-title>. <source><italic toggle="yes">WJAM</italic></source>. <year>2017</year>;<volume>27</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>27</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0138">
        <label>138.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xi</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>WZ</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>CY</given-names></string-name>, et al. <article-title>Effect of acupuncture at Tiaoshen acupoints on hyperarousal state in chronic insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Acup Moxib</italic></source>. <year>2021</year>;<volume>41</volume>(<issue>3</issue>):<fpage>263</fpage>–<lpage>267</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0139">
        <label>139.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YH</given-names></string-name>. <article-title>Gamma-aminobutyric acid levels in the anterior cingulate cortex of perimenopausal women with depression: a magnetic resonance spectroscopy study</article-title>. <source><italic toggle="yes">Front Neurosci</italic></source>. <year>2019</year>;<volume>13</volume>:<fpage>785</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2019.00785</pub-id><pub-id pub-id-type="pmid">31481863</pub-id></mixed-citation>
      </ref>
      <ref id="cit0140">
        <label>140.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duan</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Tu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Jiao</surname>
<given-names>S</given-names></string-name>. <article-title>Antidepressant effect of electroacupuncture regulates signal targeting in the brain and increases brain-derived neurotrophic factor levels</article-title>. <source><italic toggle="yes">Neural Regen Res</italic></source>. <year>2016</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1595</fpage>–<lpage>1602</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1673-5374.193238</pub-id><pub-id pub-id-type="pmid">27904490</pub-id></mixed-citation>
      </ref>
      <ref id="cit0141">
        <label>141.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>He</surname>
<given-names>XF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>XH</given-names></string-name>. <article-title>Effects of acupuncture on behavior and hippocampal amino-acid neurotransmitters in rats with depression [article in Chinese]</article-title>. <source><italic toggle="yes">J Med Res</italic></source>. <year>2010</year>;<volume>39</volume>(<issue>3</issue>):<fpage>79</fpage>–<lpage>81</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0142">
        <label>142.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schneider-Matyka</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Grochans</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lubkowska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Panczyk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Szkup</surname>
<given-names>M</given-names></string-name>. <article-title>The effect of tryptophan and serotonin levels on the severity of depressive and climacteric symptoms in perimenopausal women</article-title>. <source><italic toggle="yes">Eur Rev Med Pharmacol Sci</italic></source>. <year>2021</year>;<volume>25</volume>(<issue>9</issue>):<fpage>3425</fpage>–<lpage>3431</lpage>.<pub-id pub-id-type="pmid">34002815</pub-id></mixed-citation>
      </ref>
      <ref id="cit0143">
        <label>143.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gonzales</surname>
<given-names>GF</given-names></string-name>, <string-name><surname>Carrillo</surname>
<given-names>C</given-names></string-name>. <article-title>Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels</article-title>. <source><italic toggle="yes">Maturitas</italic></source>. <year>1993</year>;<volume>17</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0378-5122(93)90120-7</pub-id><pub-id pub-id-type="pmid">8412840</pub-id></mixed-citation>
      </ref>
      <ref id="cit0144">
        <label>144.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Albertazzi</surname>
<given-names>P</given-names></string-name>. <article-title>A review of non-hormonal options for the relief of menopausal symptoms</article-title>. <source><italic toggle="yes">Treat Endocrinol</italic></source>. <year>2006</year>;<volume>5</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>113</lpage>. doi:<pub-id pub-id-type="doi">10.2165/00024677-200605020-00004</pub-id><pub-id pub-id-type="pmid">16542050</pub-id></mixed-citation>
      </ref>
      <ref id="cit0145">
        <label>145.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ju</surname>
<given-names>Z</given-names></string-name>. <article-title>Effect of electroacupuncture on mice model of permenopausal depression</article-title>. <source><italic toggle="yes">Saudi J Biol Sci</italic></source>. <year>2019</year>;<volume>26</volume>(<issue>8</issue>):<fpage>2030</fpage>–<lpage>2036</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sjbs.2019.08.007</pub-id><pub-id pub-id-type="pmid">31885488</pub-id></mixed-citation>
      </ref>
      <ref id="cit0146">
        <label>146.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Kong</surname>
<given-names>NN</given-names></string-name>. <article-title>Regulation of acupuncture with Kidney-tonifying method on monoamine neurotransmitter in perimenopausal depression model rats [article in Chinese]</article-title>. <source><italic toggle="yes">Lishizhen Med Materia Medica Res</italic></source>. <year>2015</year>;<volume>26</volume>(<issue>9</issue>):<fpage>2299</fpage>–<lpage>2301</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0147">
        <label>147.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>MQ</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>K</given-names></string-name>. <article-title>Mechanism study of Kidney-Tonifying-and-Liver-Soothing therapy in regulating estradiol and 5-HT levels in ovariectomized rats [article in Chinese]</article-title>. <source><italic toggle="yes">J Liaoning Univ TCM</italic></source>. <year>2012</year>;<volume>14</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>188</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0148">
        <label>148.</label>
        <mixed-citation publication-type="book"><string-name><surname>Wu</surname>
<given-names>GF</given-names></string-name>. <source><italic toggle="yes">Study on the Effect and Mechanism of Electroacupuncture on Animal Model of Perimenopausal Depression with Liver-Stagnation Syndrome Pattern [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2012</year>.</mixed-citation>
      </ref>
      <ref id="cit0149">
        <label>149.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>SZ</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>. <article-title>Effect of electroacupuncture on high-density lipoprotein in rat model of perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Heilongjiang Med J</italic></source>. <year>2011</year>;<volume>24</volume>(<issue>3</issue>):<fpage>395</fpage>–<lpage>397</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0150">
        <label>150.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Tu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>P</given-names></string-name>. <article-title>Electroacupuncture restores 5-HT system deficit in chronic mild stress-induced depressed rats</article-title>. <source><italic toggle="yes">Evid Based Complement Alternat Med</italic></source>. <year>2016</year>;<volume>2016</volume>:<fpage>7950635</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2016/7950635</pub-id><pub-id pub-id-type="pmid">27994633</pub-id></mixed-citation>
      </ref>
      <ref id="cit0151">
        <label>151.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cespuglio</surname>
<given-names>R</given-names></string-name>. <article-title>Serotonin: its place today in sleep preparation, triggering or maintenance</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>49</volume>:<fpage>31</fpage>–<lpage>39</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2018.05.034</pub-id><pub-id pub-id-type="pmid">30029993</pub-id></mixed-citation>
      </ref>
      <ref id="cit0152">
        <label>152.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Teng</surname>
<given-names>JY</given-names></string-name>. <article-title>Effects and mechanism of electroacupuncture at SP6 on sleep phase in rats with perimenopausal insomnia [article in Chinese]</article-title>. <source><italic toggle="yes">JCAM</italic></source>. <year>2019</year>;<volume>35</volume>(<issue>08</issue>):<fpage>80</fpage>–<lpage>83</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0153">
        <label>153.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rybaczyk</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Bashaw</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Pathak</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Moody</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Gilders</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Holzschu</surname>
<given-names>DL</given-names></string-name>. <article-title>An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology</article-title>. <source><italic toggle="yes">BMC Womens Health</italic></source>. <year>2005</year>;<volume>5</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1472-6874-5-12</pub-id><pub-id pub-id-type="pmid">16368009</pub-id></mixed-citation>
      </ref>
      <ref id="cit0154">
        <label>154.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Geoffroy</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Miniati</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Insomnia, sleep loss, and circadian sleep disturbances in mood disorders: a pathway toward neurodegeneration and neuroprogression? A theoretical review</article-title>. <source><italic toggle="yes">CNS Spectr</italic></source>. <year>2021</year>;<fpage>1</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1092852921000018</pub-id></mixed-citation>
      </ref>
      <ref id="cit0155">
        <label>155.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gulec</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ozkol</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Selvi</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Oxidative stress in patients with primary insomnia</article-title>. <source><italic toggle="yes">Prog Neuropsychopharmacol Biol Psychiatry</italic></source>. <year>2012</year>;<volume>37</volume>(<issue>2</issue>):<fpage>247</fpage>–<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.02.011</pub-id><pub-id pub-id-type="pmid">22401887</pub-id></mixed-citation>
      </ref>
      <ref id="cit0156">
        <label>156.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Doshi</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Agarwal</surname>
<given-names>A</given-names></string-name>. <article-title>The role of oxidative stress in menopause</article-title>. <source><italic toggle="yes">J Midlife Health</italic></source>. <year>2013</year>;<volume>4</volume>(<issue>3</issue>):<fpage>140</fpage>–<lpage>146</lpage>.<pub-id pub-id-type="pmid">24672185</pub-id></mixed-citation>
      </ref>
      <ref id="cit0157">
        <label>157.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sánchez-Rodríguez</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Zacarías-Flores</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Arronte-Rosales</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Correa-Muñoz</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mendoza-Núñez</surname>
<given-names>VM</given-names></string-name>. <article-title>Menopause as risk factor for oxidative stress</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>361</fpage>–<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1097/gme.0b013e318229977d</pub-id><pub-id pub-id-type="pmid">21971210</pub-id></mixed-citation>
      </ref>
      <ref id="cit0158">
        <label>158.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Agarwal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Aponte-Mellado</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Premkumar</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Shaman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>S</given-names></string-name>. <article-title>The effects of oxidative stress on female reproduction: a review</article-title>. <source><italic toggle="yes">Reprod Biol Endocrinol</italic></source>. <year>2012</year>;<volume>10</volume>:<fpage>49</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1477-7827-10-49</pub-id><pub-id pub-id-type="pmid">22748101</pub-id></mixed-citation>
      </ref>
      <ref id="cit0159">
        <label>159.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hachul de Campos</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Brandão</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>D’Almeida</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Sleep disturbances, oxidative stress and cardiovascular risk parameters in postmenopausal women complaining of insomnia</article-title>. <source><italic toggle="yes">Climacteric</italic></source>. <year>2006</year>;<volume>9</volume>(<issue>4</issue>):<fpage>312</fpage>–<lpage>319</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13697130600871947</pub-id><pub-id pub-id-type="pmid">16857662</pub-id></mixed-citation>
      </ref>
      <ref id="cit0160">
        <label>160.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kolesnikova</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Semenova</surname>
<given-names>NV</given-names></string-name>, <string-name><surname>Solodova</surname>
<given-names>EI</given-names></string-name>, <string-name><surname>Madaeva</surname>
<given-names>LM</given-names></string-name>. <article-title>Oxidative stress in women with insomnia in different stages of menopause [article in Russian]</article-title>. <source><italic toggle="yes">Ter Arkh</italic></source>. <year>2017</year>;<volume>89</volume>(<issue>8</issue>):<fpage>50</fpage>–<lpage>56</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0161">
        <label>161.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kolesnikova</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Madaeva</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Semenova</surname>
<given-names>NV</given-names></string-name>, <string-name><surname>Solodova</surname>
<given-names>EI</given-names></string-name>, <string-name><surname>Grebenkina</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Darenskaya</surname>
<given-names>MA</given-names></string-name>. <article-title>Evaluation of lipid peroxidation - antioxidant protection in perimenopausal women with sleep disorders [article in Russian]</article-title>. <source><italic toggle="yes">Vestn Ross Akad Med Nauk</italic></source>. <year>2014</year>;<volume>69</volume>(<issue>11–12</issue>):<fpage>11</fpage>–<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.15690/vramn.v69i11-12.1177</pub-id></mixed-citation>
      </ref>
      <ref id="cit0162">
        <label>162.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>YF</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>ZD</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>WD</given-names></string-name>. <article-title>Hazards of insomnia and the effects of acupuncture treatment on insomnia</article-title>. <source><italic toggle="yes">J Integr Med</italic></source>. <year>2016</year>;<volume>14</volume>(<issue>3</issue>):<fpage>174</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2095-4964(16)60248-0</pub-id><pub-id pub-id-type="pmid">27181124</pub-id></mixed-citation>
      </ref>
      <ref id="cit0163">
        <label>163.</label>
        <mixed-citation publication-type="book"><string-name><surname>Wu</surname>
<given-names>BF</given-names></string-name>. <source><italic toggle="yes">An Experimental Study on the Mechanism of Electroacupuncture on Sleep Deprivation and Its Induced Oxidative Stress in Rats [Article in Chinese]</italic></source> [<source>Doctorate thesis</source>]. <publisher-name>Heilongjiang University of Chinese Medicine</publisher-name>; <year>2008</year>.</mixed-citation>
      </ref>
      <ref id="cit0164">
        <label>164.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hirose</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Terauchi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Akiyoshi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Owa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kubota</surname>
<given-names>T</given-names></string-name>. <article-title>Depressive symptoms are associated with oxidative stress in middle-aged women: a cross-sectional study</article-title>. <source><italic toggle="yes">Biopsychosoc Med</italic></source>. <year>2016</year>;<volume>10</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13030-016-0066-4</pub-id><pub-id pub-id-type="pmid">27118992</pub-id></mixed-citation>
      </ref>
      <ref id="cit0165">
        <label>165.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>CZ</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>GX</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>YL</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LP</given-names></string-name>. <article-title>Effect of acupuncture on urinary biomarkers of oxidative stress in vascular dementia patients [article in Chinese]</article-title>. <source><italic toggle="yes">Chin J Inf Tradit Chin Med</italic></source>. <year>2011</year>;<volume>18</volume>(<issue>7</issue>):<fpage>18</fpage>–<lpage>20</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0166">
        <label>166.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yeung</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>BYM</given-names></string-name>, <string-name><surname>Yuen</surname>
<given-names>JWM</given-names></string-name>, et al. <article-title>Semi-individualized acupuncture for insomnia disorder and oxidative stress: a randomized, double-Blind, sham-controlled trial</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2021</year>;<volume>13</volume>:<fpage>1195</fpage>–<lpage>1207</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S318874</pub-id><pub-id pub-id-type="pmid">34321944</pub-id></mixed-citation>
      </ref>
      <ref id="cit0167">
        <label>167.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sánchez-Rodríguez</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Zacarías-Flores</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Arronte-Rosales</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mendoza-Núñez</surname>
<given-names>VM</given-names></string-name>. <article-title>Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: a cross-sectional study</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2019</year>;<volume>14</volume>(<issue>9</issue>):<fpage>e0214264</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0214264</pub-id><pub-id pub-id-type="pmid">31550247</pub-id></mixed-citation>
      </ref>
      <ref id="cit0168">
        <label>168.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Miquel</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ramírez-Boscá</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ramírez-Bosca</surname>
<given-names>JV</given-names></string-name>, <string-name><surname>Alperi</surname>
<given-names>JD</given-names></string-name>. <article-title>Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants</article-title>. <source><italic toggle="yes">Arch Gerontol Geriatr</italic></source>. <year>2006</year>;<volume>42</volume>(<issue>3</issue>):<fpage>289</fpage>–<lpage>306</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.archger.2005.08.005</pub-id><pub-id pub-id-type="pmid">16442644</pub-id></mixed-citation>
      </ref>
      <ref id="cit0169">
        <label>169.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krystal</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Edinger</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wohlgemuth</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Marsh</surname>
<given-names>GR</given-names></string-name>. <article-title>Sleep in peri-menopausal and post-menopausal women</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>1998</year>;<volume>2</volume>(<issue>4</issue>):<fpage>243</fpage>–<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1087-0792(98)90011-9</pub-id><pub-id pub-id-type="pmid">15310495</pub-id></mixed-citation>
      </ref>
      <ref id="cit0170">
        <label>170.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Seo</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Moon</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>SY</given-names></string-name>, et al. <article-title>An estradiol-independent BDNF-NPY cascade is involved in the antidepressant effect of mechanical acupuncture instruments in ovariectomized rats</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>5849</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-23824-2</pub-id><pub-id pub-id-type="pmid">29643431</pub-id></mixed-citation>
      </ref>
      <ref id="cit0171">
        <label>171.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>. <article-title>Effect of electroacupuncture on hippocampal BDNF and CREB in rats with perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Liaoning J TCM</italic></source>. <year>2016</year>;<volume>43</volume>(<issue>4</issue>):<fpage>858</fpage>–<lpage>860</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0172">
        <label>172.</label>
        <mixed-citation publication-type="book"><string-name><surname>Liu</surname>
<given-names>YZ</given-names></string-name>. <source><italic toggle="yes">Comparative Effects Between Electroacupuncture at Single Acupoint and at Group of Acupoints on Learning and Memory Ability of Sleep-Deprived Rats [Article in Chinese]</italic></source> [<source>Master thesis</source>]. <publisher-name>Changchun University of Chinese Medicine</publisher-name>; <year>2019</year>.</mixed-citation>
      </ref>
      <ref id="cit0173">
        <label>173.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Xiao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Baicalin promotes hippocampal neurogenesis via the Wnt/β-catenin pathway in a chronic unpredictable mild stress-induced mouse model of depression</article-title>. <source><italic toggle="yes">Biochem Pharmacol</italic></source>. <year>2021</year>;<volume>190</volume>:<fpage>114594</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bcp.2021.114594</pub-id><pub-id pub-id-type="pmid">33964281</pub-id></mixed-citation>
      </ref>
      <ref id="cit0174">
        <label>174.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jing</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Electroacupuncture promotes neural proliferation in hippocampus of perimenopausal depression rats via Wnt/β-Catenin signaling pathway</article-title>. <source><italic toggle="yes">J Acupunct Meridian Stud</italic></source>. <year>2020</year>;<volume>13</volume>(<issue>3</issue>):<fpage>94</fpage>–<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jams.2020.03.065</pub-id><pub-id pub-id-type="pmid">32278077</pub-id></mixed-citation>
      </ref>
      <ref id="cit0175">
        <label>175.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wexler</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Geschwind</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Palmer</surname>
<given-names>TD</given-names></string-name>. <article-title>Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation</article-title>. <source><italic toggle="yes">Mol Psychiatry</italic></source>. <year>2008</year>;<volume>13</volume>(<issue>3</issue>):<fpage>285</fpage>–<lpage>292</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.mp.4002093</pub-id><pub-id pub-id-type="pmid">17968353</pub-id></mixed-citation>
      </ref>
      <ref id="cit0176">
        <label>176.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dai</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Influence of miR-155 on behaviors of depression mice through regulating Wnt/β-catenin signaling pathway</article-title>. <source><italic toggle="yes">Eur Rev Med Pharmacol Sci</italic></source>. <year>2020</year>;<volume>24</volume>(<issue>3</issue>):<fpage>1398</fpage>–<lpage>1407</lpage>.<pub-id pub-id-type="pmid">32096189</pub-id></mixed-citation>
      </ref>
      <ref id="cit0177">
        <label>177.</label>
        <mixed-citation publication-type="book"><string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>. <source><italic toggle="yes">Effect of Electroacupuncture on the Proliferation and Differentiation of Hippocampal Neural Stem Cells and Wnt Pathway in a Rat Model of Perimenopausal Depression [Article in Chinese]</italic></source> [<source>Doctorate thesis</source>]. <publisher-name>Liaoning University of Traditional Chinese Medicine</publisher-name>; <year>2017</year>.</mixed-citation>
      </ref>
      <ref id="cit0178">
        <label>178.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jing</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>. <article-title>Effect of electroacupuncture on Wnt/β-Catenin signaling pathway in hippocampus of perimenopausal depression rats model [article in Chinese]</article-title>. <source><italic toggle="yes">Chin Archiv TCM</italic></source>. <year>2018</year>;<volume>36</volume>(<issue>6</issue>):<fpage>1347</fpage>–<lpage>1350</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0179">
        <label>179.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Park</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>HJ</given-names></string-name>, et al. <article-title>Cyclized oligopeptide targeting LRP5/6-DKK1 interaction reduces the growth of tumor burden in a multiple myeloma mouse model</article-title>. <source><italic toggle="yes">Yonsei Med J</italic></source>. <year>2017</year>;<volume>58</volume>(<issue>3</issue>):<fpage>505</fpage>–<lpage>513</lpage>. doi:<pub-id pub-id-type="doi">10.3349/ymj.2017.58.3.505</pub-id><pub-id pub-id-type="pmid">28332354</pub-id></mixed-citation>
      </ref>
      <ref id="cit0180">
        <label>180.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qu</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Huan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>YY</given-names></string-name>, et al. <article-title>Involvement of Wnt/β-catenin signaling mediated hippocampal neurogenesis in sleep-deprivation induced memory impairment in mice [article in Chinese]</article-title>. <source><italic toggle="yes">Chin J Neuroanat</italic></source>. <year>2019</year>;<volume>35</volume>(<issue>02</issue>):<fpage>134</fpage>–<lpage>140</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0181">
        <label>181.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ables</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Breunig</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Eisch</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Rakic</surname>
<given-names>P</given-names></string-name>. <article-title>Not(ch) just development: notch signalling in the adult brain</article-title>. <source><italic toggle="yes">Nat Rev Neurosci</italic></source>. <year>2011</year>;<volume>12</volume>(<issue>5</issue>):<fpage>269</fpage>–<lpage>283</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn3024</pub-id><pub-id pub-id-type="pmid">21505516</pub-id></mixed-citation>
      </ref>
      <ref id="cit0182">
        <label>182.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>L</given-names></string-name>, et al. <article-title>The involvement of Notch1 signaling pathway in mid-aged female rats under chronic restraint stress</article-title>. <source><italic toggle="yes">Neurosci Lett</italic></source>. <year>2020</year>;<volume>738</volume>:<fpage>135313</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neulet.2020.135313</pub-id><pub-id pub-id-type="pmid">32827575</pub-id></mixed-citation>
      </ref>
      <ref id="cit0183">
        <label>183.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tian</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>Yi-nao-jie-yu prescription exerts a positive effect on neurogenesis by regulating Notch signals in the hippocampus of post-stroke depression rats</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>483</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00483</pub-id><pub-id pub-id-type="pmid">30386260</pub-id></mixed-citation>
      </ref>
      <ref id="cit0184">
        <label>184.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jalali</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bassuk</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Kan</surname>
<given-names>L</given-names></string-name>, et al. <article-title>HeyL promotes neuronal differentiation of neural progenitor cells</article-title>. <source><italic toggle="yes">J Neurosci Res</italic></source>. <year>2011</year>;<volume>89</volume>(<issue>3</issue>):<fpage>299</fpage>–<lpage>309</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jnr.22562</pub-id><pub-id pub-id-type="pmid">21259317</pub-id></mixed-citation>
      </ref>
      <ref id="cit0185">
        <label>185.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>L</given-names></string-name>. <article-title>Effect of electroacupuncture on expression of hippocampal Notch signaling pathway in rats with perimenopausal depression [article in Chinese]</article-title>. <source><italic toggle="yes">Liaoning J TCM</italic></source>. <year>2017</year>;<volume>44</volume>(<issue>3</issue>):<fpage>595</fpage>–<lpage>601</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0186">
        <label>186.</label>
        <mixed-citation publication-type="book"><string-name><surname>Mathews</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Epperson</surname>
<given-names>CN</given-names></string-name>. <part-title>Clinical management of menopause-related sleep disturbance</part-title>. In: <string-name><surname>Pal</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sayegh</surname>
<given-names>R</given-names></string-name>, editors. <source><italic toggle="yes">Essentials of Menopause Management</italic></source>. <publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2017</year>:<fpage>105</fpage>–<lpage>127</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0187">
        <label>187.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Davis</surname>
<given-names>SR</given-names></string-name>. <article-title>The Kupperman Index undressed</article-title>. <source><italic toggle="yes">Maturitas</italic></source>. <year>2019</year>;<volume>126</volume>:<fpage>90</fpage>–<lpage>91</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.maturitas.2019.04.219</pub-id><pub-id pub-id-type="pmid">31072622</pub-id></mixed-citation>
      </ref>
      <ref id="cit0188">
        <label>188.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Befus</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Coeytaux</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Goldstein</surname>
<given-names>KM</given-names></string-name>, et al. <article-title>Management of menopause symptoms with acupuncture: an umbrella systematic review and meta-analysis</article-title>. <source><italic toggle="yes">J Altern Complement Med</italic></source>. <year>2018</year>;<volume>24</volume>(<issue>4</issue>):<fpage>314</fpage>–<lpage>323</lpage>. doi:<pub-id pub-id-type="doi">10.1089/acm.2016.0408</pub-id><pub-id pub-id-type="pmid">29298078</pub-id></mixed-citation>
      </ref>
      <ref id="cit0189">
        <label>189.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jin</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>ZY</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Mi</surname>
<given-names>HQ</given-names></string-name>. <article-title>Discussion of the effect on ethology of perimenopausal syndrome rats by electroacupuncture in different periods [article in Chinese]</article-title>. <source><italic toggle="yes">CJTCMP</italic></source>. <year>2010</year>;<volume>25</volume>(<issue>10</issue>):<fpage>1689</fpage>–<lpage>1693</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0190">
        <label>190.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jin</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Mi</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>HF</given-names></string-name>. <article-title>Discussion of the best intervention time for electroacupuncture in treating rats with perimenopausal syndrome</article-title>. <source><italic toggle="yes">J Acupunct Tuina Sci</italic></source>. <year>2011</year>;<volume>9</volume>(<issue>5</issue>):<fpage>273</fpage>–<lpage>277</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11726-011-0530-4</pub-id></mixed-citation>
      </ref>
      <ref id="cit0191">
        <label>191.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ebrahimi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tayebi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Fatemeh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Akbarzadeh</surname>
<given-names>M</given-names></string-name>. <article-title>Investigation of the role of herbal medicine, acupressure, and acupuncture in the menopausal symptoms: an evidence-based systematic review study</article-title>. <source><italic toggle="yes">J Fam Med Prim Care</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>6</issue>):<fpage>2638</fpage>–<lpage>2649</lpage>. doi:<pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_1094_19</pub-id></mixed-citation>
      </ref>
      <ref id="cit0192">
        <label>192.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ee</surname>
<given-names>C</given-names></string-name>, <string-name><surname>French</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Xue</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Pirotta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Teede</surname>
<given-names>H</given-names></string-name>. <article-title>Acupuncture for menopausal hot flashes: clinical evidence update and its relevance to decision making</article-title>. <source><italic toggle="yes">Menopause</italic></source>. <year>2017</year>;<volume>24</volume>(<issue>8</issue>):<fpage>980</fpage>–<lpage>987</lpage>. doi:<pub-id pub-id-type="doi">10.1097/GME.0000000000000850</pub-id><pub-id pub-id-type="pmid">28350757</pub-id></mixed-citation>
      </ref>
      <ref id="cit0193">
        <label>193.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Alraek</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Birch</surname>
<given-names>S</given-names></string-name>. <article-title>Acupuncture in sham device controlled trials may not be as effective as acupuncture in the real world: a preliminary network meta-analysis of studies of acupuncture for hot flashes in menopausal women</article-title>. <source><italic toggle="yes">Acupunct Med</italic></source>. <year>2020</year>;<volume>38</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>44</lpage>. doi:<pub-id pub-id-type="doi">10.1136/acupmed-2018-011671</pub-id><pub-id pub-id-type="pmid">31517500</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
